CA1112644A - Dioxopyranoquinoline dicarboxylic acid derivatives - Google Patents
Dioxopyranoquinoline dicarboxylic acid derivativesInfo
- Publication number
- CA1112644A CA1112644A CA302,479A CA302479A CA1112644A CA 1112644 A CA1112644 A CA 1112644A CA 302479 A CA302479 A CA 302479A CA 1112644 A CA1112644 A CA 1112644A
- Authority
- CA
- Canada
- Prior art keywords
- compound
- formula
- group
- dioxo
- quinoline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- VQECVYMDHVGDEN-UHFFFAOYSA-N 4,5-dioxo-3H-pyrano[2,3-h]quinoline-2,3-dicarboxylic acid Chemical class O=C1C=2C(C(C(=NC2C=2C(=C1)OC=CC2)C(=O)O)C(=O)O)=O VQECVYMDHVGDEN-UHFFFAOYSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 claims abstract description 166
- 238000000034 method Methods 0.000 claims abstract description 42
- -1 5-tetrazolyl group Chemical group 0.000 claims abstract description 34
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 29
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 26
- 239000001257 hydrogen Substances 0.000 claims abstract description 26
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 17
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 150000002431 hydrogen Chemical class 0.000 claims abstract description 11
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 9
- 150000002367 halogens Chemical class 0.000 claims abstract description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 8
- 125000005518 carboxamido group Chemical group 0.000 claims abstract description 7
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 6
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 4
- 125000003884 phenylalkyl group Chemical group 0.000 claims abstract description 3
- 238000006243 chemical reaction Methods 0.000 claims description 52
- 239000002253 acid Chemical group 0.000 claims description 41
- 239000002904 solvent Substances 0.000 claims description 39
- 150000002148 esters Chemical class 0.000 claims description 35
- 150000003839 salts Chemical class 0.000 claims description 19
- 150000001408 amides Chemical class 0.000 claims description 12
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 11
- 150000004820 halides Chemical class 0.000 claims description 10
- 150000001540 azides Chemical class 0.000 claims description 9
- 239000012024 dehydrating agents Substances 0.000 claims description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 8
- 229920006395 saturated elastomer Polymers 0.000 claims description 8
- 230000003301 hydrolyzing effect Effects 0.000 claims description 6
- 125000002560 nitrile group Chemical group 0.000 claims description 6
- 150000008064 anhydrides Chemical class 0.000 claims description 5
- 230000007062 hydrolysis Effects 0.000 claims description 5
- 238000006460 hydrolysis reaction Methods 0.000 claims description 5
- ULRPISSMEBPJLN-UHFFFAOYSA-N 2h-tetrazol-5-amine Chemical compound NC1=NN=NN1 ULRPISSMEBPJLN-UHFFFAOYSA-N 0.000 claims description 4
- 150000001768 cations Chemical class 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- 230000002378 acidificating effect Effects 0.000 claims description 3
- 229910052783 alkali metal Chemical group 0.000 claims description 3
- 150000001340 alkali metals Chemical group 0.000 claims description 3
- 125000002947 alkylene group Chemical group 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- XOMFTESSIFMXOX-UHFFFAOYSA-N 10-bromo-4,6-dioxo-9h-pyrano[3,2-g]quinoline-2,8-dicarboxylic acid Chemical compound BrC1=C2NC(C(=O)O)=CC(=O)C2=CC2=C1OC(C(O)=O)=CC2=O XOMFTESSIFMXOX-UHFFFAOYSA-N 0.000 claims description 2
- 125000003368 amide group Chemical group 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052794 bromium Inorganic materials 0.000 claims description 2
- 125000002843 carboxylic acid group Chemical group 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 2
- 229910052720 vanadium Inorganic materials 0.000 claims description 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 4
- NXCBUWQFUFNEDL-UHFFFAOYSA-N 6H-pyrano[3,2-g]quinoline-2,8-dicarboxylic acid Chemical compound O1C(=CC=C2C=C3CC=C(N=C3C=C21)C(=O)O)C(=O)O NXCBUWQFUFNEDL-UHFFFAOYSA-N 0.000 claims 2
- OUQIFIWJMWDQFT-UHFFFAOYSA-N 1,10-dioxo-7H-pyrano[3,2-f]quinoline-3,8-dicarboxylic acid Chemical compound OC1=CC(=NC2=CC=C3C(=C12)C(C=C(O3)C(=O)O)=O)C(=O)O OUQIFIWJMWDQFT-UHFFFAOYSA-N 0.000 claims 1
- NMYAIMDQLXXFEM-UHFFFAOYSA-N 4,10-dioxo-3H-pyrano[2,3-h]quinoline-2,8-dicarboxylic acid Chemical compound O=C1CC(=NC2=C3C(=CC=C12)OC(=CC3=O)C(=O)O)C(=O)O NMYAIMDQLXXFEM-UHFFFAOYSA-N 0.000 claims 1
- HFVLQFQRPKKIKN-UHFFFAOYSA-N 7-(3-methylbutyl)-4,10-dioxopyrano[2,3-f]quinoline-2,8-dicarboxylic acid Chemical compound CC(CCN1C(=CC(C2=C3C(=CC=C12)C(C=C(O3)C(=O)O)=O)=O)C(=O)O)C HFVLQFQRPKKIKN-UHFFFAOYSA-N 0.000 claims 1
- JZOZWPOCSWDJKR-UHFFFAOYSA-N 9-(3-methylbutyl)-4,6-dioxopyrano[3,2-g]quinoline-2,8-dicarboxylic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=C1N(CCC(C)C)C(C(O)=O)=CC(=O)C1=C2 JZOZWPOCSWDJKR-UHFFFAOYSA-N 0.000 claims 1
- RTTSBFRIMCKSQF-UHFFFAOYSA-N 9-ethyl-10-propyl-2,8-bis(2H-tetrazol-5-yl)pyrano[3,2-g]quinoline-4,6-dione Chemical compound C(C)N1C(=CC(C2=CC3=C(C(=C12)CCC)OC(=CC3=O)C3=NN=NN3)=O)C3=NN=NN3 RTTSBFRIMCKSQF-UHFFFAOYSA-N 0.000 claims 1
- 229910052740 iodine Inorganic materials 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 61
- 230000003266 anti-allergic effect Effects 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 126
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 107
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 89
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 88
- 239000000047 product Substances 0.000 description 81
- 239000007787 solid Substances 0.000 description 61
- 239000000243 solution Substances 0.000 description 49
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 45
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 43
- 238000010992 reflux Methods 0.000 description 32
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 30
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 30
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 30
- 235000019439 ethyl acetate Nutrition 0.000 description 30
- 229940093499 ethyl acetate Drugs 0.000 description 29
- 239000003921 oil Substances 0.000 description 25
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
- 238000004949 mass spectrometry Methods 0.000 description 23
- 229960000583 acetic acid Drugs 0.000 description 20
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 19
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 17
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 16
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 16
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 16
- 229910052757 nitrogen Inorganic materials 0.000 description 16
- 229910052708 sodium Inorganic materials 0.000 description 16
- 239000011734 sodium Substances 0.000 description 16
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 15
- 238000005481 NMR spectroscopy Methods 0.000 description 15
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 15
- 235000019341 magnesium sulphate Nutrition 0.000 description 15
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 14
- 239000012362 glacial acetic acid Substances 0.000 description 14
- 239000003208 petroleum Substances 0.000 description 14
- 239000002244 precipitate Substances 0.000 description 14
- 239000011541 reaction mixture Substances 0.000 description 14
- 239000000741 silica gel Substances 0.000 description 13
- 229910002027 silica gel Inorganic materials 0.000 description 13
- 229960001866 silicon dioxide Drugs 0.000 description 13
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 12
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 11
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 11
- 238000001704 evaporation Methods 0.000 description 11
- 230000008020 evaporation Effects 0.000 description 11
- 150000002500 ions Chemical class 0.000 description 11
- 238000003756 stirring Methods 0.000 description 11
- 238000001035 drying Methods 0.000 description 10
- 238000001914 filtration Methods 0.000 description 10
- 238000004611 spectroscopical analysis Methods 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 9
- 239000003039 volatile agent Substances 0.000 description 9
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- 239000003054 catalyst Substances 0.000 description 8
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 8
- 229920000137 polyphosphoric acid Polymers 0.000 description 8
- WHSSOGYCQXMHCL-UHFFFAOYSA-N quinoline-2,8-dicarboxylic acid Chemical compound C1=CC=C(C(O)=O)C2=NC(C(=O)O)=CC=C21 WHSSOGYCQXMHCL-UHFFFAOYSA-N 0.000 description 8
- 235000017557 sodium bicarbonate Nutrition 0.000 description 8
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 8
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 7
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- 229910000104 sodium hydride Inorganic materials 0.000 description 7
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 6
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 229960004132 diethyl ether Drugs 0.000 description 6
- WYACBZDAHNBPPB-UHFFFAOYSA-N diethyl oxalate Chemical compound CCOC(=O)C(=O)OCC WYACBZDAHNBPPB-UHFFFAOYSA-N 0.000 description 6
- VHILMKFSCRWWIJ-UHFFFAOYSA-N dimethyl acetylenedicarboxylate Chemical compound COC(=O)C#CC(=O)OC VHILMKFSCRWWIJ-UHFFFAOYSA-N 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 6
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- 239000012044 organic layer Substances 0.000 description 6
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 6
- 239000012312 sodium hydride Substances 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 5
- 229910021529 ammonia Inorganic materials 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 5
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 5
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 4
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- JPJALAQPGMAKDF-UHFFFAOYSA-N selenium dioxide Chemical compound O=[Se]=O JPJALAQPGMAKDF-UHFFFAOYSA-N 0.000 description 4
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 3
- 230000005526 G1 to G0 transition Effects 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- XDXHAEQXIBQUEZ-UHFFFAOYSA-N Ropinirole hydrochloride Chemical compound Cl.CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2 XDXHAEQXIBQUEZ-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 125000003282 alkyl amino group Chemical group 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- 238000002011 beta-particle spectroscopy Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 125000001309 chloro group Chemical group Cl* 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 125000004185 ester group Chemical group 0.000 description 3
- JUINSXZKUKVTMD-UHFFFAOYSA-N hydrogen azide Chemical compound N=[N+]=[N-] JUINSXZKUKVTMD-UHFFFAOYSA-N 0.000 description 3
- 239000002198 insoluble material Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 229910021653 sulphate ion Inorganic materials 0.000 description 3
- 239000001117 sulphuric acid Substances 0.000 description 3
- 235000011149 sulphuric acid Nutrition 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- XNMQEEKYCVKGBD-UHFFFAOYSA-N 2-butyne Chemical group CC#CC XNMQEEKYCVKGBD-UHFFFAOYSA-N 0.000 description 2
- ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical compound C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical group O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- XTEGARKTQYYJKE-UHFFFAOYSA-M Chlorate Chemical compound [O-]Cl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-M 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- YKIOKAURTKXMSB-UHFFFAOYSA-N adams's catalyst Chemical compound O=[Pt]=O YKIOKAURTKXMSB-UHFFFAOYSA-N 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000001342 alkaline earth metals Chemical class 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- 235000010290 biphenyl Nutrition 0.000 description 2
- 125000006267 biphenyl group Chemical group 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- PYRZPBDTPRQYKG-UHFFFAOYSA-N cyclopentene-1-carboxylic acid Chemical compound OC(=O)C1=CCCC1 PYRZPBDTPRQYKG-UHFFFAOYSA-N 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 150000005690 diesters Chemical class 0.000 description 2
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- TWAOQVMPIYQPKG-UHFFFAOYSA-N ethanone Chemical compound C[C+]=O TWAOQVMPIYQPKG-UHFFFAOYSA-N 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 229960002523 mercuric chloride Drugs 0.000 description 2
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 2
- UKWHYYKOEPRTIC-UHFFFAOYSA-N mercury(ii) oxide Chemical compound [Hg]=O UKWHYYKOEPRTIC-UHFFFAOYSA-N 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- WTEVQBCEXWBHNA-YFHOEESVSA-N neral Chemical compound CC(C)=CCC\C(C)=C/C=O WTEVQBCEXWBHNA-YFHOEESVSA-N 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000009158 reflex pathway Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 229910001923 silver oxide Inorganic materials 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- XTHPWXDJESJLNJ-UHFFFAOYSA-N sulfurochloridic acid Chemical compound OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 2
- IRFHMTUHTBSEBK-QGZVFWFLSA-N tert-butyl n-[(2s)-2-(2,5-difluorophenyl)-3-quinolin-3-ylpropyl]carbamate Chemical compound C1([C@H](CC=2C=C3C=CC=CC3=NC=2)CNC(=O)OC(C)(C)C)=CC(F)=CC=C1F IRFHMTUHTBSEBK-QGZVFWFLSA-N 0.000 description 2
- 125000004299 tetrazol-5-yl group Chemical group [H]N1N=NC(*)=N1 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 238000001665 trituration Methods 0.000 description 2
- LZDKZFUFMNSQCJ-UHFFFAOYSA-N 1,2-diethoxyethane Chemical compound CCOCCOCC LZDKZFUFMNSQCJ-UHFFFAOYSA-N 0.000 description 1
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 1
- ZQXCQTAELHSNAT-UHFFFAOYSA-N 1-chloro-3-nitro-5-(trifluoromethyl)benzene Chemical compound [O-][N+](=O)C1=CC(Cl)=CC(C(F)(F)F)=C1 ZQXCQTAELHSNAT-UHFFFAOYSA-N 0.000 description 1
- DCYGAPKNVCQNOE-UHFFFAOYSA-N 2,2,2-triphenylacetic acid Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)O)C1=CC=CC=C1 DCYGAPKNVCQNOE-UHFFFAOYSA-N 0.000 description 1
- RIZUCYSQUWMQLX-UHFFFAOYSA-N 2,3-dimethylbenzoic acid Chemical compound CC1=CC=CC(C(O)=O)=C1C RIZUCYSQUWMQLX-UHFFFAOYSA-N 0.000 description 1
- OXQGTIUCKGYOAA-UHFFFAOYSA-N 2-Ethylbutanoic acid Chemical compound CCC(CC)C(O)=O OXQGTIUCKGYOAA-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- ZLBRYWTYPCYOKF-UHFFFAOYSA-N 2-hydroxy-1-phenylpentan-1-one Chemical compound CCCC(O)C(=O)C1=CC=CC=C1 ZLBRYWTYPCYOKF-UHFFFAOYSA-N 0.000 description 1
- ZWVHTXAYIKBMEE-UHFFFAOYSA-N 2-hydroxyacetophenone Chemical compound OCC(=O)C1=CC=CC=C1 ZWVHTXAYIKBMEE-UHFFFAOYSA-N 0.000 description 1
- QRAFJHXNLQTXQW-UHFFFAOYSA-N 2-methylpropyl hydrogen carbonate Chemical compound CC(C)COC(O)=O QRAFJHXNLQTXQW-UHFFFAOYSA-N 0.000 description 1
- ZGKVRYOUJKEBAL-UHFFFAOYSA-N 2h-chromen-2-amine Chemical compound C1=CC=C2C=CC(N)OC2=C1 ZGKVRYOUJKEBAL-UHFFFAOYSA-N 0.000 description 1
- GSSXLFACIJSBOM-UHFFFAOYSA-N 2h-pyran-2-ol Chemical compound OC1OC=CC=C1 GSSXLFACIJSBOM-UHFFFAOYSA-N 0.000 description 1
- QVSKZDSGYNUVEC-UHFFFAOYSA-N 3-(ethylamino)-2-propylphenol Chemical compound CCCC1=C(O)C=CC=C1NCC QVSKZDSGYNUVEC-UHFFFAOYSA-N 0.000 description 1
- FLROJJGKUKLCAE-UHFFFAOYSA-N 3-amino-2-methylphenol Chemical compound CC1=C(N)C=CC=C1O FLROJJGKUKLCAE-UHFFFAOYSA-N 0.000 description 1
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- 125000004208 3-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C([H])C(*)=C1[H] 0.000 description 1
- DMAYBPBPEUFIHJ-UHFFFAOYSA-N 4-bromobut-1-ene Chemical compound BrCCC=C DMAYBPBPEUFIHJ-UHFFFAOYSA-N 0.000 description 1
- KXFBGXZEKANBLZ-UHFFFAOYSA-M 4-ethoxy-4-oxobut-2-ynoate Chemical compound CCOC(=O)C#CC([O-])=O KXFBGXZEKANBLZ-UHFFFAOYSA-M 0.000 description 1
- RSIWALKZYXPAGW-NSHDSACASA-N 6-(3-fluorophenyl)-3-methyl-7-[(1s)-1-(7h-purin-6-ylamino)ethyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one Chemical compound C=1([C@@H](NC=2C=3N=CNC=3N=CN=2)C)N=C2SC=C(C)N2C(=O)C=1C1=CC=CC(F)=C1 RSIWALKZYXPAGW-NSHDSACASA-N 0.000 description 1
- RBWNDBNSJFCLBZ-UHFFFAOYSA-N 7-methyl-5,6,7,8-tetrahydro-3h-[1]benzothiolo[2,3-d]pyrimidine-4-thione Chemical compound N1=CNC(=S)C2=C1SC1=C2CCC(C)C1 RBWNDBNSJFCLBZ-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- IVRMZWNICZWHMI-UHFFFAOYSA-N Azide Chemical compound [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 206010006440 Bronchial obstruction Diseases 0.000 description 1
- 241000237074 Centris Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 101100285518 Drosophila melanogaster how gene Proteins 0.000 description 1
- 239000004150 EU approved colour Substances 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- 208000035126 Facies Diseases 0.000 description 1
- 206010017943 Gastrointestinal conditions Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 238000006898 Intramolecular Friedel-Crafts reaction Methods 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- LOMVENUNSWAXEN-UHFFFAOYSA-N Methyl oxalate Chemical compound COC(=O)C(=O)OC LOMVENUNSWAXEN-UHFFFAOYSA-N 0.000 description 1
- 238000006845 Michael addition reaction Methods 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 208000009793 Milk Hypersensitivity Diseases 0.000 description 1
- 201000010859 Milk allergy Diseases 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- ATTZFSUZZUNHBP-UHFFFAOYSA-N Piperonyl sulfoxide Chemical compound CCCCCCCCS(=O)C(C)CC1=CC=C2OCOC2=C1 ATTZFSUZZUNHBP-UHFFFAOYSA-N 0.000 description 1
- PQUGCKBLVKJMNT-UHFFFAOYSA-N SC560 Chemical compound C1=CC(OC)=CC=C1N1C(C=2C=CC(Cl)=CC=2)=CC(C(F)(F)F)=N1 PQUGCKBLVKJMNT-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000212342 Sium Species 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- JVVXZOOGOGPDRZ-SLFFLAALSA-N [(1R,4aS,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthren-1-yl]methanamine Chemical compound NC[C@]1(C)CCC[C@]2(C)C3=CC=C(C(C)C)C=C3CC[C@H]21 JVVXZOOGOGPDRZ-SLFFLAALSA-N 0.000 description 1
- UCTLHLZWKJIXJI-LXIBVNSESA-N [(3s,8r,9s,10r,13s,14s)-17-chloro-16-formyl-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1h-cyclopenta[a]phenanthren-3-yl] acetate Chemical compound C([C@@H]12)C[C@]3(C)C(Cl)=C(C=O)C[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)C)C1 UCTLHLZWKJIXJI-LXIBVNSESA-N 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 125000000777 acyl halide group Chemical group 0.000 description 1
- 150000001266 acyl halides Chemical class 0.000 description 1
- 125000005041 acyloxyalkyl group Chemical group 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 1
- UAZDIGCOBKKMPU-UHFFFAOYSA-O azanium;azide Chemical compound [NH4+].[N-]=[N+]=[N-] UAZDIGCOBKKMPU-UHFFFAOYSA-O 0.000 description 1
- 125000003943 azolyl group Chemical group 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- YTIVTFGABIZHHX-UHFFFAOYSA-N butynedioic acid Chemical compound OC(=O)C#CC(O)=O YTIVTFGABIZHHX-UHFFFAOYSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- XTEGARKTQYYJKE-UHFFFAOYSA-N chloric acid Chemical compound OCl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-N 0.000 description 1
- 229940005991 chloric acid Drugs 0.000 description 1
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 1
- OTAFHZMPRISVEM-UHFFFAOYSA-N chromone Chemical compound C1=CC=C2C(=O)C=COC2=C1 OTAFHZMPRISVEM-UHFFFAOYSA-N 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N citral A Natural products CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229910052681 coesite Inorganic materials 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 229910052906 cristobalite Inorganic materials 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 229930007927 cymene Natural products 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 1
- 150000004683 dihydrates Chemical class 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical compound CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 description 1
- 125000005677 ethinylene group Chemical group [*:2]C#C[*:1] 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 150000002237 fumaric acid derivatives Chemical class 0.000 description 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 201000005298 gastrointestinal allergy Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 125000001145 hydrido group Chemical group *[H] 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 108010054330 hydrolysin Proteins 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 201000001371 inclusion conjunctivitis Diseases 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- ACKFDYCQCBEDNU-UHFFFAOYSA-J lead(2+);tetraacetate Chemical compound [Pb+2].CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O ACKFDYCQCBEDNU-UHFFFAOYSA-J 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- GUWHRJQTTVADPB-UHFFFAOYSA-N lithium azide Chemical compound [Li+].[N-]=[N+]=[N-] GUWHRJQTTVADPB-UHFFFAOYSA-N 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- LBSANEJBGMCTBH-UHFFFAOYSA-N manganate Chemical compound [O-][Mn]([O-])(=O)=O LBSANEJBGMCTBH-UHFFFAOYSA-N 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940101209 mercuric oxide Drugs 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- BRMYZIKAHFEUFJ-UHFFFAOYSA-L mercury diacetate Chemical compound CC(=O)O[Hg]OC(C)=O BRMYZIKAHFEUFJ-UHFFFAOYSA-L 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- ILLSOBRFRPADIT-UHFFFAOYSA-N methyl 6-acetyl-1-but-3-enyl-7-hydroxy-4-oxo-8-propylquinoline-2-carboxylate Chemical compound C(C)(=O)C=1C=C2C(C=C(N(C2=C(C=1O)CCC)CCC=C)C(=O)OC)=O ILLSOBRFRPADIT-UHFFFAOYSA-N 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- LTLVDDLKVWMGQV-UHFFFAOYSA-N n-(4-acetyl-3-hydroxy-2-propylphenyl)acetamide Chemical compound CCCC1=C(O)C(C(C)=O)=CC=C1NC(C)=O LTLVDDLKVWMGQV-UHFFFAOYSA-N 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- KERBAAIBDHEFDD-UHFFFAOYSA-N n-ethylformamide Chemical compound CCNC=O KERBAAIBDHEFDD-UHFFFAOYSA-N 0.000 description 1
- 235000000010 nanu Nutrition 0.000 description 1
- 244000082862 nanu Species 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- RQTOOFIXOKYGAN-UHFFFAOYSA-N nedocromil Chemical compound CCN1C(C(O)=O)=CC(=O)C2=C1C(CCC)=C1OC(C(O)=O)=CC(=O)C1=C2 RQTOOFIXOKYGAN-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940099990 ogen Drugs 0.000 description 1
- 229940006093 opthalmologic coloring agent diagnostic Drugs 0.000 description 1
- 150000002892 organic cations Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 150000003901 oxalic acid esters Chemical class 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000006400 oxidative hydrolysis reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- PAYRUJLWNCNPSJ-UHFFFAOYSA-O phenylazanium Chemical compound [NH3+]C1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-O 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- ATBFWDFURWPLLX-UHFFFAOYSA-O piperidin-1-ium;azide Chemical class [N-]=[N+]=[N-].C1CC[NH2+]CC1 ATBFWDFURWPLLX-UHFFFAOYSA-O 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- CHKVPAROMQMJNQ-UHFFFAOYSA-M potassium bisulfate Chemical compound [K+].OS([O-])(=O)=O CHKVPAROMQMJNQ-UHFFFAOYSA-M 0.000 description 1
- 239000001120 potassium sulphate Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- LYYKXLNKDJVDPU-UHFFFAOYSA-N pyrano[2,3-h]quinolin-2-one Chemical class O1C=CC=C2C3=NC(=O)C=CC3=CC=C21 LYYKXLNKDJVDPU-UHFFFAOYSA-N 0.000 description 1
- ZWRPFWFOCBFFRE-UHFFFAOYSA-N quinoline-2,8-dicarboxamide Chemical compound C1=CC=C(C(N)=O)C2=NC(C(=O)N)=CC=C21 ZWRPFWFOCBFFRE-UHFFFAOYSA-N 0.000 description 1
- QRDZFPUVLYEQTA-UHFFFAOYSA-M quinoline-8-carboxylate Chemical compound C1=CN=C2C(C(=O)[O-])=CC=CC2=C1 QRDZFPUVLYEQTA-UHFFFAOYSA-M 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- CMXPERZAMAQXSF-UHFFFAOYSA-M sodium;1,4-bis(2-ethylhexoxy)-1,4-dioxobutane-2-sulfonate;1,8-dihydroxyanthracene-9,10-dione Chemical compound [Na+].O=C1C2=CC=CC(O)=C2C(=O)C2=C1C=CC=C2O.CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC CMXPERZAMAQXSF-UHFFFAOYSA-M 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 230000003019 stabilising effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229910052682 stishovite Inorganic materials 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 239000004291 sulphur dioxide Substances 0.000 description 1
- 235000010269 sulphur dioxide Nutrition 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 229940066769 systemic antihistamines substituted alkylamines Drugs 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- UGNWTBMOAKPKBL-UHFFFAOYSA-N tetrachloro-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(Cl)=C(Cl)C1=O UGNWTBMOAKPKBL-UHFFFAOYSA-N 0.000 description 1
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 1
- 206010044325 trachoma Diseases 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229910052905 tridymite Inorganic materials 0.000 description 1
- JFALSRSLKYAFGM-UHFFFAOYSA-N uranium(0) Chemical compound [U] JFALSRSLKYAFGM-UHFFFAOYSA-N 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Abstract
DIOXOPYRANOQUINOLINE DICARBOXYLIC ACID DERIVATIVES
ABSTRACT
There are described compounds of formula I
I
in which an adjacent pair of R5, R6, R7 and R8 form a chain -COCH=CE-O-, and the remainder of R5, R6, R7 and R8, which may be the same or different, each represent hydrogen, hydroxy, alkyl, halogen, alkenyl, alkoxy, or -NR1R2 in which R1 and R2, which are the same or different, are each hydrogen or alkyl, Rg is hydrogen, alkyl, alkenyl or phenyl-alkyl, and E is -COOH, a 5-tetrazolyl group or an (N-tetra-5-yl) carboxamido group, and phrmaceutically acceptable derivatives thereof.
There are also described processes for making the compounds and pharmaceutical, e.g. anti-allergic, compositions containing the compounds.
ABSTRACT
There are described compounds of formula I
I
in which an adjacent pair of R5, R6, R7 and R8 form a chain -COCH=CE-O-, and the remainder of R5, R6, R7 and R8, which may be the same or different, each represent hydrogen, hydroxy, alkyl, halogen, alkenyl, alkoxy, or -NR1R2 in which R1 and R2, which are the same or different, are each hydrogen or alkyl, Rg is hydrogen, alkyl, alkenyl or phenyl-alkyl, and E is -COOH, a 5-tetrazolyl group or an (N-tetra-5-yl) carboxamido group, and phrmaceutically acceptable derivatives thereof.
There are also described processes for making the compounds and pharmaceutical, e.g. anti-allergic, compositions containing the compounds.
Description
z6~49L 02JB/87 B~ 18957/77 This invention relates to new pyranoquinolinone derivatives, composi~ions containing them and methods -for thsir prepa~ation.
~cording to our invention ~e provide compounds of formula I, R
8 Rg in which an adjacent pair of R5, R6, R7 and R8 form a chain -COCH= OE-0-, and the remainder of R5, R6, ~ and R8, which may be the same or different, each ~epresent hydrogen, hydrox~, -) ~ alkyl, halogen~ alkenyl, alkoxy, or - ~ ~ in which ~ and ~ , which are the same or different, are each hydrogen or alkyl, Rg is-hydrogen, alkyl, alkenyl or phenyl-alkyl, and :~
E is -COOH, a 5-tetrazolyl group or an (N-tetrazol-5-yl~
car~oxamido group, and pharmaceutically acceptable derivatives thereof.
According to our invention we also provide a p~ocess for ~he production of a compound of ~ormula I, or a pharmaceutically acceptable derivative thereo~, which comprises, (a~ producing a compound of formwla I in which E is -CCC~I by se~ectively hydrolysing or oxidising a compound of formula II, ,;, " ,'.
'' ' ': ,, : ,' ,, :~, ~` :
- 3 - ..
R
R6a~
R8a Rg S in which Rg is as defined above, R5a, ~a, R7a and R8a have the sa~e significances as R5, R6, R7 and R8 above, save 1:han an adjacen,t pair of R5aJ R6a, R7a i, - and ~a may represent a chain of ~ormula -OOCH-C~Dl)O, and one or both of D and Dl represents a group hydrolysable or oxidisable to a ~ group, and the other may represent a -COOH
grou~ 9 ~b) producing a co~olmd o:f fonmlla I ~n which E is -COCH by cyclising a con~pound of fo~la III or IVJ -~
~5b 1- ~b III
Rg Rb ~0 5 R6b ~ ~COC~I
R7b ~ ~ COOH
~8b Rg 25or all ester of ei~er thereo~, .
in which Rg is as defined above, R5b, ~ b, ~ ~nd ~ have the sam~ significances as R5, R6, '~ R7 and ~ abo~e, save that an adjacent pair of R5b9 R6b7 R7b an~
~b may represent ~he pair of groups -H and -O-C~GOOH)=CH-oOOH, (c~ producin$ a compound of formula I in which E is -COOH by cyclising a compound of formula V, :, .
~ ~ R5c o lo .J~;J~, co~ V
:~` ' R8C Ig `~
or an ester thereof, m which Rg is as defined above, .~ .
~C9 ~C, R7c and R8c have ~he s2me signi~icances as R5~ Rs, . 15 ~ and ~ above sa~e that an adjacent pair of R5c, ~ c5 R7c and ~ c, instead of forming a chain -COCH=C(oOOH)-O-~ represent the : pairs of groups: _ _ ti~ - ~ OO-COR~' or -OOCH=CtOOOH)-NLlL2, or a sui~able ; derivative thereof; and -CM or a halogen atom, or (ii) -H and -O-C(~OR")=CH-OOR"
~" represents -CM~ or a group which is hydrolysable thereto, and L2 ~hich may be the same or different are each hydrogen, aryl or alkyl9 or together form a saturatea or unsaturated alkylene chain, and M represents hydrogen or an al~ali metal, 05/B/87 ;
6~ .
: and if necessary or desired hydrolysing the group -COR", to :
a group -COOM, ~d) con~ersion of a compound of for~ula Vl, d ~ ~ O
E Vl d Rg or an ester thereof, in which Rg and E are as defined above, R~d, R6d, R7d and R8d have the same significances as R5, R6, 1?7 and R8 above save that an adjacent pc.ir of R~d, R6d, R7d and d ~ay represent ~he chain -C(~o)CH=cE-o-, at least one of the pairs of groups ~ and Rlo together 15 forn a =S or together ~orm an -S(~)nS- chaLn in which n is 2 or 39 .~nd the other pair ~ , ~ O may lepresent =0, ~o a corresponding compound of formu~a I, ~ (e3 selecti~ely removing the group5 A and B from a compound o~
- ~ormula VII; ~ e O
~ e ~ - H VII
R8~ Rg or an ester thereof~
in which Rg and E are as defined above, ~ 5 -r~ ' .
,,, , , ,.' , .
06/B/&7 , =~_ .
R5e, R6e, R7e and R8e have the same si ~ -~icances as R5, R6, and ~ above save ~hat an adjacen pair of R5e, R6e, ~ e and e may represent a chain -00CHA-CBE-0-7 in at least one o~ the pairs of groups A and B both A and B .
~; 5 a~e hydrogen, or one of A and B is hydrogen and the o~her is halogen OT hydroxy9 and the o~her pair A5 B may together form a douhle bond, (f) producing a compound of ~ormula I in which F. is -COOH by .
- ~yclising a compound of ~ormula VIII, ~ ~CiOIl VIII
or an es~er thereof~
in which Rg is as def m ed abuv~ f, R6f~ R7f and ~ f have the same significances a~ R5, R63 R7 ~nd R8 above save~hat an adjacent pair of R5f, ~Of, ~ f and ~ f, ~ tead of forming a chain -COCH=C(COCH)-O-, represen~ ~he pai~ of groups -CoCH(S0 ~ 0~-CH(OH)-oOOR" and -CM, ~" and ~ are as defined above, and ~ 0 represents an alkyl C 1 to 10 group, (g) producing a compound of formula I in which E is a 5-tet~azolyl group by reacting a corresponding compound of formula I in which E is -CN.
,, , , , , ~ - , with an azide in a solvent which is inert under the reaction : conditions, (h) producing a compound of formula I in which E is an (N-tetra-zol-5-yl)carboxamido group by reaGting a corresponding compound ; 5 of formula I in which E is -COOH, or an acid halide, ester or mixed anhydride thereof, with 5-aminotetrazole, or (i) producing a pharmaceutically acceptable salt of a compound of formula I, by treating a compound of formula Ic, R7~ ~ ~ X
R~j Rg in which Rg is as defined above, R5j~ ~6i, R7j and R8j have the same significances as R5, R6, R7 and R~ above, save that an adjacent pair of R5j, R6j, R7j and R8j may form a chain -O-C(X)=CHCO-, and X is a 5-tetrazolyl group, an (N-tetrazol-5-yl) carboxamido group, a carboxylic acid group (or an ester thereof, or another salt thereof), a nitrile group, an acid halide group or an amide group, with a compound containing an available pharmaceutically acceptable cation and capable of converting the group X to a pharmaceutically accep-table salt of group E, and if neeessary or desired hydrolysin~ the ester of the compolmd of formula I and/or converting the compound of formula I to a pharmaceutically aceeptable derivative thereof.
' ''; :; : . : ' - 7a -In process (a) the group D may be, for example an ester, acid halide, amide or a nitrile group, which may be hydrolysed to a -COOH yroup. The hydrolysis may be carried out using conventional techniques, for example under mildly basic conditions, e.g. using sodium carbonate, sodium hydroxide, sodium bicarbonate, or under acidic conditions, e.g. a mixture of aqueous dioxan and hydrochIoric acid, or hydrogen bromide in acetic acid. The hydrolysis may be carried out at a temperature of from about 25 to 120C depending on the compounds used.
~lternatively the ~roup D may be an alkyl, e.g. a lower alkyl such as methyl, a hydroxymethyl, an aralkenyl, e.g. styryl, an acyl, e.g. a lower alkanoyl such as acetyl, or a formyl group. -;
The oxidation may be carried out using conventional techniques ~;-which do not otherwise modify the molecule to such an extent that the yield of the desired product is uneconomical, for example an . . . . . . . . . . . . . . . . . . . . . . . . . .
- 7a -..... ,:
..~ .
"
... ..
64~4 alkyl or a hydroxy~e~hyl group may be oxidised using selenium : dioxide, e.g. under re1ux in aqueous dioxan; or chromic acid, - e.g. under reflux in aqueous acetic acid. Aralke~yl groups may be oxidised using~ ~or ex ~ le neutral o~ alkaline potassium ~:
5 pe~manganate in aqueous ethanol, and aey7 groups may be oxidised :
using, for example c~romic acid or a~ aqueous hypochlorite, e.g. .
sodium hypochlorite. The formyl group may be oxidised using, . for example ~hromic acid or silver oxide.
In process Cb) ~he eyclisation may ~e carried out by treating the compound of formula III or IY, with a cyclising agent, for example a dbhydra~ing agent such as chlorosulphonic, sulphuric o~ polyphosphoric acid. The reaction is preferably car~ied out under anhydrous conditions and may be carried out at a temperature of from abou~ 25 to 150, and preferably from 75 to 150C~ We have found that isomerisation of *he maleic acid der;vative of foxmula rv to the corTesponding fumarîc ad d derivati~e of . ...
formNla III *akes place when polyphosphoric acid is used to cyclise ~hese co ~ unds to a compound of ~ormula 1, ~hus enabling a satisfactory yield of the compound of formula I to be obtained from a ~ facie unsatlsfactory mixbure of s~mpounds of fo~mulae III and rv. Compounds of formula III ma~ also be cyclised by subjecting the compound to an ele~ated temperature, e.g. of from 200 to 250C, optio~ally in the presence of a hi~h boiling solYent which is inert under ~he reaction conditions, e.g. diphenyl e.~her~
: 25 When one of the groups is -oM the ~yclisation of p~ocess 09/~/87 :~ - 9 - :
tc)ti) may be carried out by heating, or under basic or neu~raI
conditioDs. It is however preferred to carry out the cyclisation in ~he presence of an acid~ e.g hydrochloric acid, and in a solvent which is inert under the reacti~n conditions, e.g ethanol~
The reaction may be carried out at from about 20~ to 150C The .
group -COR" is preferably an ester group, e.g R" may be a lower alko~y group. When one of the groups is COCH=C~COOH3-NLlL2 the deriva~ive o~ the -COOH group may be a group -CONLlL2 in which L
and L2 are as defined above. It is preferred that Ll and L2 are hyd~ogen~ phenyl, alXyl C 1 to 6 or together form a 4 or 5 - membered alkylene chain, e.g. together with the nitrogen atom foTm a piperidine ringO When one of the gro ~ s is halogen the - cyclîsation mar be carTied out in a solvent which is inert und~er the reac~îon conditîons, pre~erably a high boiling polar solven~; -e~g pyridine, dimethyl~ormamide or hexamethylphssphoramide. The : neactîo~ is preferably carried out wn~h ~he aid ~f a strong base, ~or example a~ alkali m~tal-hydride, e.g sodium hydride~ me ~~- ~ -eaction is prefera~ly carried ou~ at a temperature of from about 80 *o 200C, In ~he absenre of ~ree oxygen, e.g under an inert atmosphere .such as nitrogen. ~-lhe cyclisation of process (c~ (ii) may be carried out by treating the compound of ~ormula V wqth a cyclising agent7 for example a dehydrating agent such as chlorosulphonic~ polyphosphoric or sulphuric acid. The reaction is pre~eTably carried out under anhydrous conditions and may be carried out at a temperature o~
....... , . . ~ . ~
. : ~ . . ... ~ ~
:: :
rom 0 to 1Q0C. Alternatiyely cyclisation may be achieved by converting the free carboxy groups of ~he co~pound of formula V
to acyl halide groups and subjeting the resulting acyl halide *o an intramolecular Friedel-Crafts reaction.
In processes (d), when ~ and ~ O together forn a cha m -S-( ~ 3~-S-, ~he conve~sion may comprise oxidative hydrolysis and may be carried out in an aqueous polar organic solvent, for example aqueous ethanol, acetone or tetrahydrofuran. The oxidati~e hydrolysis may be carried ou~ in the presence of an oxidising agent, for example mercuric chloride, an N-halosuccin-imide such as N-brono- or N-chloro-succinimide, a per acid such as periodic acid; or ~-toluenesulphonchloramide or a salt - thereof. When mercuric chloride is used the reaction may b~
carried out in the presence o a base, e.g. mercuric oxide, cadmi~n carbonate or calcium carbonate. N-halosuccinimides may be used alolle or in the presence of a sil~r salt, e.g. silver perchlorate, or sll~er nitrate. The reaction ~ay conveniently be carried out at a temperature of from abou~ 15 to 100C.
When ~ and ~ 0 together form a =S group the conversion may co~prise (oxidative) hrdrolysis and may be carried out in the presence of a heavy metal compound, e.g a compound of group Ib~
IIb or IIIb of the Periodic Table of Mendeleef, as catalyst.
Suitable compounds include mercury, ~hallium and sil~er compounds, e.g. mercury (II) acetate or chloride, ~hallium (III~ trifluoro-acetate, or silver oxide. The reaction may be carried out in the ` '' ' ' " ' ~
' '' ' ' ~
ll~B/87 presence o water and an organic sol~ent system such as acetone-acetic acid9 alkanols,-tetrahydrofuran/methanol, or tetrahydro-furan. Alternatively the ~eaction ma~ be carried out by alkylation ~ollawed by hydroly~is. In such cases the reaction may be ef~ected 5 by (i) an alkyl halicle or sulphonate (e.g. methyl iodide~J in a moist solvent, e.g. acetone, (ii~ an alkylfluorosulphonate and water m sulphur dioxide, or (iii) a trialkyl oxonium fluoroborate followed by aqueous sodium hydroxide.
~hen both A and B are hydrogen process (e) is a dehydrogenation and may be carried out by oxidation using a nald oxidising agent~ ~or example selenium dioxide, palladium blac~
chloranil, lead tetraacetate or triphenyl nethyl pe~chlorate.
Alternatively the dehydI~genation of a compound of formwla VII in which both A and B are hydrogen may be carried out indirectly by 15 halogenation ~ollo~ed by dehydTohalogenation, e.g. by treatment with N~brom~succinimlde or pyridim um bromade perbromide ~o yield a compound of fo~mula VII in which A is halogen and B is hydro~en, ~hich is subsequen~ly dehydrobromanated. I~hen one of A and B i5 hydroxy ~he dehydration may be catalysed by an acid, e~gO sulphuric or oxalic acid; a base, e.g. potassium hydroxide; or a salt, e.g. potassium hydrogen sulphate; or N b~omosuccinimide. The reaction may be carried out in a solvent which is mert under the reaction conditions7 e.g. a halogenated ~ydroca~bon, xylene, or glacial acetic acid. The reaction may be carried out at an elevated temperat-ure, e.g. ~rom 20 to 150C.
. .
, 12 ~L~L2 6~
The cyclisa~ion o~ process (f3 may be carried out in a solvent which is inert under the reac~ion conditions9 e.g.
diethyl e~her or benzene. The reaction may also, if desired, be carried ou~ in the presence of a Lewis acid, e.g. boron 5 trifluoride. The reaction is preferably carried out at a temperature of from 10 to 120~ in presence of an organic base, .g. piperidene.
Suitable solvents which are inert under the reaction conditions of process (g) include those in which both the reagents are soluble, e.gO N,N-dimethylformamide. Other solvents which may be mentioned include dimethylsulphoxide, tetrahydro~uran~ diethyl glycol and ethyl me~hyl glycol. The reaction is pre~erably car~ied out at a temperature of from about 20 to 130C ~or from about 1 to 20 hours~
~he azide used in ~he reaction is preerably ammonium or an alkali 15- metal azide, e.g. sodium or lithium azide~ but other azides, e.g.
alumlnium azid~ or the azides of nitrogen cont ~ ng bases9 eOg.
m~no-, di-, tri-, and tetra- me~hyl- ammonium, anilinium~ _ mDrpholinium and piperidinium azides, may also be used i~ desired.
Where an azide other ~han that of an alkali metal is used ~his ~0 azide may be pTepared in the reaction m~xture by double decomposition.
The ~eaction ma~ desired, be carried ou~ in the presence of an ~lectron acceptor, e.g. aluminium chloride, boron trifluoride, ethyl sulphonic acid or benzene sulphonic acidO As an alternati~e to the reaction con~;tions se~ out above, the reaction may be carried out using hydrazoic acid ~hydrogen azide) at a temperature - ., .
` , ;
.
', "~ ~' 13~B/87 ~2~
of from about 20 to 150C in a suitable solvent~ under greater than abmospheric pressure. When an azide other than hydrazoic acid is used, e.g. sodium azide, the product of the reaction will be the corresponding tetrazole salt. This salt may rea~ily be converted to the free acid by treatment with strong acid, e.g.
hydrochloric acid. ;
In process Ch3 the anhydride is preferably a mixed anhydride o such a ~ype that it will cleave preferentially, to give the desired chromone carboxamidotetrazole, as the major product when reacted wi~h the S-aminotetrazole. Examples of suitable acids from which the mixed anhydride may be derived are sulphonic acids e~g. benzene sulphonic acid, sterically hindered carboxylic -~` acids, e.g. pivalic, iso~aleric, diethylacetic or triphenylacetic acid, and alkoxy formic acids, e.g. a lower alkoxy formic acid such as ethoxy or isobutoxy formic acid. When an acid halide is used it ma~ co~veniently be an acid chloride. The reaction is preerably carried ou~ under anhydrous conditions in a solvent which will not react wi~h either the S-an~note~razole or the mLxed ~ydride or acid halide~ e~g. pyridine or dimethylfo~mamide.
; 20 H~we~er when the reaction is carried out in a non-basic sol~ent7 e.g. dimethyl~ormamide, an adequate proportion of an acid - acceptor, e.g. triethylamine, should also preferably be present.
The reaction is preferably carried out at a temperature of from about -15 to ~20~C. When an ester is used we pre~er to use a lower alkoxy ester and to carry out the Teaction in a solvent - - - -:
, ~4/~/~7 6~ :
which is inert under the reaction conditions, e.g. glacial acetic acid, at a temperature of from about 100 to 150C. When a compound of formula I m which ~ is -C~OH is used as startLng ma~erial the reaction may be carried out by heating ~he compound of formula I and the 5-aminotetrazole in a solvent which is ineTt under the reaction conditions, e.g. dimethylacetamide9 at a temperature of ~rom 100 to 200C. Alternatively the reaction may be carried out in ~he presence of a condensation agent, e.g.
N,N'-carbonyl-diimidazole or dicyclohexyl carbodiimide, in an ap~otic solYent, e.g. dimethylfo~mlmide~ at a temperature o from about 10 to 40C.
The starting materials Eor process tb) may be made by reacti~g l a compound of formula IX, Rsb R~b ^ ~b in which R~ ~b, R6b~ ~b and ~b a~e as defined abovep with a compound of formula X, Da-C-C-Da X
,~ , in which Da is an ester group~ ~
to produce a mixture o~ compounds of formulae XI and XII, , .. _, .. , ,. , , ; ,, ,; , ; ~
:- ,. , - .
:- .:
.. .
~, ,: : , :, .. ..
. . .
, :
:,:
~ 15 ~ 64~L :
R5b R b R b X~)~`N~ Da R b ~3" N 3~~a ~8b ~ Rg in which Rg, Da, ~b, R6b, R7b and ~ b are as defined aboYe. :
lhe compounds of formula XI and XII may be hydrolysed to give ~:
compounds of formulae rv and III. Alternatively the groups Da :
In the compounds of ~o~mulae XI ~nd XII may be converted using conventional techniques kn~wn ~ se, to other groups D and the resulting compounds cyclised, using thQ same conditions as -for process ~b3 above, to yield a co~pound of formula II. As a further and preferred alternative the compounds of formula XI and XII may be cyclised, using the same conditions as for process ~b~ above, to give a compound of formul~ II in ~hich D is an ester group, and the resulting compound of ~ormula II is used itself in process (a), or the D group con~erted to another gr~up Dg e.g an acid halide, amide or nitrile group, using techniques knolYn ~ se.
The ~nara~e isom~r of fo~la XII (or ~e corresponding compound ~n which D~ has been converted to D3 is the only isomer which can cyclise to give the required compounds of ~ormula II.
The propo~ti~n o~ ~he ~Yo isomers may be ~eadily determined by : nuclear ~agnetic resonnance spectrosccpy and ~e have found ~hat, in general, ~he desired fumaric acid derivative is only a minor proportion of the mixLure of isomers obtaîned from the reaction.
'~ ' ' "'. ' i~ ~ ' .. , ~ , " " :
. '~ ' 16/~/87 The compounds Of formula V, in ~nich an adjacent pair of R5c, R6c, R7c and R8c represent ~e groups -COC~12COCOR" and ~(~ or .
halogen~ may he made by reacting a compound of formula XIII~
S 6g ~ O H XIII
, - R~g ~g or an ester ~hereof, in which Rg is as defined above j and ~g, ~g~ R7g and R~g have ~he same significances as R5, and RB above, save that an adjacent pair of R5g~ R6g~ R7g and R8g, instead of forming a -COCH=CHtCOOH)-0- chain, represent the ~:
~ groups -COCH3 and ~1; or halogen~ in ~l~ch M is as defined above, ; 15 with a compound o formula XIV~
RtCZ-C~R" xrv ~. ...... .`
:; in whi~h R~ is as de:fined above, R9 is a suit~ble leaving grouP, e.g an alkoxy, halo, amino~
alkylamino, slibstituted zmLnO (a.g an arylsulphonylamino grol~?) or substituted alkylamino group, reactive with the carbanion of the -COCH3 group of the compound of formula XIII, and -each Z is a carbonyl oxygen atom, or one Z may represent two halogen atoms and the other a carbonyl oxygen atom, and if necessary hydrolysing the resulting compound to a : ....
:~
....
.: ., ~
''~ ' " .. , '' , , ~Z6~
compound of formula V. The preferred compounds of formula XIV
are dialkyl oxalates, e.g. diethyl oxalate.
Compounds of formula V bearing a -COCH=C(COOH)-NLlL2 group, or a derivative thereof, may be made from known compounds in one or more steps using processes known per se.
The Compounds of formula II may be made as described above or by a process analogous to process (c)~i).
Alternatively the compounds of formula II may, for example in the case of the acid halide, the amide and the nitrile, be made from compounds of formula I using conventional techniques, e.g. reaction of an ester of the compound of formula I with ammonia to produce the amide, followed by dehydration of the amide to form the nltrile.
The compounds of formula V carrying substituents -H and -O-C(COR''~=CH-CORI' may be made by xeacting a compound of formula XV, R h O
R6h ,~N ~L COOH XV
7h R8h R
:~ g or an ester thereof, in which Rg is as defined above, and R5h, R6h, R7h and R8h have the same significances as R5, R6, R7 and R8 above, save that an adjacent pair of R5h, R6h, R7h and R8h, instead of forming a -COCH=C(COOH)-O~ chain, O . . . . . . . . . . . . . . . . . . . .
~ 17 -,. ; ,, ",. .. ..
.
.
,, 6~
Tepresent ~he groups -H and -OH, with a dialkyl acetylene dicarboxylate, Ln co~ventional manner, followed i.f necessary by hydrolysis of the reaction product.
S Compounds o formula VIII may be made by reacting a compound of formul~ XV~, R5i o R7i~ COOH
. Rg or an ester thereof, :1 in which Rg is as defined above7 i and R8i have the same significances as R59 ~ , R7 and ~ -above, save that an adjacent pair of R5i, R6i, ~i and R8i, mstead of formcng a chain -COCH-C(COOH~-O-,i~epYesent the .~ . .
pai~ of gTOUpS -OH and -COC~Alkyl, with a methyl alkyl sulphoxide anion, e.g. the anion of dimethyl sulphoxid~, ~:. 20 and ~eacting the resulting _-hydroxy-2~a1ky1sulphinyl c pound with glyoxalic ad d or an ester ~hereof.
:.~, .The ompounds of formula I in l~hich E is -CN may be made by dehydrating the corresponding pyranoquinolinone amide using, ~or example, phosphorus oxychloride, as dehydrating agent. The reaction is preferably carried out using at least one molar equivalent of , ~ , , , , ~
, " : " . .-:: ~ : , ., ',.".: ., :: ."
l~/B~87
~cording to our invention ~e provide compounds of formula I, R
8 Rg in which an adjacent pair of R5, R6, R7 and R8 form a chain -COCH= OE-0-, and the remainder of R5, R6, ~ and R8, which may be the same or different, each ~epresent hydrogen, hydrox~, -) ~ alkyl, halogen~ alkenyl, alkoxy, or - ~ ~ in which ~ and ~ , which are the same or different, are each hydrogen or alkyl, Rg is-hydrogen, alkyl, alkenyl or phenyl-alkyl, and :~
E is -COOH, a 5-tetrazolyl group or an (N-tetrazol-5-yl~
car~oxamido group, and pharmaceutically acceptable derivatives thereof.
According to our invention we also provide a p~ocess for ~he production of a compound of ~ormula I, or a pharmaceutically acceptable derivative thereo~, which comprises, (a~ producing a compound of formwla I in which E is -CCC~I by se~ectively hydrolysing or oxidising a compound of formula II, ,;, " ,'.
'' ' ': ,, : ,' ,, :~, ~` :
- 3 - ..
R
R6a~
R8a Rg S in which Rg is as defined above, R5a, ~a, R7a and R8a have the sa~e significances as R5, R6, R7 and R8 above, save 1:han an adjacen,t pair of R5aJ R6a, R7a i, - and ~a may represent a chain of ~ormula -OOCH-C~Dl)O, and one or both of D and Dl represents a group hydrolysable or oxidisable to a ~ group, and the other may represent a -COOH
grou~ 9 ~b) producing a co~olmd o:f fonmlla I ~n which E is -COCH by cyclising a con~pound of fo~la III or IVJ -~
~5b 1- ~b III
Rg Rb ~0 5 R6b ~ ~COC~I
R7b ~ ~ COOH
~8b Rg 25or all ester of ei~er thereo~, .
in which Rg is as defined above, R5b, ~ b, ~ ~nd ~ have the sam~ significances as R5, R6, '~ R7 and ~ abo~e, save that an adjacent pair of R5b9 R6b7 R7b an~
~b may represent ~he pair of groups -H and -O-C~GOOH)=CH-oOOH, (c~ producin$ a compound of formula I in which E is -COOH by cyclising a compound of formula V, :, .
~ ~ R5c o lo .J~;J~, co~ V
:~` ' R8C Ig `~
or an ester thereof, m which Rg is as defined above, .~ .
~C9 ~C, R7c and R8c have ~he s2me signi~icances as R5~ Rs, . 15 ~ and ~ above sa~e that an adjacent pair of R5c, ~ c5 R7c and ~ c, instead of forming a chain -COCH=C(oOOH)-O-~ represent the : pairs of groups: _ _ ti~ - ~ OO-COR~' or -OOCH=CtOOOH)-NLlL2, or a sui~able ; derivative thereof; and -CM or a halogen atom, or (ii) -H and -O-C(~OR")=CH-OOR"
~" represents -CM~ or a group which is hydrolysable thereto, and L2 ~hich may be the same or different are each hydrogen, aryl or alkyl9 or together form a saturatea or unsaturated alkylene chain, and M represents hydrogen or an al~ali metal, 05/B/87 ;
6~ .
: and if necessary or desired hydrolysing the group -COR", to :
a group -COOM, ~d) con~ersion of a compound of for~ula Vl, d ~ ~ O
E Vl d Rg or an ester thereof, in which Rg and E are as defined above, R~d, R6d, R7d and R8d have the same significances as R5, R6, 1?7 and R8 above save that an adjacent pc.ir of R~d, R6d, R7d and d ~ay represent ~he chain -C(~o)CH=cE-o-, at least one of the pairs of groups ~ and Rlo together 15 forn a =S or together ~orm an -S(~)nS- chaLn in which n is 2 or 39 .~nd the other pair ~ , ~ O may lepresent =0, ~o a corresponding compound of formu~a I, ~ (e3 selecti~ely removing the group5 A and B from a compound o~
- ~ormula VII; ~ e O
~ e ~ - H VII
R8~ Rg or an ester thereof~
in which Rg and E are as defined above, ~ 5 -r~ ' .
,,, , , ,.' , .
06/B/&7 , =~_ .
R5e, R6e, R7e and R8e have the same si ~ -~icances as R5, R6, and ~ above save ~hat an adjacen pair of R5e, R6e, ~ e and e may represent a chain -00CHA-CBE-0-7 in at least one o~ the pairs of groups A and B both A and B .
~; 5 a~e hydrogen, or one of A and B is hydrogen and the o~her is halogen OT hydroxy9 and the o~her pair A5 B may together form a douhle bond, (f) producing a compound of ~ormula I in which F. is -COOH by .
- ~yclising a compound of ~ormula VIII, ~ ~CiOIl VIII
or an es~er thereof~
in which Rg is as def m ed abuv~ f, R6f~ R7f and ~ f have the same significances a~ R5, R63 R7 ~nd R8 above save~hat an adjacent pair of R5f, ~Of, ~ f and ~ f, ~ tead of forming a chain -COCH=C(COCH)-O-, represen~ ~he pai~ of groups -CoCH(S0 ~ 0~-CH(OH)-oOOR" and -CM, ~" and ~ are as defined above, and ~ 0 represents an alkyl C 1 to 10 group, (g) producing a compound of formula I in which E is a 5-tet~azolyl group by reacting a corresponding compound of formula I in which E is -CN.
,, , , , , ~ - , with an azide in a solvent which is inert under the reaction : conditions, (h) producing a compound of formula I in which E is an (N-tetra-zol-5-yl)carboxamido group by reaGting a corresponding compound ; 5 of formula I in which E is -COOH, or an acid halide, ester or mixed anhydride thereof, with 5-aminotetrazole, or (i) producing a pharmaceutically acceptable salt of a compound of formula I, by treating a compound of formula Ic, R7~ ~ ~ X
R~j Rg in which Rg is as defined above, R5j~ ~6i, R7j and R8j have the same significances as R5, R6, R7 and R~ above, save that an adjacent pair of R5j, R6j, R7j and R8j may form a chain -O-C(X)=CHCO-, and X is a 5-tetrazolyl group, an (N-tetrazol-5-yl) carboxamido group, a carboxylic acid group (or an ester thereof, or another salt thereof), a nitrile group, an acid halide group or an amide group, with a compound containing an available pharmaceutically acceptable cation and capable of converting the group X to a pharmaceutically accep-table salt of group E, and if neeessary or desired hydrolysin~ the ester of the compolmd of formula I and/or converting the compound of formula I to a pharmaceutically aceeptable derivative thereof.
' ''; :; : . : ' - 7a -In process (a) the group D may be, for example an ester, acid halide, amide or a nitrile group, which may be hydrolysed to a -COOH yroup. The hydrolysis may be carried out using conventional techniques, for example under mildly basic conditions, e.g. using sodium carbonate, sodium hydroxide, sodium bicarbonate, or under acidic conditions, e.g. a mixture of aqueous dioxan and hydrochIoric acid, or hydrogen bromide in acetic acid. The hydrolysis may be carried out at a temperature of from about 25 to 120C depending on the compounds used.
~lternatively the ~roup D may be an alkyl, e.g. a lower alkyl such as methyl, a hydroxymethyl, an aralkenyl, e.g. styryl, an acyl, e.g. a lower alkanoyl such as acetyl, or a formyl group. -;
The oxidation may be carried out using conventional techniques ~;-which do not otherwise modify the molecule to such an extent that the yield of the desired product is uneconomical, for example an . . . . . . . . . . . . . . . . . . . . . . . . . .
- 7a -..... ,:
..~ .
"
... ..
64~4 alkyl or a hydroxy~e~hyl group may be oxidised using selenium : dioxide, e.g. under re1ux in aqueous dioxan; or chromic acid, - e.g. under reflux in aqueous acetic acid. Aralke~yl groups may be oxidised using~ ~or ex ~ le neutral o~ alkaline potassium ~:
5 pe~manganate in aqueous ethanol, and aey7 groups may be oxidised :
using, for example c~romic acid or a~ aqueous hypochlorite, e.g. .
sodium hypochlorite. The formyl group may be oxidised using, . for example ~hromic acid or silver oxide.
In process Cb) ~he eyclisation may ~e carried out by treating the compound of formula III or IY, with a cyclising agent, for example a dbhydra~ing agent such as chlorosulphonic, sulphuric o~ polyphosphoric acid. The reaction is preferably car~ied out under anhydrous conditions and may be carried out at a temperature of from abou~ 25 to 150, and preferably from 75 to 150C~ We have found that isomerisation of *he maleic acid der;vative of foxmula rv to the corTesponding fumarîc ad d derivati~e of . ...
formNla III *akes place when polyphosphoric acid is used to cyclise ~hese co ~ unds to a compound of ~ormula 1, ~hus enabling a satisfactory yield of the compound of formula I to be obtained from a ~ facie unsatlsfactory mixbure of s~mpounds of fo~mulae III and rv. Compounds of formula III ma~ also be cyclised by subjecting the compound to an ele~ated temperature, e.g. of from 200 to 250C, optio~ally in the presence of a hi~h boiling solYent which is inert under ~he reaction conditions, e.g. diphenyl e.~her~
: 25 When one of the groups is -oM the ~yclisation of p~ocess 09/~/87 :~ - 9 - :
tc)ti) may be carried out by heating, or under basic or neu~raI
conditioDs. It is however preferred to carry out the cyclisation in ~he presence of an acid~ e.g hydrochloric acid, and in a solvent which is inert under the reacti~n conditions, e.g ethanol~
The reaction may be carried out at from about 20~ to 150C The .
group -COR" is preferably an ester group, e.g R" may be a lower alko~y group. When one of the groups is COCH=C~COOH3-NLlL2 the deriva~ive o~ the -COOH group may be a group -CONLlL2 in which L
and L2 are as defined above. It is preferred that Ll and L2 are hyd~ogen~ phenyl, alXyl C 1 to 6 or together form a 4 or 5 - membered alkylene chain, e.g. together with the nitrogen atom foTm a piperidine ringO When one of the gro ~ s is halogen the - cyclîsation mar be carTied out in a solvent which is inert und~er the reac~îon conditîons, pre~erably a high boiling polar solven~; -e~g pyridine, dimethyl~ormamide or hexamethylphssphoramide. The : neactîo~ is preferably carried out wn~h ~he aid ~f a strong base, ~or example a~ alkali m~tal-hydride, e.g sodium hydride~ me ~~- ~ -eaction is prefera~ly carried ou~ at a temperature of from about 80 *o 200C, In ~he absenre of ~ree oxygen, e.g under an inert atmosphere .such as nitrogen. ~-lhe cyclisation of process (c~ (ii) may be carried out by treating the compound of ~ormula V wqth a cyclising agent7 for example a dehydrating agent such as chlorosulphonic~ polyphosphoric or sulphuric acid. The reaction is pre~eTably carried out under anhydrous conditions and may be carried out at a temperature o~
....... , . . ~ . ~
. : ~ . . ... ~ ~
:: :
rom 0 to 1Q0C. Alternatiyely cyclisation may be achieved by converting the free carboxy groups of ~he co~pound of formula V
to acyl halide groups and subjeting the resulting acyl halide *o an intramolecular Friedel-Crafts reaction.
In processes (d), when ~ and ~ O together forn a cha m -S-( ~ 3~-S-, ~he conve~sion may comprise oxidative hydrolysis and may be carried out in an aqueous polar organic solvent, for example aqueous ethanol, acetone or tetrahydrofuran. The oxidati~e hydrolysis may be carried ou~ in the presence of an oxidising agent, for example mercuric chloride, an N-halosuccin-imide such as N-brono- or N-chloro-succinimide, a per acid such as periodic acid; or ~-toluenesulphonchloramide or a salt - thereof. When mercuric chloride is used the reaction may b~
carried out in the presence o a base, e.g. mercuric oxide, cadmi~n carbonate or calcium carbonate. N-halosuccinimides may be used alolle or in the presence of a sil~r salt, e.g. silver perchlorate, or sll~er nitrate. The reaction ~ay conveniently be carried out at a temperature of from abou~ 15 to 100C.
When ~ and ~ 0 together form a =S group the conversion may co~prise (oxidative) hrdrolysis and may be carried out in the presence of a heavy metal compound, e.g a compound of group Ib~
IIb or IIIb of the Periodic Table of Mendeleef, as catalyst.
Suitable compounds include mercury, ~hallium and sil~er compounds, e.g. mercury (II) acetate or chloride, ~hallium (III~ trifluoro-acetate, or silver oxide. The reaction may be carried out in the ` '' ' ' " ' ~
' '' ' ' ~
ll~B/87 presence o water and an organic sol~ent system such as acetone-acetic acid9 alkanols,-tetrahydrofuran/methanol, or tetrahydro-furan. Alternatively the ~eaction ma~ be carried out by alkylation ~ollawed by hydroly~is. In such cases the reaction may be ef~ected 5 by (i) an alkyl halicle or sulphonate (e.g. methyl iodide~J in a moist solvent, e.g. acetone, (ii~ an alkylfluorosulphonate and water m sulphur dioxide, or (iii) a trialkyl oxonium fluoroborate followed by aqueous sodium hydroxide.
~hen both A and B are hydrogen process (e) is a dehydrogenation and may be carried out by oxidation using a nald oxidising agent~ ~or example selenium dioxide, palladium blac~
chloranil, lead tetraacetate or triphenyl nethyl pe~chlorate.
Alternatively the dehydI~genation of a compound of formwla VII in which both A and B are hydrogen may be carried out indirectly by 15 halogenation ~ollo~ed by dehydTohalogenation, e.g. by treatment with N~brom~succinimlde or pyridim um bromade perbromide ~o yield a compound of fo~mula VII in which A is halogen and B is hydro~en, ~hich is subsequen~ly dehydrobromanated. I~hen one of A and B i5 hydroxy ~he dehydration may be catalysed by an acid, e~gO sulphuric or oxalic acid; a base, e.g. potassium hydroxide; or a salt, e.g. potassium hydrogen sulphate; or N b~omosuccinimide. The reaction may be carried out in a solvent which is mert under the reaction conditions7 e.g. a halogenated ~ydroca~bon, xylene, or glacial acetic acid. The reaction may be carried out at an elevated temperat-ure, e.g. ~rom 20 to 150C.
. .
, 12 ~L~L2 6~
The cyclisa~ion o~ process (f3 may be carried out in a solvent which is inert under the reac~ion conditions9 e.g.
diethyl e~her or benzene. The reaction may also, if desired, be carried ou~ in the presence of a Lewis acid, e.g. boron 5 trifluoride. The reaction is preferably carried out at a temperature of from 10 to 120~ in presence of an organic base, .g. piperidene.
Suitable solvents which are inert under the reaction conditions of process (g) include those in which both the reagents are soluble, e.gO N,N-dimethylformamide. Other solvents which may be mentioned include dimethylsulphoxide, tetrahydro~uran~ diethyl glycol and ethyl me~hyl glycol. The reaction is pre~erably car~ied out at a temperature of from about 20 to 130C ~or from about 1 to 20 hours~
~he azide used in ~he reaction is preerably ammonium or an alkali 15- metal azide, e.g. sodium or lithium azide~ but other azides, e.g.
alumlnium azid~ or the azides of nitrogen cont ~ ng bases9 eOg.
m~no-, di-, tri-, and tetra- me~hyl- ammonium, anilinium~ _ mDrpholinium and piperidinium azides, may also be used i~ desired.
Where an azide other ~han that of an alkali metal is used ~his ~0 azide may be pTepared in the reaction m~xture by double decomposition.
The ~eaction ma~ desired, be carried ou~ in the presence of an ~lectron acceptor, e.g. aluminium chloride, boron trifluoride, ethyl sulphonic acid or benzene sulphonic acidO As an alternati~e to the reaction con~;tions se~ out above, the reaction may be carried out using hydrazoic acid ~hydrogen azide) at a temperature - ., .
` , ;
.
', "~ ~' 13~B/87 ~2~
of from about 20 to 150C in a suitable solvent~ under greater than abmospheric pressure. When an azide other than hydrazoic acid is used, e.g. sodium azide, the product of the reaction will be the corresponding tetrazole salt. This salt may rea~ily be converted to the free acid by treatment with strong acid, e.g.
hydrochloric acid. ;
In process Ch3 the anhydride is preferably a mixed anhydride o such a ~ype that it will cleave preferentially, to give the desired chromone carboxamidotetrazole, as the major product when reacted wi~h the S-aminotetrazole. Examples of suitable acids from which the mixed anhydride may be derived are sulphonic acids e~g. benzene sulphonic acid, sterically hindered carboxylic -~` acids, e.g. pivalic, iso~aleric, diethylacetic or triphenylacetic acid, and alkoxy formic acids, e.g. a lower alkoxy formic acid such as ethoxy or isobutoxy formic acid. When an acid halide is used it ma~ co~veniently be an acid chloride. The reaction is preerably carried ou~ under anhydrous conditions in a solvent which will not react wi~h either the S-an~note~razole or the mLxed ~ydride or acid halide~ e~g. pyridine or dimethylfo~mamide.
; 20 H~we~er when the reaction is carried out in a non-basic sol~ent7 e.g. dimethyl~ormamide, an adequate proportion of an acid - acceptor, e.g. triethylamine, should also preferably be present.
The reaction is preferably carried out at a temperature of from about -15 to ~20~C. When an ester is used we pre~er to use a lower alkoxy ester and to carry out the Teaction in a solvent - - - -:
, ~4/~/~7 6~ :
which is inert under the reaction conditions, e.g. glacial acetic acid, at a temperature of from about 100 to 150C. When a compound of formula I m which ~ is -C~OH is used as startLng ma~erial the reaction may be carried out by heating ~he compound of formula I and the 5-aminotetrazole in a solvent which is ineTt under the reaction conditions, e.g. dimethylacetamide9 at a temperature of ~rom 100 to 200C. Alternatively the reaction may be carried out in ~he presence of a condensation agent, e.g.
N,N'-carbonyl-diimidazole or dicyclohexyl carbodiimide, in an ap~otic solYent, e.g. dimethylfo~mlmide~ at a temperature o from about 10 to 40C.
The starting materials Eor process tb) may be made by reacti~g l a compound of formula IX, Rsb R~b ^ ~b in which R~ ~b, R6b~ ~b and ~b a~e as defined abovep with a compound of formula X, Da-C-C-Da X
,~ , in which Da is an ester group~ ~
to produce a mixture o~ compounds of formulae XI and XII, , .. _, .. , ,. , , ; ,, ,; , ; ~
:- ,. , - .
:- .:
.. .
~, ,: : , :, .. ..
. . .
, :
:,:
~ 15 ~ 64~L :
R5b R b R b X~)~`N~ Da R b ~3" N 3~~a ~8b ~ Rg in which Rg, Da, ~b, R6b, R7b and ~ b are as defined aboYe. :
lhe compounds of formula XI and XII may be hydrolysed to give ~:
compounds of formulae rv and III. Alternatively the groups Da :
In the compounds of ~o~mulae XI ~nd XII may be converted using conventional techniques kn~wn ~ se, to other groups D and the resulting compounds cyclised, using thQ same conditions as -for process ~b3 above, to yield a co~pound of formula II. As a further and preferred alternative the compounds of formula XI and XII may be cyclised, using the same conditions as for process ~b~ above, to give a compound of formul~ II in ~hich D is an ester group, and the resulting compound of ~ormula II is used itself in process (a), or the D group con~erted to another gr~up Dg e.g an acid halide, amide or nitrile group, using techniques knolYn ~ se.
The ~nara~e isom~r of fo~la XII (or ~e corresponding compound ~n which D~ has been converted to D3 is the only isomer which can cyclise to give the required compounds of ~ormula II.
The propo~ti~n o~ ~he ~Yo isomers may be ~eadily determined by : nuclear ~agnetic resonnance spectrosccpy and ~e have found ~hat, in general, ~he desired fumaric acid derivative is only a minor proportion of the mixLure of isomers obtaîned from the reaction.
'~ ' ' "'. ' i~ ~ ' .. , ~ , " " :
. '~ ' 16/~/87 The compounds Of formula V, in ~nich an adjacent pair of R5c, R6c, R7c and R8c represent ~e groups -COC~12COCOR" and ~(~ or .
halogen~ may he made by reacting a compound of formula XIII~
S 6g ~ O H XIII
, - R~g ~g or an ester ~hereof, in which Rg is as defined above j and ~g, ~g~ R7g and R~g have ~he same significances as R5, and RB above, save that an adjacent pair of R5g~ R6g~ R7g and R8g, instead of forming a -COCH=CHtCOOH)-0- chain, represent the ~:
~ groups -COCH3 and ~1; or halogen~ in ~l~ch M is as defined above, ; 15 with a compound o formula XIV~
RtCZ-C~R" xrv ~. ...... .`
:; in whi~h R~ is as de:fined above, R9 is a suit~ble leaving grouP, e.g an alkoxy, halo, amino~
alkylamino, slibstituted zmLnO (a.g an arylsulphonylamino grol~?) or substituted alkylamino group, reactive with the carbanion of the -COCH3 group of the compound of formula XIII, and -each Z is a carbonyl oxygen atom, or one Z may represent two halogen atoms and the other a carbonyl oxygen atom, and if necessary hydrolysing the resulting compound to a : ....
:~
....
.: ., ~
''~ ' " .. , '' , , ~Z6~
compound of formula V. The preferred compounds of formula XIV
are dialkyl oxalates, e.g. diethyl oxalate.
Compounds of formula V bearing a -COCH=C(COOH)-NLlL2 group, or a derivative thereof, may be made from known compounds in one or more steps using processes known per se.
The Compounds of formula II may be made as described above or by a process analogous to process (c)~i).
Alternatively the compounds of formula II may, for example in the case of the acid halide, the amide and the nitrile, be made from compounds of formula I using conventional techniques, e.g. reaction of an ester of the compound of formula I with ammonia to produce the amide, followed by dehydration of the amide to form the nltrile.
The compounds of formula V carrying substituents -H and -O-C(COR''~=CH-CORI' may be made by xeacting a compound of formula XV, R h O
R6h ,~N ~L COOH XV
7h R8h R
:~ g or an ester thereof, in which Rg is as defined above, and R5h, R6h, R7h and R8h have the same significances as R5, R6, R7 and R8 above, save that an adjacent pair of R5h, R6h, R7h and R8h, instead of forming a -COCH=C(COOH)-O~ chain, O . . . . . . . . . . . . . . . . . . . .
~ 17 -,. ; ,, ",. .. ..
.
.
,, 6~
Tepresent ~he groups -H and -OH, with a dialkyl acetylene dicarboxylate, Ln co~ventional manner, followed i.f necessary by hydrolysis of the reaction product.
S Compounds o formula VIII may be made by reacting a compound of formul~ XV~, R5i o R7i~ COOH
. Rg or an ester thereof, :1 in which Rg is as defined above7 i and R8i have the same significances as R59 ~ , R7 and ~ -above, save that an adjacent pair of R5i, R6i, ~i and R8i, mstead of formcng a chain -COCH-C(COOH~-O-,i~epYesent the .~ . .
pai~ of gTOUpS -OH and -COC~Alkyl, with a methyl alkyl sulphoxide anion, e.g. the anion of dimethyl sulphoxid~, ~:. 20 and ~eacting the resulting _-hydroxy-2~a1ky1sulphinyl c pound with glyoxalic ad d or an ester ~hereof.
:.~, .The ompounds of formula I in l~hich E is -CN may be made by dehydrating the corresponding pyranoquinolinone amide using, ~or example, phosphorus oxychloride, as dehydrating agent. The reaction is preferably carried out using at least one molar equivalent of , ~ , , , , ~
, " : " . .-:: ~ : , ., ',.".: ., :: ."
l~/B~87
2~
dehydrating agent per mole of the pyr~noquinolinone amide. Where the dehydrating agent reacts with one of ~ , R6, ~ or R8 ~e.g. a substituent comprising an -OH group) suficient dehydrating agent should be used to satisfy the side reaction as well as the main reaction. The reaction may, if desired, be carried out in the presence of an acid binding agent, e.g. triethylamm e, The Teaction may be carried out in the presence of a solvent, e.g. N,N-dime~hyl-~orm~mide, dimethyl sulphoxide, pyridine, benzene or hexamethyl phosphoramade, or an excess of the dehydrating agent may be used ~; 10 as the reaction medium. The reaction may be carried out at a temperature o from about 0 to 200C depending on the dehydrating agent used. When phosphorus oxychloride is used a temperature of from 0 to 100C is preferred.
The chromone amide starting materials may be made by reacting a corresponding pyranoquinol~nonè ester ~ith ammonia, using techniques con~entional in the production of amides rom esters9 e.g. using an alkanol as solvent at a temperature of 0 to 120C.
Conpo~ds of ~rnwlae VI, VII, IX, XIII~ XIV, XV and XVI are - either known or may be made from Xnown COmpQUlldS using conventional techniques known ~ s~.
The processes as described above may produce ~he compouna of .
- form~la I or a ~erivative thereo. It is also within ~he scope of this inventio~ to treat any derivative so produced to liberate the ~ree compound of formula I, or to convert one derivative into another.
lg - .
,,~.
.'~
. "~ - :
~ ~Z~
- ~0-l~e compounds of formula I and the interm~diates therefore may be isolated from ~hei~ reaction nuxtures using con~entional -~echniques.
: Pharmaceutically acceptable derivatives of the compounds of ~rmula I include pharmaceutically acceptable sal~s, and ~hen E
is a -CCOH group, esters and amides of the 2-carboxylic acid group.
Sui~able salts mclude ammonium, alkali ne~al (e.g sodium, potassium and lithium~ and alkaline earth metal (e.g, calcium or magnesium) salts~ and salts with suitable organic bases; e.g. salts with :
hydroxylamine, lower alkylamines such as methylamine or ethylamine, with substituted lower alkylammes, e.g hydroxy substituted alkylamines such as tris~hydroxymethyl)me~lylamine, or with simple - nocyclic nitrogen heterocyclic compo~nds, e.g piperidine or morpholine. Suitable esters include simple lower alkyl esters, e.g the ethyl ester, esters derived ~rom alcohols containLng basic groups, e.g di-lower alkyl amino substituted alkanols such as the ~-(diethylamino)-ethyl ester,-and acyloxy alkyl esters, e.g a lower ac~loxy-low~r alkyl ester such as the pi~aloyloxym~thyl ester, or a bis-ester derived ~rom a di-hydroxy compound~ e.g a di~hydroxy-lower alkyl3 ether~ e.g ~he bis-2-oxapropan-1,3-diyl ester. The pharmaceutically acceptable acid additio~ sal~s of the basic esters9 and also of those compounds in which one of ~ , R6, ~ and R8 is a group ~ ag the hydroch~oride, the hydrobromide, the oxalate, the maleate or the flmarate sal~s; m~y also be used. The esteTs ~ay be made by convent;onal t~c ~ ques, e.g esteri~ication or - 20 ~
21 ~ 6~41' transesterification. The amides may be9 for example, unsubstituted or mono- or di- C 1 to 6 alkyl amides and may be made by con~entional techniques, e.g reaction of an ester of the corresponding acid with ammonia or an app~opriate amine.
The compounds o~ -formula I and pha~maceutically acceptable derivatives thereof are useful because they possess pharmacological activity in animals; in particular they are useful because they inhibit the release and/or action of pharmacological mediators w~ich result from the in viYo combination o certaLn ~ypes of ; 10 antibody and specific antigen, e.g the combination of reaginic antibody wqth speciic an~igen ~see Exampl~ 27 of British Patent Specifisation No 1~292,601). The new compounds have also been found to inte~fare with reflex pathways in experimental animals and ~an and in particular those reflexes associated with lung function. In man, both subjective and o~jective changes which result.from the inhalatîo~ of speci~ic antigen by sensitised sub~ects a~e inhibited ~y p~ior adm;nistration of the new compounds. Thus the new compounds are indicated for use in the treatm~nt of reversable airway ~bstruction and/or to prevent the secretion of ; 20 excess ~ucous. The new compounds are thus indicated or ~he treatment of allergic asthma, so-called 'intrinsic' asthma tin which no sensitivity to extrinsic antigen c~n be demDnstrated), bronchitis, coughs and the nasal and bronchial obstructions associated with ~he common colds. l~le new compounds may also be of value in the 25 treatment of o~her oond~tions in which an~igen-antibody reactions or -~^
.
.,, ., ~ , ~ 22 ~ L~L'~6~4 excess mucous secretion are responsible for, or are an adjunct to9 disease, for example, hay fever; certain eye conditions, e.g trachoma; alimentary allergy, e.g urticaria and atopic ec~ema; cmd gastrointestinal conditions, for example gastrointestinal allergy, S especially in children, e.g milk allergy, or ulcerati~e colitis.
For the aboYe mentio~ed uses the dosage administered ~nll, o course9 vary with the compound employed, the m~de of ~dministration and the treatment desiTed However, in general~
satisEactory ~esults are obtained ~hen ~le compounds are administered at a dosage of from 0.001 to 50 mg per kg of animal body weight in the test set out in Example 27 o~ British Patent Specification No lt292,601. For m~n the indioated total daily 1 dosage is in ~he range o from 0.01 mg to 1,~00 mg preferably from 0.01 mg to 200 mg and more preerably from 1 mg to 60 mg, which may be administered in divided doses fiom 1 to 6 times a day or in sus~ained release form. Thus unit (~sage ~orns sui~able ~OT
.
administration (by inhalation or oesophageally~ comprise from 0.01 mg to 50 mg, preferably 0.01 mg to 20 mg and more pre~erably from 0.01 mg to 10 mg of the compound preferably admixed with a solid or liquid pharmaceutically acceptable diluent~ carrier or adjuvant.
. The comFounds o~ formula I, and phaTmaceutically acceptable derivatives thereof, ha~e the advantage that they are n~re ef~icacious in certaLn pharmacological mDdels, or a~e longer acting than compounds of similar structure to the compounds ~f . :
' " '~' .' ' , ~ :
1, . .
02/~/30 - 23 -~
formula I. Furthermore the compounds of formula I, and pharma-ceu-tically acceptable derivatives thereof, are advantageous in that they are more efficaceous in interfering with reflex pathways and in inhibiting the ~ecretion of mucous than are compounds of similar structure to the compounds of formula I.
We prefer each of Ry, R5, R6, R7 and R8, when they contain carbon, to contain up to 8, and preferably up to 4 carbon atoms~
Specifically we prefer R5, R6, R7 and R8 to be selected from hydrogen, methoxy, propyl, allyl, methyl, ethyl, chlorine, bromine and hydroxy. The -COCH=CE-O- chain may be bonded to the benzene ring in any sense and in any of the adjacent positions R5, R6, R7, R8. However, we prefer the chain to ~e bonded in the positions R6 and R7 the -O- part of the chain being in position R7. We also prefer the group E to be a -COOH group.
According to the invention there is also provided a process for the produc-tion of a pharmaceut:ically acceptable salt of a compound of formula I, which compr:ises treating a compound of formula Ic, R5j O
R6~ ~ Ic R8j R .
in which Rg is as defined above, R5j, R6j, R7j and R8j have the same significances as R5, R6, R7 and R8 above, save that an adjacent pair of R5j, R6j, R7j and .,~-. ~
' ' ' ' ;',~, , ~3/~/30 - 24 ~
~j ~ay form a chain -O-C~X)=CHCO-, and X is a 5-tetrazolyl group; an (N-tetrazol-S-yl)carboxamido group, a carboxylic acid.group ~or an ester thereo~, or another ~alt thereof), a nitrile group, an acid halide group or an amide s ~roup, wqth a compound containing an available pharmaceutically acceptable cation and capable of co~verting the group X to a Fharmaceutically acceptable salt of an H group.
Compounds capable of converting the group X to a pharmaceutically acceptable salt of an E group include compounds, e.g bases and ion exchange resinsS containing pharmaceuticalIy acceptable cations, e~g sodium~ potassium, calcium, ammonium and appropriate nitrogen contain;ng organic cations. In g~neral we prefer to form the pharmaceutically acceptable salt by treatIng ~he free acid of formula I with an appropriate base, e.g with an alkaline-earth or alkali metal . hyd~oxide, carbona*e or biearbonate in aqueous solution or by a --.
m~ta~he~ical process wlth an appropriate salt. When a stronglr basic compound~is used care should be taken, e~g by keeping the ~0 te~perature suf~iciently l~wS to ensure that the compound o~
fo i a I is not h~drolysed or o~herwise degraded. The .
phanmaceutically acceptable salt may be recovered from the reaction maxture by~ for example, solvent precipitation and/or removal of the solvent by evaporation, e.g by reeze drying.
According to ou~ invention we also provide a pharmaceutical :~ - 24 - .
~. :
:::;. :: ~ :i:; . . .: "
, : :, .: ' ' ~' '. ' :
:'': ., . :. :~
composition comprising (preferably less than 80~, and more preerably less than 50% by weight~ of a compound of ~ormula I, or a pharmaceutically acceptable derivativ~ thereo-f, in combination ~ h a pharmaceutically acceptable adjuvant, diluent or carrier.
Examples of suitable adjuvc~nts, diluents or carriers are:- for tablets capsules and dragees; microcrystalline cellulose, calcium phosphate, diatom~ceous ear~h, a sugar such as lactose, dextrose - or mannitol, talc, stearic acid, StarGh, sodium bicarbonate and/or gelatin; ~or suppositories, natural or hardened oils or waxes;
and for inhalation compositions, coarse lactose. The compound of ~ormula I; o~ the pharmaceutically acceptable deri~ative thereof, preferably is m a form having a mass median diam~ter o from 0.01 to lO mQcrons. The compositions may also contain suitable preserving, stabilising and w~tting agents9 solubilizeTs, sweetening and colouring agents and ~avourings. The co.~positions may1 if deslred7 be formulated in sustained release form. We prefer con~osîti~ns ~ich aIe designed to be taken oesoq?hageally and to r~lease their contents in the gastrointestinal tract. r~
The 5-tetrazolyl and (N-tetrazol-S-yl)car~oxamido groups are of orm~1ae XVII and XVIII respecti~ely, `
XVII - C \ ll CONH~ XVIII
N - N N
. ~ I
H H
, ~ ` .
, 05/~/30 The group5 of ormu1ae XVII and XVIII may exist in tautoneric forms and such tautomeric forms are in d uded within the defini~ion of the compounds of formula I.
~ le invention is illustrated, but in no way limited by the following Examples.
le 1 4 6 Dioxo-10 o 1-4H 6H- ano C3,2-~ 7 uinoline-2,8-dicarboxylic acid 9 ~ py / pyr _ c> q -(a) 4 Acetamido-2-allyloxyacetophenone 4-Acetamado-2-hydroxyacetophenone (19.3g) allyl bromide ~12.1 ml~
and anhydrous po~assium carbonate (21.$g~ were stirred in dry dimethylformamide (250 ml) at room temperature for 24 hours. The reaction mixture was poured into water and ~he product was extracted with e~hyl.acetate. The organic solution was ~hen washed well wi~h water dried over magnesium sulphate an~ evaporated to dryness. The su~-title product was obtained as buf coloured solid (20.Sg). The structure of the product was confirmed b~r N~IR and mass spectroscopy~
tb) ~ =~
The above allyl ether (18.4g) was hea~ed at Z00-210C for 4 hours. 17~1g of the thermally rearranged sub-ti le product was obtained as brown solid~ Again ~he structure was confirmed by MR and mass spect~oscopy.
~c) 4-Aceta~ido-Z-hydroxy-3-p~Ey-~acetophenone The product of step (b~ (17g) was dissolved in glacial acetic acid and hydrogenated in the presence of Adans catalyst ~til -~ 25 hydrogen uptake had ceased~ The catalyst was filtered off through ':
06/B~30 2~
a kieselg~r filter and the filtrate was evaporated to leave 13.0g o allnost colourless solid. The mass and ~IR spectra confilmed t~e struc~cure of ~he product.
(d) E~2~1 7-acetamido-4-oxo-8-propyl-4H-l-benzopyran-2-carbo~ylate A n~xture of diefflyl oxalate ~19.3g; 17.9 ml) and the above product of step tc) (12.4g) in dry ethanol (100 ml~ was added to a stilTed solution o sodi~ e~oxide in et:hanol (prepared by dissolving sodi~n (6.1g) in dry ethanol ~200 n~)). The reaction mLxture was refluxed for 3 ho~s and ~hen poured into dilute hydrochloric acid and chloro:Eorm. The chloroform layer was separated"
washed with wate~ and dried. The solvent was evapora~ed to leave a br~: solid which wa~ dissolved in ethanol t3Q0 m~) contai~ing concentrated hydrochloric acid t3 n~) and the ~ole was reLuxed ~or 1 hour. lhe ~eaction mixture was poured into wa~er and t~he ~: 15 product was extTacted into ethyl acetate which was washed with ~ water aIId dried. l~e solvent was evaporated to leave 10 g of a; sticky solid whiçh had n~ss- and NMR spectra consistent with the expected product.
~ (e) Eth ~ am mo~4-oxo-8~E~eyl-4H-l-benzopyr - 20 A solution of the amide of step (d) (lOg) in ethanol ~300 m~)~
contaLning concent~ated hydrochloric acid ~5 ~1), was refluxed fiDr 8 hours. The Teaction mixture was diluted with water and extracted into ethyl acetate. The extract was washed ~ith water, dried and the solvent was evaporated to leave a dark ~rown semi-25 solid. This was chromatographed o~ a silica gel column, using ~ 27 -, , 07~B/30 - 28 ~ 64~
ether as eluant to give 4.8g of the required product whose structure w~s confirmed by mass and NMR spectral evidence; mp 84 87~C.
~f) 8-Ethoxycarbonyl-2-me~hoxycarbonyl-476-dioxo-10-propyl-4H,6H-pyranoL3 ,2-g~q linoline The amino benzopyran of step ~e3 (2.0g) and dimethyl acetylene dicaTboxylate ~1.24g; 1.01 n~) were refluxed ~n ethanol ~30 ml) -for 26 hours. The reaction maxtllre was cooled to 0C and the insoluble yellow-brown solid was collected by filtration and washed wqth a little ethanol and dried to gi~e 2.0g of a product which was a -mixture of maleic and ~umaric este~s obtained ~y Michael addition of the amine to the acetylene.
This mixture of esters t2.0g) was treated with polyphosphoric 1-- acid (30 ma~ and heated on the stean bath with stirring for 20 m~nutes. The reaction mix*ure was then poured onto ice and stirred with ethyl aceta~e. The organic layer w s separated~ washed with ~; water and dried. The solvent was evaporated ~o leave ~6g of a yel~ow o~an~e solid. P~c~rstallisation of ~is solid from e~yl aceta~e gave the ~equired product as fluf~y orange needles np 18Y-1~8~C.
~0 ~al~
F~nd: C~ 62~0~o; H3 5.1%; H, 3.7~0 C2 ~ 9N7 Required: C 62.3~; H, 4.9~; N, 3.6~
(g) ~,6-~ioxo-10-propyl-4H,6H-pyrano~ 2-g7quinoline-2~8-_carb~n~lic a~d The above bis ester (2.5g) was ~efluxed w~:h sodium bicarbona~e , .. .
, , . :, , .; , : .
:, ' , - 29 ~ ~L~L~ 44 ~1.64g) in e~hanol (100 ml) ~nd water ~50 ml) for 12 hours. The ~hole was poured into water and acidified to precipitate a gelatinous solid. This was collected by filtration, refluxed with ethanol and the protluct was separated by centri~ugation (1.4g) mp 303-304C dec. The s~ructure of the product was confirmed by mass and Nh~ evidence.
~h) sodium 4,6-dioxo-10~ 4H,6H-E~ran L~3,2-g 7quinoline-- 2,8-di.carboxylate The bis acid from step (g) (1.35g) and sodium bicarbonate (0.661g) in water ~150 ml) were warned and stirred until a clear solution was obtained~ This solution was filtered and ~he filtrate was ~r~eze dried to give 1.43g of the required disodium salt~
Analysis Found: C, 46.1~; H, 4~0%; N~ 2.9 ~ 7~ 1NO7Na2 12.5~ ~ 0 requi~ed: Cg 46.1%; H~ 3.8%; N, 3~15 ` Ex~ple 2 4~Dioxo- thyl-10-propyl-4H ~ -g 7quinoline-2,8-car~oxylic acid ~a) 4-tN Acetyl-N~ethyl)~nino-2-allyluxyaoetophenone ~ 20 4-~N-acetyl-N-ethyl~amino-2-hydroxyacetophenone (92~6g), allyl : bromide (51 m~s~ and anhyd~ous pvtassium carbonate ~90.4g) were stirred in dry dimethylform~mide ~500 n~s) for 17 hours. The reaction mixture was poured into water and the produc~ was ext~acted with e~her. The organic solution was then washed well with water, dried over magnesium sulphate and evaporated to ' '/ ' ' ~ `" ` ' ' ~ . , , dryness. The product ~as obtained as an oil (102.5g). ~he st~ucture of the product was con~irmed by NMR and mass spectroscopy.
Cb) 4-~N-A~etyl-N-e~hyl)amm o-~propyl-2-hydroxyacetophenone , The allyl ether product of step (a) (lOO.Sg) was refluxed in diethylaniline (300 nls) for 3 hours. The reaction mnxture was cooled and poured into dilute hydrochloric acid and extracted into ether, ~lich latter was washed with dilute hydrochloric acid, and ~hen with water. The organic solution was extracted with 10 sodium hyd~oxide solution which was then acidified. The precipitated product was extracted with e~her which was dri~d -over mag~esiu~ sulp~ate. The resulting ethereal solution was evàporated ~o dryness to give a yellow-brown oil C78.7g~ This oil was a n~xture of 4-~N~acetyl-N-ethyl)amino-3-allyl-2-. ., hydroxyacetop~enone and 6-QN-acetyl-N-~thyl~amino-3-allyl~2-hydroxyacetophenone.
This mixture was dissol ~ d in ethanol (500 nls) and glacial acetic acid ~20 mls) and hydrog~nated ~n the pTesence of Adams catalyst until hydrogen ~p~ake had c~ased. The catalyst was ~ , filte~ed of~ ~hrough kieselguh~ and ~he filt~ate evaporated to leave 79.9g of brown oil. Ihis brown oil was a mixture and was separated by hi~h pressure liquid chromatography using etheT/petroleum ether ~1:1) as solvent to give 44.2g of the sub-title conpound and 23.8g of 6-~N-acetyl-N-ethyl)amino-3-propyl-2-hydroxyacetophenone.
, . . .. ~
~%~
(c~ 4-N-Ethylamino-~propyl-2-hydroxyacetophenone 4-(N-Acetyl-N~ethyl)amino-3 propyl-2-hydroxyacetophenone (44g) was refluxed in 48~ hydrogen bromide in glacial acetic acid ; (100 mls), glacial acetic acid (S00 mls) and water (20 mls~ for 6 hours~ The reaction ~ixture was poured on to ice-water and extracted with ethyl acetate which was washed with water, sodium bicarbonate solution, then water again and dried over magnesium sulphate. The organic solYent was evaporated to dryness to leave the sub-title compound as a red oil (34g). The structure was confirmed by NMR and mass spectroscopyO
(d) Me~hyl 6-acetyl-1-ethyl-7-~y_roxy-4-oxG-8-propyl-4H-uinoline-2~carbo~y_ate he amine product oL step ~c) (17g) and dime~hacetylenedi-carboxylate tll.3 mls) were re~luxed ~l e~hanol (300 mls) for 17 hrs.
The reaction mixture was cooled and evaporated to dryness to leave a deep red oil. Thi5 oil was chromatographed on a silica gel -~ column using e~her/pe~roleum ether (1:1~ as eluant to give l9.1g of dimethyl l-t4 acetyl-3-hydroxy-2-propylphenyl~-N-ethylamino-maleate, m.p. 83~87C.
The maleic ester (Sg) was heated and s~irred in polyphosphoric acid ClC0 mls) on the steam bath for 10 minutes. The reaction m~xture was cooled and poured on to a mixture of ice-water and ethyl acetate. The organic solution was separa~ed-, washed with water and dried ove~ magnesium sulphate. The solvent was evaporated ~o dryness to lea~e a pale yellow solid. lhis '' ~, ' ll/B/30 26~
product was purified by high pressure liq~id chroma~ography to give 2.6g of the sub title compound m.pD 121-123C.
An~ysis Found: C: 65.5~ H; 6.6% N; 4.2~
C18~21N05 Requlred: C~ 65-3~ H; 6~34% N; 4.23%
~e~yl 6-acel~ ethyl-5-hydro~y-4-oxo-4H-quinoline-2-ca~boxylate was obtained from the purification as a pale yellow solid (100 mgs).
(e) qwnoline-2,8-dicarboxylate The hydroxy keto~e product of step ~d) (l.Og) and diethyl ~!`, oxalate (3.3 mls) in dry dimethylformamide (25 mls) were added to ; ether washed 50% sodium hydride (0.581g~ in dry dimethylformamide ~, . , . ~
C20 mls) and the reaction mixture stirred for 4 hou~s. The ~eaction mdxture was then poured into water,acidîfied and ext~acted wi~h ethyl acetate, which was then washed wqth water ~nd.dried over magn0sium sulphate. ~he solvent was evaporated to dryness to give an oil whic~ was dissolved in ethanol ~100 mls) .~, .
; and concentrated hydrochloric acid ~a few drops) added. The 20 solution was refluxed for 2 hr, cooled~ poured into water and extracted with.ethyl acetate, which was washed with water and dried over magnesium sulphate. The solvent was evaporated to dryness to leave an oil which solidified on trituration with 40-60 petroleum ether (1.2g). The structure of ~he compound was conirmed by NMR.
t - 32a - ~ %
~f) ~l~l ~g~quinoline-' 2~8-diciarb~ lic acid The abo~e bis ester ~l.Og) and sodium bicarbonate (00787g) in ethanol (~5 mls) and water ~32 mls~ were ref~uxed for 4 hours. The 5 reaction mixture was poured into water, acidified and the precipitate .;
was collected by filtration &nd dried. The product was purified by :~x~tula.~,~n.~,wi~ bQ~lihg ethanol9 then twice with boil m g acëtone.
~fter each trituration the mixture was centrifuged and ~he ` supernatent liquid was removed by decantation. The residual solid was dried to give 0.547g o ~he requi~ed di~acid as a yellow powder m.p. 298-3~0 dec~ , Pound: C: 61.3~ H; S.0% N; 3~6%
.
~'', C1 ~17N07 Required: C: 61.5~ H; 4~6~ N; 3.79 tg) Disodlum 4~6-Dioxo-l-ethyl-lo-propyl- H ~ 3,2-~:7 , 15 quinoline-2,8-dicarboxylate The abo~e di-acid (4.098g), s~spended in ~ater ,~100 mls) and was treated with sodium bicar~onate ~1~82g). The ~esul~ing solu~ion was filtered and the filtrate ~as treated with acetone '~
until co~plete precipitation of the product had occurTed. l~e required di-sodium salt was il~ered off ~nd dried to give 3~39g of a pale yellow powder.
~;
' Found: C; 51.1~ H; 4.3~N; 3.0 19~115NNa27R~quired: C: 51.1~ H; 4.1~N; 3.1 2S t6.9~ water) ', ' ,. ':
_ 32a -1 . , ... .
. 12/B/30 - 33 ~ L'~6 Exa~ple 3 The ~ollowin~ compounds may also be made by the processes described abo~e:-(i) 5-E~hyl-4,8-dioxo-10-propyl-4H,8H-pyrano r2~3-h~7-q ~loline-2,6-dicarboxylic acid (ii) 4l10-Dioxo-4H,lOH-pyranoL~,3-~7quinoline-2,8- .
dicarboxylic ad d r ~;. (iii) 10-Bromo-4,6-dioxo-4H,6H-pyrano L3,2-g~7quinoline-2,8-dicarboxylic acid ` 10 (iv) 5-Hydro2y-4,6-dioxo-10-prow 1-4H,6H-pyrano L 3~2-g,7 .
quQnoline~2,8-dicarboxylic acid ~v) 4,9-Dioxo-4H,9H-pyranoL~2,3-g~7quinoline-2,7-~- dicarboxylic acid (vi) 4,10 Dioxo-4HJlOH-pyrano C2,3-~:7quinoline 2,8-dif~N-~- 15 ~tetrazol-5-yl) 7carboxa~de .. ~ . -~vii~ 10-Bromo-4,6-dioxo-2,8-di-(tetrazol-5-yl)-4H,6H-~, pyranoL~3,2-g~7quinoline.
' ' .
-: ;, ., ... .
:
, , , : .: :
,..... .. . .
_ 3a~ _ )~ pp/~r~er~ t!c~r~ S c/o S~tre '~'^`' Exa~le 4 ne-2,8_dicarboxy1ate (a) Methyl-6-acetyl-1-ethyl-5-hydroxy-4-oxo-4~1-quinoline-2-carboxylate :
A mixture of di~ethyl acetylene dicarboxylate (13g; 91.5 n~ole) and 4-e~hylamino-2-hydroxyacetophenone (16.1g, 89.8 mmoles) in ethanol t250 ml3 was re~luxed on a steambath for 7 hours. The mixture was cooled before being poured into water. The n~xture was concentrated by removing some o~ the ethanol and was then extracted with ethylacetate. The organic extract was washed with a large volume of water and then was dried (~nhydrous sodium sulphate). Solvent was rem~ved by evaporation to giYe a light brown oil. When triturated with petroleum ether/ether mixture a yellol~ solid was obtained. Both N~ and MS showed it to be consistent 1~ith *he expected structure.
l~e above dimethyl acetylene dicarboxylate adduc* of 4-ethylamino 2-h~fdroxy acetophenone (5.5g, 17~1 ~moles) was ~yclised by heating with polyphosphoric acid (19Og) for 20 minutes. The dark viscous solutio~ was treated with ice/water mixture and the resulting suspenLsion w~s extracted with ethylacetatç. The organic layer was washed with large volume of water, and this w~s then dried (anhydrous sodium sulphate).
Solvent was removed to give a light brohn solid. ~ ~ and ~
showed this compound to be a mixtuTe, the sub-title compound I~...~i ' ' ' . ', , ~,, `: ~
6~
being the main produot. A pure sample was obtained by chromatography on silica gel using petroleum ether/ether as eluent. A yellow solid with MP = 155-58C and N~ and consistent with the desired structure was obtained.
~b) Diethyl 7~ethyl-4?10-dioxo-4H,lOH-pyTanoL~,3-f:7quinoline-2,8-dicarboxylate A mixture of the product of step (a) (2.6g~ 8.99 mmoles) ~nd diethyl oxalate (11 nls, 75.3 mmoles) I~ dry dimethylformamide ~70 mls) was added to a stirred suspension of 57~ sodium hydride (1.8g, 43.48 mmoles) under nitrogen at room temperature. After addition, the mixture was left to stir at room temperature for 28 hours.
,~ .
The mixture ~as then acidified with lO~o hydrochloric acid. A
bright yellow precipitate was obtained. The mixture was extracted wi~h ethyl acetate which was dried and evaporated to gi~re a yellow solidO This solid was redissolved in an ethanollh~rdrochloric acid ~ixture. This solu~io~ w~s brought to reflux on a steambath for 2 hours and cooled befare pouring into an ice/water mix~ure. The mixture was extracted ~ith e~hyl acetate, dried, and e~aporated to give a br~wn oil which ~hen triturated with a petroleum ether/ether mixture yielded a brow~ solid whose h~ and ~S spectr~ ~ere consistent with the desired structure.
(c) 7-Ethyl-4710-dioxo-4H,lO~l-pyrano LZj3-f~Tquinoline-b~ 9~C~-d O.lN Sodium hydroxide (75ml, 7.4815 mmoles) was added slowly to a boiling solution of the product of step (b) (1.440g;
- . :: -, , :
dehydrating agent per mole of the pyr~noquinolinone amide. Where the dehydrating agent reacts with one of ~ , R6, ~ or R8 ~e.g. a substituent comprising an -OH group) suficient dehydrating agent should be used to satisfy the side reaction as well as the main reaction. The reaction may, if desired, be carried out in the presence of an acid binding agent, e.g. triethylamm e, The Teaction may be carried out in the presence of a solvent, e.g. N,N-dime~hyl-~orm~mide, dimethyl sulphoxide, pyridine, benzene or hexamethyl phosphoramade, or an excess of the dehydrating agent may be used ~; 10 as the reaction medium. The reaction may be carried out at a temperature o from about 0 to 200C depending on the dehydrating agent used. When phosphorus oxychloride is used a temperature of from 0 to 100C is preferred.
The chromone amide starting materials may be made by reacting a corresponding pyranoquinol~nonè ester ~ith ammonia, using techniques con~entional in the production of amides rom esters9 e.g. using an alkanol as solvent at a temperature of 0 to 120C.
Conpo~ds of ~rnwlae VI, VII, IX, XIII~ XIV, XV and XVI are - either known or may be made from Xnown COmpQUlldS using conventional techniques known ~ s~.
The processes as described above may produce ~he compouna of .
- form~la I or a ~erivative thereo. It is also within ~he scope of this inventio~ to treat any derivative so produced to liberate the ~ree compound of formula I, or to convert one derivative into another.
lg - .
,,~.
.'~
. "~ - :
~ ~Z~
- ~0-l~e compounds of formula I and the interm~diates therefore may be isolated from ~hei~ reaction nuxtures using con~entional -~echniques.
: Pharmaceutically acceptable derivatives of the compounds of ~rmula I include pharmaceutically acceptable sal~s, and ~hen E
is a -CCOH group, esters and amides of the 2-carboxylic acid group.
Sui~able salts mclude ammonium, alkali ne~al (e.g sodium, potassium and lithium~ and alkaline earth metal (e.g, calcium or magnesium) salts~ and salts with suitable organic bases; e.g. salts with :
hydroxylamine, lower alkylamines such as methylamine or ethylamine, with substituted lower alkylammes, e.g hydroxy substituted alkylamines such as tris~hydroxymethyl)me~lylamine, or with simple - nocyclic nitrogen heterocyclic compo~nds, e.g piperidine or morpholine. Suitable esters include simple lower alkyl esters, e.g the ethyl ester, esters derived ~rom alcohols containLng basic groups, e.g di-lower alkyl amino substituted alkanols such as the ~-(diethylamino)-ethyl ester,-and acyloxy alkyl esters, e.g a lower ac~loxy-low~r alkyl ester such as the pi~aloyloxym~thyl ester, or a bis-ester derived ~rom a di-hydroxy compound~ e.g a di~hydroxy-lower alkyl3 ether~ e.g ~he bis-2-oxapropan-1,3-diyl ester. The pharmaceutically acceptable acid additio~ sal~s of the basic esters9 and also of those compounds in which one of ~ , R6, ~ and R8 is a group ~ ag the hydroch~oride, the hydrobromide, the oxalate, the maleate or the flmarate sal~s; m~y also be used. The esteTs ~ay be made by convent;onal t~c ~ ques, e.g esteri~ication or - 20 ~
21 ~ 6~41' transesterification. The amides may be9 for example, unsubstituted or mono- or di- C 1 to 6 alkyl amides and may be made by con~entional techniques, e.g reaction of an ester of the corresponding acid with ammonia or an app~opriate amine.
The compounds o~ -formula I and pha~maceutically acceptable derivatives thereof are useful because they possess pharmacological activity in animals; in particular they are useful because they inhibit the release and/or action of pharmacological mediators w~ich result from the in viYo combination o certaLn ~ypes of ; 10 antibody and specific antigen, e.g the combination of reaginic antibody wqth speciic an~igen ~see Exampl~ 27 of British Patent Specifisation No 1~292,601). The new compounds have also been found to inte~fare with reflex pathways in experimental animals and ~an and in particular those reflexes associated with lung function. In man, both subjective and o~jective changes which result.from the inhalatîo~ of speci~ic antigen by sensitised sub~ects a~e inhibited ~y p~ior adm;nistration of the new compounds. Thus the new compounds are indicated for use in the treatm~nt of reversable airway ~bstruction and/or to prevent the secretion of ; 20 excess ~ucous. The new compounds are thus indicated or ~he treatment of allergic asthma, so-called 'intrinsic' asthma tin which no sensitivity to extrinsic antigen c~n be demDnstrated), bronchitis, coughs and the nasal and bronchial obstructions associated with ~he common colds. l~le new compounds may also be of value in the 25 treatment of o~her oond~tions in which an~igen-antibody reactions or -~^
.
.,, ., ~ , ~ 22 ~ L~L'~6~4 excess mucous secretion are responsible for, or are an adjunct to9 disease, for example, hay fever; certain eye conditions, e.g trachoma; alimentary allergy, e.g urticaria and atopic ec~ema; cmd gastrointestinal conditions, for example gastrointestinal allergy, S especially in children, e.g milk allergy, or ulcerati~e colitis.
For the aboYe mentio~ed uses the dosage administered ~nll, o course9 vary with the compound employed, the m~de of ~dministration and the treatment desiTed However, in general~
satisEactory ~esults are obtained ~hen ~le compounds are administered at a dosage of from 0.001 to 50 mg per kg of animal body weight in the test set out in Example 27 o~ British Patent Specification No lt292,601. For m~n the indioated total daily 1 dosage is in ~he range o from 0.01 mg to 1,~00 mg preferably from 0.01 mg to 200 mg and more preerably from 1 mg to 60 mg, which may be administered in divided doses fiom 1 to 6 times a day or in sus~ained release form. Thus unit (~sage ~orns sui~able ~OT
.
administration (by inhalation or oesophageally~ comprise from 0.01 mg to 50 mg, preferably 0.01 mg to 20 mg and more pre~erably from 0.01 mg to 10 mg of the compound preferably admixed with a solid or liquid pharmaceutically acceptable diluent~ carrier or adjuvant.
. The comFounds o~ formula I, and phaTmaceutically acceptable derivatives thereof, ha~e the advantage that they are n~re ef~icacious in certaLn pharmacological mDdels, or a~e longer acting than compounds of similar structure to the compounds ~f . :
' " '~' .' ' , ~ :
1, . .
02/~/30 - 23 -~
formula I. Furthermore the compounds of formula I, and pharma-ceu-tically acceptable derivatives thereof, are advantageous in that they are more efficaceous in interfering with reflex pathways and in inhibiting the ~ecretion of mucous than are compounds of similar structure to the compounds of formula I.
We prefer each of Ry, R5, R6, R7 and R8, when they contain carbon, to contain up to 8, and preferably up to 4 carbon atoms~
Specifically we prefer R5, R6, R7 and R8 to be selected from hydrogen, methoxy, propyl, allyl, methyl, ethyl, chlorine, bromine and hydroxy. The -COCH=CE-O- chain may be bonded to the benzene ring in any sense and in any of the adjacent positions R5, R6, R7, R8. However, we prefer the chain to ~e bonded in the positions R6 and R7 the -O- part of the chain being in position R7. We also prefer the group E to be a -COOH group.
According to the invention there is also provided a process for the produc-tion of a pharmaceut:ically acceptable salt of a compound of formula I, which compr:ises treating a compound of formula Ic, R5j O
R6~ ~ Ic R8j R .
in which Rg is as defined above, R5j, R6j, R7j and R8j have the same significances as R5, R6, R7 and R8 above, save that an adjacent pair of R5j, R6j, R7j and .,~-. ~
' ' ' ' ;',~, , ~3/~/30 - 24 ~
~j ~ay form a chain -O-C~X)=CHCO-, and X is a 5-tetrazolyl group; an (N-tetrazol-S-yl)carboxamido group, a carboxylic acid.group ~or an ester thereo~, or another ~alt thereof), a nitrile group, an acid halide group or an amide s ~roup, wqth a compound containing an available pharmaceutically acceptable cation and capable of co~verting the group X to a Fharmaceutically acceptable salt of an H group.
Compounds capable of converting the group X to a pharmaceutically acceptable salt of an E group include compounds, e.g bases and ion exchange resinsS containing pharmaceuticalIy acceptable cations, e~g sodium~ potassium, calcium, ammonium and appropriate nitrogen contain;ng organic cations. In g~neral we prefer to form the pharmaceutically acceptable salt by treatIng ~he free acid of formula I with an appropriate base, e.g with an alkaline-earth or alkali metal . hyd~oxide, carbona*e or biearbonate in aqueous solution or by a --.
m~ta~he~ical process wlth an appropriate salt. When a stronglr basic compound~is used care should be taken, e~g by keeping the ~0 te~perature suf~iciently l~wS to ensure that the compound o~
fo i a I is not h~drolysed or o~herwise degraded. The .
phanmaceutically acceptable salt may be recovered from the reaction maxture by~ for example, solvent precipitation and/or removal of the solvent by evaporation, e.g by reeze drying.
According to ou~ invention we also provide a pharmaceutical :~ - 24 - .
~. :
:::;. :: ~ :i:; . . .: "
, : :, .: ' ' ~' '. ' :
:'': ., . :. :~
composition comprising (preferably less than 80~, and more preerably less than 50% by weight~ of a compound of ~ormula I, or a pharmaceutically acceptable derivativ~ thereo-f, in combination ~ h a pharmaceutically acceptable adjuvant, diluent or carrier.
Examples of suitable adjuvc~nts, diluents or carriers are:- for tablets capsules and dragees; microcrystalline cellulose, calcium phosphate, diatom~ceous ear~h, a sugar such as lactose, dextrose - or mannitol, talc, stearic acid, StarGh, sodium bicarbonate and/or gelatin; ~or suppositories, natural or hardened oils or waxes;
and for inhalation compositions, coarse lactose. The compound of ~ormula I; o~ the pharmaceutically acceptable deri~ative thereof, preferably is m a form having a mass median diam~ter o from 0.01 to lO mQcrons. The compositions may also contain suitable preserving, stabilising and w~tting agents9 solubilizeTs, sweetening and colouring agents and ~avourings. The co.~positions may1 if deslred7 be formulated in sustained release form. We prefer con~osîti~ns ~ich aIe designed to be taken oesoq?hageally and to r~lease their contents in the gastrointestinal tract. r~
The 5-tetrazolyl and (N-tetrazol-S-yl)car~oxamido groups are of orm~1ae XVII and XVIII respecti~ely, `
XVII - C \ ll CONH~ XVIII
N - N N
. ~ I
H H
, ~ ` .
, 05/~/30 The group5 of ormu1ae XVII and XVIII may exist in tautoneric forms and such tautomeric forms are in d uded within the defini~ion of the compounds of formula I.
~ le invention is illustrated, but in no way limited by the following Examples.
le 1 4 6 Dioxo-10 o 1-4H 6H- ano C3,2-~ 7 uinoline-2,8-dicarboxylic acid 9 ~ py / pyr _ c> q -(a) 4 Acetamido-2-allyloxyacetophenone 4-Acetamado-2-hydroxyacetophenone (19.3g) allyl bromide ~12.1 ml~
and anhydrous po~assium carbonate (21.$g~ were stirred in dry dimethylformamide (250 ml) at room temperature for 24 hours. The reaction mixture was poured into water and ~he product was extracted with e~hyl.acetate. The organic solution was ~hen washed well wi~h water dried over magnesium sulphate an~ evaporated to dryness. The su~-title product was obtained as buf coloured solid (20.Sg). The structure of the product was confirmed b~r N~IR and mass spectroscopy~
tb) ~ =~
The above allyl ether (18.4g) was hea~ed at Z00-210C for 4 hours. 17~1g of the thermally rearranged sub-ti le product was obtained as brown solid~ Again ~he structure was confirmed by MR and mass spect~oscopy.
~c) 4-Aceta~ido-Z-hydroxy-3-p~Ey-~acetophenone The product of step (b~ (17g) was dissolved in glacial acetic acid and hydrogenated in the presence of Adans catalyst ~til -~ 25 hydrogen uptake had ceased~ The catalyst was filtered off through ':
06/B~30 2~
a kieselg~r filter and the filtrate was evaporated to leave 13.0g o allnost colourless solid. The mass and ~IR spectra confilmed t~e struc~cure of ~he product.
(d) E~2~1 7-acetamido-4-oxo-8-propyl-4H-l-benzopyran-2-carbo~ylate A n~xture of diefflyl oxalate ~19.3g; 17.9 ml) and the above product of step tc) (12.4g) in dry ethanol (100 ml~ was added to a stilTed solution o sodi~ e~oxide in et:hanol (prepared by dissolving sodi~n (6.1g) in dry ethanol ~200 n~)). The reaction mLxture was refluxed for 3 ho~s and ~hen poured into dilute hydrochloric acid and chloro:Eorm. The chloroform layer was separated"
washed with wate~ and dried. The solvent was evapora~ed to leave a br~: solid which wa~ dissolved in ethanol t3Q0 m~) contai~ing concentrated hydrochloric acid t3 n~) and the ~ole was reLuxed ~or 1 hour. lhe ~eaction mixture was poured into wa~er and t~he ~: 15 product was extTacted into ethyl acetate which was washed with ~ water aIId dried. l~e solvent was evaporated to leave 10 g of a; sticky solid whiçh had n~ss- and NMR spectra consistent with the expected product.
~ (e) Eth ~ am mo~4-oxo-8~E~eyl-4H-l-benzopyr - 20 A solution of the amide of step (d) (lOg) in ethanol ~300 m~)~
contaLning concent~ated hydrochloric acid ~5 ~1), was refluxed fiDr 8 hours. The Teaction mixture was diluted with water and extracted into ethyl acetate. The extract was washed ~ith water, dried and the solvent was evaporated to leave a dark ~rown semi-25 solid. This was chromatographed o~ a silica gel column, using ~ 27 -, , 07~B/30 - 28 ~ 64~
ether as eluant to give 4.8g of the required product whose structure w~s confirmed by mass and NMR spectral evidence; mp 84 87~C.
~f) 8-Ethoxycarbonyl-2-me~hoxycarbonyl-476-dioxo-10-propyl-4H,6H-pyranoL3 ,2-g~q linoline The amino benzopyran of step ~e3 (2.0g) and dimethyl acetylene dicaTboxylate ~1.24g; 1.01 n~) were refluxed ~n ethanol ~30 ml) -for 26 hours. The reaction maxtllre was cooled to 0C and the insoluble yellow-brown solid was collected by filtration and washed wqth a little ethanol and dried to gi~e 2.0g of a product which was a -mixture of maleic and ~umaric este~s obtained ~y Michael addition of the amine to the acetylene.
This mixture of esters t2.0g) was treated with polyphosphoric 1-- acid (30 ma~ and heated on the stean bath with stirring for 20 m~nutes. The reaction mix*ure was then poured onto ice and stirred with ethyl aceta~e. The organic layer w s separated~ washed with ~; water and dried. The solvent was evaporated ~o leave ~6g of a yel~ow o~an~e solid. P~c~rstallisation of ~is solid from e~yl aceta~e gave the ~equired product as fluf~y orange needles np 18Y-1~8~C.
~0 ~al~
F~nd: C~ 62~0~o; H3 5.1%; H, 3.7~0 C2 ~ 9N7 Required: C 62.3~; H, 4.9~; N, 3.6~
(g) ~,6-~ioxo-10-propyl-4H,6H-pyrano~ 2-g7quinoline-2~8-_carb~n~lic a~d The above bis ester (2.5g) was ~efluxed w~:h sodium bicarbona~e , .. .
, , . :, , .; , : .
:, ' , - 29 ~ ~L~L~ 44 ~1.64g) in e~hanol (100 ml) ~nd water ~50 ml) for 12 hours. The ~hole was poured into water and acidified to precipitate a gelatinous solid. This was collected by filtration, refluxed with ethanol and the protluct was separated by centri~ugation (1.4g) mp 303-304C dec. The s~ructure of the product was confirmed by mass and Nh~ evidence.
~h) sodium 4,6-dioxo-10~ 4H,6H-E~ran L~3,2-g 7quinoline-- 2,8-di.carboxylate The bis acid from step (g) (1.35g) and sodium bicarbonate (0.661g) in water ~150 ml) were warned and stirred until a clear solution was obtained~ This solution was filtered and ~he filtrate was ~r~eze dried to give 1.43g of the required disodium salt~
Analysis Found: C, 46.1~; H, 4~0%; N~ 2.9 ~ 7~ 1NO7Na2 12.5~ ~ 0 requi~ed: Cg 46.1%; H~ 3.8%; N, 3~15 ` Ex~ple 2 4~Dioxo- thyl-10-propyl-4H ~ -g 7quinoline-2,8-car~oxylic acid ~a) 4-tN Acetyl-N~ethyl)~nino-2-allyluxyaoetophenone ~ 20 4-~N-acetyl-N-ethyl~amino-2-hydroxyacetophenone (92~6g), allyl : bromide (51 m~s~ and anhyd~ous pvtassium carbonate ~90.4g) were stirred in dry dimethylform~mide ~500 n~s) for 17 hours. The reaction mixture was poured into water and the produc~ was ext~acted with e~her. The organic solution was then washed well with water, dried over magnesium sulphate and evaporated to ' '/ ' ' ~ `" ` ' ' ~ . , , dryness. The product ~as obtained as an oil (102.5g). ~he st~ucture of the product was con~irmed by NMR and mass spectroscopy.
Cb) 4-~N-A~etyl-N-e~hyl)amm o-~propyl-2-hydroxyacetophenone , The allyl ether product of step (a) (lOO.Sg) was refluxed in diethylaniline (300 nls) for 3 hours. The reaction mnxture was cooled and poured into dilute hydrochloric acid and extracted into ether, ~lich latter was washed with dilute hydrochloric acid, and ~hen with water. The organic solution was extracted with 10 sodium hyd~oxide solution which was then acidified. The precipitated product was extracted with e~her which was dri~d -over mag~esiu~ sulp~ate. The resulting ethereal solution was evàporated ~o dryness to give a yellow-brown oil C78.7g~ This oil was a n~xture of 4-~N~acetyl-N-ethyl)amino-3-allyl-2-. ., hydroxyacetop~enone and 6-QN-acetyl-N-~thyl~amino-3-allyl~2-hydroxyacetophenone.
This mixture was dissol ~ d in ethanol (500 nls) and glacial acetic acid ~20 mls) and hydrog~nated ~n the pTesence of Adams catalyst until hydrogen ~p~ake had c~ased. The catalyst was ~ , filte~ed of~ ~hrough kieselguh~ and ~he filt~ate evaporated to leave 79.9g of brown oil. Ihis brown oil was a mixture and was separated by hi~h pressure liquid chromatography using etheT/petroleum ether ~1:1) as solvent to give 44.2g of the sub-title conpound and 23.8g of 6-~N-acetyl-N-ethyl)amino-3-propyl-2-hydroxyacetophenone.
, . . .. ~
~%~
(c~ 4-N-Ethylamino-~propyl-2-hydroxyacetophenone 4-(N-Acetyl-N~ethyl)amino-3 propyl-2-hydroxyacetophenone (44g) was refluxed in 48~ hydrogen bromide in glacial acetic acid ; (100 mls), glacial acetic acid (S00 mls) and water (20 mls~ for 6 hours~ The reaction ~ixture was poured on to ice-water and extracted with ethyl acetate which was washed with water, sodium bicarbonate solution, then water again and dried over magnesium sulphate. The organic solYent was evaporated to dryness to leave the sub-title compound as a red oil (34g). The structure was confirmed by NMR and mass spectroscopyO
(d) Me~hyl 6-acetyl-1-ethyl-7-~y_roxy-4-oxG-8-propyl-4H-uinoline-2~carbo~y_ate he amine product oL step ~c) (17g) and dime~hacetylenedi-carboxylate tll.3 mls) were re~luxed ~l e~hanol (300 mls) for 17 hrs.
The reaction mixture was cooled and evaporated to dryness to leave a deep red oil. Thi5 oil was chromatographed on a silica gel -~ column using e~her/pe~roleum ether (1:1~ as eluant to give l9.1g of dimethyl l-t4 acetyl-3-hydroxy-2-propylphenyl~-N-ethylamino-maleate, m.p. 83~87C.
The maleic ester (Sg) was heated and s~irred in polyphosphoric acid ClC0 mls) on the steam bath for 10 minutes. The reaction m~xture was cooled and poured on to a mixture of ice-water and ethyl acetate. The organic solution was separa~ed-, washed with water and dried ove~ magnesium sulphate. The solvent was evaporated ~o dryness to lea~e a pale yellow solid. lhis '' ~, ' ll/B/30 26~
product was purified by high pressure liq~id chroma~ography to give 2.6g of the sub title compound m.pD 121-123C.
An~ysis Found: C: 65.5~ H; 6.6% N; 4.2~
C18~21N05 Requlred: C~ 65-3~ H; 6~34% N; 4.23%
~e~yl 6-acel~ ethyl-5-hydro~y-4-oxo-4H-quinoline-2-ca~boxylate was obtained from the purification as a pale yellow solid (100 mgs).
(e) qwnoline-2,8-dicarboxylate The hydroxy keto~e product of step ~d) (l.Og) and diethyl ~!`, oxalate (3.3 mls) in dry dimethylformamide (25 mls) were added to ; ether washed 50% sodium hydride (0.581g~ in dry dimethylformamide ~, . , . ~
C20 mls) and the reaction mixture stirred for 4 hou~s. The ~eaction mdxture was then poured into water,acidîfied and ext~acted wi~h ethyl acetate, which was then washed wqth water ~nd.dried over magn0sium sulphate. ~he solvent was evaporated to dryness to give an oil whic~ was dissolved in ethanol ~100 mls) .~, .
; and concentrated hydrochloric acid ~a few drops) added. The 20 solution was refluxed for 2 hr, cooled~ poured into water and extracted with.ethyl acetate, which was washed with water and dried over magnesium sulphate. The solvent was evaporated to dryness to leave an oil which solidified on trituration with 40-60 petroleum ether (1.2g). The structure of ~he compound was conirmed by NMR.
t - 32a - ~ %
~f) ~l~l ~g~quinoline-' 2~8-diciarb~ lic acid The abo~e bis ester ~l.Og) and sodium bicarbonate (00787g) in ethanol (~5 mls) and water ~32 mls~ were ref~uxed for 4 hours. The 5 reaction mixture was poured into water, acidified and the precipitate .;
was collected by filtration &nd dried. The product was purified by :~x~tula.~,~n.~,wi~ bQ~lihg ethanol9 then twice with boil m g acëtone.
~fter each trituration the mixture was centrifuged and ~he ` supernatent liquid was removed by decantation. The residual solid was dried to give 0.547g o ~he requi~ed di~acid as a yellow powder m.p. 298-3~0 dec~ , Pound: C: 61.3~ H; S.0% N; 3~6%
.
~'', C1 ~17N07 Required: C: 61.5~ H; 4~6~ N; 3.79 tg) Disodlum 4~6-Dioxo-l-ethyl-lo-propyl- H ~ 3,2-~:7 , 15 quinoline-2,8-dicarboxylate The abo~e di-acid (4.098g), s~spended in ~ater ,~100 mls) and was treated with sodium bicar~onate ~1~82g). The ~esul~ing solu~ion was filtered and the filtrate ~as treated with acetone '~
until co~plete precipitation of the product had occurTed. l~e required di-sodium salt was il~ered off ~nd dried to give 3~39g of a pale yellow powder.
~;
' Found: C; 51.1~ H; 4.3~N; 3.0 19~115NNa27R~quired: C: 51.1~ H; 4.1~N; 3.1 2S t6.9~ water) ', ' ,. ':
_ 32a -1 . , ... .
. 12/B/30 - 33 ~ L'~6 Exa~ple 3 The ~ollowin~ compounds may also be made by the processes described abo~e:-(i) 5-E~hyl-4,8-dioxo-10-propyl-4H,8H-pyrano r2~3-h~7-q ~loline-2,6-dicarboxylic acid (ii) 4l10-Dioxo-4H,lOH-pyranoL~,3-~7quinoline-2,8- .
dicarboxylic ad d r ~;. (iii) 10-Bromo-4,6-dioxo-4H,6H-pyrano L3,2-g~7quinoline-2,8-dicarboxylic acid ` 10 (iv) 5-Hydro2y-4,6-dioxo-10-prow 1-4H,6H-pyrano L 3~2-g,7 .
quQnoline~2,8-dicarboxylic acid ~v) 4,9-Dioxo-4H,9H-pyranoL~2,3-g~7quinoline-2,7-~- dicarboxylic acid (vi) 4,10 Dioxo-4HJlOH-pyrano C2,3-~:7quinoline 2,8-dif~N-~- 15 ~tetrazol-5-yl) 7carboxa~de .. ~ . -~vii~ 10-Bromo-4,6-dioxo-2,8-di-(tetrazol-5-yl)-4H,6H-~, pyranoL~3,2-g~7quinoline.
' ' .
-: ;, ., ... .
:
, , , : .: :
,..... .. . .
_ 3a~ _ )~ pp/~r~er~ t!c~r~ S c/o S~tre '~'^`' Exa~le 4 ne-2,8_dicarboxy1ate (a) Methyl-6-acetyl-1-ethyl-5-hydroxy-4-oxo-4~1-quinoline-2-carboxylate :
A mixture of di~ethyl acetylene dicarboxylate (13g; 91.5 n~ole) and 4-e~hylamino-2-hydroxyacetophenone (16.1g, 89.8 mmoles) in ethanol t250 ml3 was re~luxed on a steambath for 7 hours. The mixture was cooled before being poured into water. The n~xture was concentrated by removing some o~ the ethanol and was then extracted with ethylacetate. The organic extract was washed with a large volume of water and then was dried (~nhydrous sodium sulphate). Solvent was rem~ved by evaporation to giYe a light brown oil. When triturated with petroleum ether/ether mixture a yellol~ solid was obtained. Both N~ and MS showed it to be consistent 1~ith *he expected structure.
l~e above dimethyl acetylene dicarboxylate adduc* of 4-ethylamino 2-h~fdroxy acetophenone (5.5g, 17~1 ~moles) was ~yclised by heating with polyphosphoric acid (19Og) for 20 minutes. The dark viscous solutio~ was treated with ice/water mixture and the resulting suspenLsion w~s extracted with ethylacetatç. The organic layer was washed with large volume of water, and this w~s then dried (anhydrous sodium sulphate).
Solvent was removed to give a light brohn solid. ~ ~ and ~
showed this compound to be a mixtuTe, the sub-title compound I~...~i ' ' ' . ', , ~,, `: ~
6~
being the main produot. A pure sample was obtained by chromatography on silica gel using petroleum ether/ether as eluent. A yellow solid with MP = 155-58C and N~ and consistent with the desired structure was obtained.
~b) Diethyl 7~ethyl-4?10-dioxo-4H,lOH-pyTanoL~,3-f:7quinoline-2,8-dicarboxylate A mixture of the product of step (a) (2.6g~ 8.99 mmoles) ~nd diethyl oxalate (11 nls, 75.3 mmoles) I~ dry dimethylformamide ~70 mls) was added to a stirred suspension of 57~ sodium hydride (1.8g, 43.48 mmoles) under nitrogen at room temperature. After addition, the mixture was left to stir at room temperature for 28 hours.
,~ .
The mixture ~as then acidified with lO~o hydrochloric acid. A
bright yellow precipitate was obtained. The mixture was extracted wi~h ethyl acetate which was dried and evaporated to gi~re a yellow solidO This solid was redissolved in an ethanollh~rdrochloric acid ~ixture. This solu~io~ w~s brought to reflux on a steambath for 2 hours and cooled befare pouring into an ice/water mix~ure. The mixture was extracted ~ith e~hyl acetate, dried, and e~aporated to give a br~wn oil which ~hen triturated with a petroleum ether/ether mixture yielded a brow~ solid whose h~ and ~S spectr~ ~ere consistent with the desired structure.
(c) 7-Ethyl-4710-dioxo-4H,lO~l-pyrano LZj3-f~Tquinoline-b~ 9~C~-d O.lN Sodium hydroxide (75ml, 7.4815 mmoles) was added slowly to a boiling solution of the product of step (b) (1.440g;
- . :: -, , :
3.7402 mmoles~ in methanol (50 mls). After addition the mixture was allowed to reflux for 2 hours, then cooled, and acidified with 10 hydrochloric acid. A light brown precipitate was obtained, which was iltered and dried In vacuo. ~ and MS were consistent with the desired structureO
Elemental Analysis: C = 58.8% H = 3.37% N = 4.25%
Found: C = 51.8 H = 4.3 N - 3.7 Containing 11.9~ ~ 0 ~d~ Disodium 7-ethyl-4~10-dioxo-4H,lOH-pyrano C~,3- D ~uinoline-Z,8-dicarboxylate Excess acetone was added to a solution of the product of step (c) ~0.755g, 2.2948 mnoles) and sodium bicarbonate ~0.3856g,
Elemental Analysis: C = 58.8% H = 3.37% N = 4.25%
Found: C = 51.8 H = 4.3 N - 3.7 Containing 11.9~ ~ 0 ~d~ Disodium 7-ethyl-4~10-dioxo-4H,lOH-pyrano C~,3- D ~uinoline-Z,8-dicarboxylate Excess acetone was added to a solution of the product of step (c) ~0.755g, 2.2948 mnoles) and sodium bicarbonate ~0.3856g,
4.5892 mm~les) in water (5 mls). A pale yellow precipitate was obtained and was dried in vacuo. N~ was consistent wqth the desired structure.
Ele~nental Analysis: C - 51.49~ H = 2.43~ N = 3.75 Found: ~ = 44.1~ H = 3.7~ N = 3~2nO
Containing 14.4~ H20 , Disodium-9-(3-methylbutyl)-4 ? 6-dioxo-4H/6H-pyTano L3,2-g 7 quinoline-2,8-dicarboxylate (a~ Methyl 6-acety~ 7-hydr xy-1-(3-methylbutyl)-4-oxo-4H-quinoline-2-. ~ .
Polyphosphoric acid ~50 ml) was added to E-dimethyl 2- ~N-(4-acetyl-3-hydroxyphenyl)-N-~3-methylbutyl)amino~7-but-2-ene-1,4-- 36 ~
~f~
dioate, (10089g) and the resultin~ viscous dar~ red oil ~as stirred on a steambath for ten mlnutes9 then poured into an iced l~rater/
ethyl acetate mixture and stirred vigorously ~or one hour. The ~esulting moxture ~as extracted into ethyl acetate? dried using magnesium sulphate, iltered and the volatiles were removed m vacuo af~ording a mixture (8.0g) of the required sub-title eo~pound and methyl 6-acetyl-S-hydroxy-1-(3-methylbutyl)-4-oxo-4~-quinoline-2-carboxyla~e.
~ eparation of the isomers was achie~ed using column chromatography wi~h sIlica gel as the stationary phase and eluting primarily with ether~ then chlorofonm. This process removed some of the unwanted isomerJ the required sub-title compound being adsorbed on the silica-gel. The silica gel was removed from the column, refluxed with ethyl acetate, filtered o~ and ~he filtTate evaporated yiélding a cTude sample of the required sub-title compound ~2.7g).
This was further purifled us m~ high pressure liquid chromatgraphy affording 0.5g o the sub-title compound. MP 108-110C.
Anal~is Found: CJ 65.4~0: H, 6.3~o: N~ 3.9~
C18H21N03 Requires: C, 55.3~: H~ 6.3~0: N, 4~2~o N~ spectroscopy and mass spectroscopy con~inmed the structure.
(b) Diethyl-9-(3-meth~lbu~yl)-4~6-dioxo-4H~6H-pylano L3,2-g 7quinolin~-2,8-dica boxylate A solution o the product o~ step (a~ (2~3g) and diethyl o~alate (~.5 ml) in dry dImethyl-Eormamide (60 ml3 was adde~ to a stirred ~;
, ~ , ., ' ;
suspension of ether waslled sodium hydride (0~65g) in dry dLmethylformamide ~75 ml) under nitrogen. I~e whole was then stirred at a~bient *emperature for t~en~y four hours9 then poured into iced water and extracted into ethyl acetate. This solution was dried using magnesium sulphate, filtered and volatiles removed in vacuo, affording an oil.
To this oil was added saturated ethanolic hydrogen chloride t300 ml) and the whole heated under reflux for two hours, then poured into iced water and ex*racted into ethyl acetate, which was washed with water, saturated aqueous sodium chloride solution and then dried using magnesium sulphate. The organic solution was filtered and Yolatiles were removed in acuo. The resulting oil was subjected to column ~hromatography with silica gel as the statio~ary phase and diethyl ether as eluan~ affording a solid, ~hich was triturated with light petroleum ether>w~shed with a little ether, and dried undeT
reduced pressure oYer phosphorus pentoxide at 100C for three hours yielding l.Zg of sub-title co~p~und. MP 149-150C.
Analysis Found: C, 64.2~: H, 6.0~: N, 3.0 C23H2~i!107 Requi~es: C, 64O6~i~ H, 5.9~: N~, 3.3~
NMR a~ectroscopy a~d mass spectroscopy confi~med ~e structure.
~c~ 9 (3-Methylbutyl) -4 ~6-dioxo-4H,6H-pyranoL~3,2-~7quinol~
di~ic acid The product of step ~b) (l.OOOg) was dissolved in methanol ~150 ml) and heated to re~lux. 0.1 M NaCH (46.8 ml) was then added and the whole ~ 1 6~
heated at re1ux for ~hree minutes. The soluti~n was cooled, acidified, and the precipitated product collected and dried under reduced pressure over phosphorus pentoxide at 80C for ~o hours, and then at 100C for one and one half hours, affording the sub-title compound (0.7g) MP 302-304C.
Analysis Found: C, 59.7~: H, 4.9~: N, 3.5 ClgH17N07 Requires: C, 59.7~: H, 4.6%: N, 3.6 2.9~ H20 Hemihydrate requireso C, 60,0~: H, 4.5%: N, 3.7~
(d) Disodium-9-~3-methylbutyl)-4~6-dioxo-4H~6H-pyTanoL 3~2-g~7quinoline-2,8-dicarboxylate - The product of step (c) 2.9% H20 (0.5g) was suspended in distill~d water (100 ml). Sodium bicarbonate ~0~243g) was added and the whole mixture was shaken vigoIously. The r~sulting solution was filteTed and freeze drled a~fording 0.7 g o~ the title compoundi .
Found: C, 45.4~: H, 5.2~: N, 2~g5 C19H15NNa207 Requires: C, 45.4~: ~, 4.9~: N, 2.8%
17.Z~ H20 NMR spectroscopy confirmed the structure.
.
- 3~ -" ~, "
.~
,6~
a~ple 6 Disod;um 7-(3-me~ylbutyl)-4~lo-dioxo-4H?loH-pyTan-o--c223-fJ quinoline-2 ~-dicarboxy~
(a) N-(3-Methoxyphenyl)-N (3-methylbutyl)ethanoamide Sodium hydride ~14.4gm) was washed with dry ether, then suspended in dry di~ethylformamide CloO ml) under dry nitrogen. N-t3-Methoxy-phenyl)ethanoan~de ~74.3g~ was dissolved in dry dimethylform3mide (400 ml) and added to ~he NaH suspension. The resulting suspension was cooled to 0C and stirred until hydrogen evolu~ion ceased.
3-~lethylbutylbromQde ~88.5g) was then added dropwise and the whole stirred at room temperature for two hours The mixture was then poured in~o water containing a little ethanol, extracted into ether, washed l~th water~ dried UsiIIg magr~esium sulphate, filtered and the volatiles were removed in vacuo. The resulting oil was subjected to a vacuum distillation~ accepting the raction at 126~146C and 0.5 mm Hg p~essure3 yleldin~ 9S.5 gm o~ the sub-title compound. N~
spectroscopy and ~ss sepctroscopy confilmed the stru~ture.
~b) N-t3-Hydroxyphenyl)-N-~3-methylbutyl)ethanoamide To a stirred solution of the product of step ~a) (10.8g) in d~y dichloroethane ~100 ml) at -70C was added borontribromide (1~.4g).
The tempera~ure was allowed to rise to room temperature and the mixture was stirred at this temperature ~or 12 hours, then poured into water, extracted into chloroform, dried using magnesium sulphate~
iltered and the ~olatiles were removed în ~acuo, afording (10.4g) o the sub-title compound. NMR spectroscopy and mass spectrDscopy . ~,. .
: .. . : ,. .
.. ,~ :
confirmed the structure.
(c) N-Acetyl-N-(3-methylbutyl) aminophenyl-ethano te To the product of step (b) ~92.2g) in dry *oluene ~2L~ was added acetyl chloride (49.1g) and pyridine (2 ml). The resulting solution was re~luxed for five hours, poured into water and the organic layer ~Tas separated, ~ashed with more water, dried using magnesium sulphate9 filtered and the volatiles were removed in vacuo, aEforalng (102g) of the sub-title compound.
N~R spectroscopy and mass spectroscopy confiTmed the structure.
(d) N-~4-Acetyl-3-hydroxyphen~ N-(3-methy-lbutyl)-ethanoamide The produc~ of step ~c~ (11.3g) was mixed with aluminium chloride (18g) and sodium chloride (2~5g) and then heated a* 160C
for two hours. Iced water was added cautiously and the resultm g nixture was extracted with 10~ sodium hydroxide solution,which was the~ washed wlth ether. ~e alkaline extracts were acid;fied, extracted in*o ether, dried using magnesium sulphate, filtered and the Yolatiles ~ere r ~ Yed in vacuo, af~ording 7.5g o the sub-title compound.
N~R spectroscopy ~nd ~ss spectroscopy confirmed the structure.
(e) l L ~ 4-~3-methylbutyl)amino-phenyl~7-et~mone To the product of step (d~ ~49.9g) in gIacial acetic acid ~550 ml~
~as added 48~ aqueous hydrogen bromide solution ~110 ml). The mixture was ~efluxed for two hours, poured into water and extracted into diethyl ether. The ether was washed well wqth water, then with saturated sodiumn bicarbonate solution7 dried using magnesium sulphate, -. , ~ ,... . . .
: : , :
~ : :
~ 42 -filtered and finally the volatiles were removed in vacuo, afording 38.0g of the sub-title compoundO
N~ spectroscopy and mass spectroscopy confinmed the structure.
(f~ Iy~ aL~3-hydroxyphenyl)-N-(3-methylbutyl~-amino-1,4-but-2-enedioate To the product of step (e~ (38.0g) in ary ethanol (300 ml) was added dimethyl acetylene dicarboxylate ~31.8g). The resulting solu~ion was heated under reflux for seven hours, after which time the volatiles were removed in vacuo, affording ~75 gm) of crude sub-title compound. The crude sample YaS sub~ected to column chromatography using silica-gel as the stationary phase and a 1:1 mixture of petroleum ether and diethyl ether as eluant. This process aforded (41.4 gm) of pure su~-title compound.
~ ~ spectroscopy and mass spectroscopy confirmed the st~ucture and that of the iso~ric fo~m of the product~
(~ thyl 6-Acetyl-5-hv~rox~ 3-methylbu~y_)-4-oxo-4H-c- . .
quinolIne-2-carbox~ate The product of step ~f) ~3.3g) was added to stirred viscous polyphosphoric acid ~15 ~1~ and the moxture was heated o~ a $team bath for fifte~n minutes. The whole was then poured onto ~n iced water~ ethyl acetate ~i~ture and vigorously stirred for one hour.
The organic layer was sepa~ated, washed well wqth water, dried using magnesium s~lphate~ filtered and Yolatiles ~ere removed m Ya~lo affo~ding a crude sample ~1.7g3 sub-title conpound, 0.7g of which was recrystallised from methanol to gi~e 0.3g of the pure .. ,, ~; i .
,, ~, , i; , .: ~ .. ~.... . .
.
.. ..
. . . ~
~.
sub-title compound. MP 140-141C.
A~alysis Found: C, 65~2%: H, 6.5~ N~ 4.1 ClgH21N05 Requires: C, 65~3~o H~ 6~3~o N, 4.2~
N~ spectroscopy and mass spectroscopy confirmed preparation of the sub-title compound.
Ch) Diethyl 7-(3-met~ylbutyl)-4,10-dioxo-4H,lOH-EyT~c~L~73- D -quinoline~2,8-dicarboxylate To sodium hydride ~0~26g)~ which had been washed lnth dry ether, was added dry dimethylformamide (20 ml) under nitr~gen, with stirr mg. The product of s~ep tg) (0.9g) and diethyl oxalate 3.18g~ in dry dimethylformamide ~20 ml) were added to the above N~H suspension and the whole ~s stirred at room temperature ~or twenty four hours, the~ heated on a steam bath for two hours. The reaction mixture was cooled, poured into water, acidified and extracted Lnto ethyl acetate. The organic layer was dried using m2gnesium sulphate~ il.ered and volatiles were Temoved in va wo.
The residue was dissolv~d in saturated ethanolic HCl ~200 ml) and re1uxed for 15 ~ tes. The whole ~as poured into water7 extracted into ethyl acetate and dried. Evaporation gave a sticky solid which was crystallised from aqueous ethanol to give 0.5g ~f a light bro~n crystalline solid. This was fur~her purified using c~lumn chromatography wnth silica gel as the stationary phase and et~yl acetate as eluant~ affording 0.26g of sub-title compound. MP 144-146C.
.
., : " .' :' ~
.:.
.. .
~.; ~. .
~ 44 - ~L~L
~lysis Found: C, 64.2~: H, 6.2~: N, 3.37~
C23H25N07 Requ;res: C~ 64.6~: H, 5.84~: N, 3.2g~
N~ spectroscopy and mass spectroscopy confi~med prcparation of the sub-title compound (i) 7-(3-Me hylbutyl)-4,10-dioxo-4H,l~H-pyra o L~,3-f~7quinoline-2,8-dicarboxylic acid The product of step th) ~0.9lgg~ was dissolved in methanol ~50 ml) and ~eated to ~eflux. O.lM NaOH ~43 ml) was added and the whole was refluxed for ive ~anutes. The resulting solution was then acidified with O.lNHCl and allowed to cool. A yellow solid crystallised out of solution, was filte~ed off, washed with ether and dried under a ~educed pressure of 0.2 mm Hg at 70C over phosphorus pentoxide, affording 0.67g of sub-title co~ound.
~nalysis Found: C~ 55~7~: H, 4.9~: N, 3.0%
ClgH17N07 9.4~ ~ O ~eo~ui,es: C, 55.7~: H, 5~2~: N, 3.4~
Dihydrate R~qui.es: C, 56.0~: Ho 5.16~: N, 3.4%
Dis~dium-7-(3-m thylbutyl)-4,10-dioxo_4H,lOH_pyrano L~,3- V -quinoline-2~8-dicarboxylate l~e product of step ~i) 9~4~ H20 (005568g) was suspended in distilled wrater ~40 ml). Solium bicarbonate tO.~3g) was then added ~nd the whole vigorously shaken until solution was achievedD The solution was then filtered, and the filtrate freeze-dried3 to give 0~59g of the title compound.
g~
, :, ,, , . ,:
, . . ,. . : .
, ; .: ,, ~, , :
. i : , " ., ,:; '., . ~,, 64~
Analysis Fo~d: C, 46.7%: H, 407% N, 2.8~
ClgH15NNa207 Requires: C, 46.7~o H, 4~7~ N, 2~8Co 14.9% H20 N~R spectroscopy confirmed preparation of the ti~le con~ d.
.:
.
- 45 - .
. ~, : , ,........ ~ .
., .,.~
....
.. , . : .~ :,:
, . . ..
Example 7 Disodium 5~m~hoxy-4,7-dioxo-4H ? 7H-pyranoL~,2-~7quinoline-2,9 dica~boxylate ~a) N~(3-Acetyl~2-hydro~y-4-m~thoxyQhenyl~acetamide 1-~3-~mino-2-hydroxy-6-n~ho~y-phenyl)ethanone (12.9g) was added to a mixture of acetic acid ~3 mls) and water (20 m~s) and heated to 60C. Acetic aRhydride (9.5 mls) was then added and the ~hole heated on a steam bath for ~hirty minutes. The reaction mixture was poured into water and extracted into ether, which was 1~ dried using magn~sium sulphat~, and after filt~ation the volatiles WeTe ~emoved in vacuo7 affording a golden b~own:solid which was triturated wqth chloroform and dried under reduced pressure, yielding 3.7g of the sub t;tle compound, mp 160-162C.
~b) Ethyl 8-~mmo-6-metho~y-4-ox~ 4H~l-benzoEy~ 2-carbox~l te : 15 Sodium (1.4g) was reacted wnth ethan~l (150 m~s3. me ~esultant solu~ion was cooled and sti~red vigorously, and to this solution was added a slurry of the product o~ step ~a) (305g) and Methyl oxalate ~5.4 mls) in ethanol (50 n~s)~ The maxture was heated under reflux for three hours, poured into water ~nd the aqueous solution w~s extracted into ethyl aceta~e, which was washed with a little water and dried using magnesium sulphate. After filtration the solvent was reved in vacuo. Ihis procedure yielded an oil to which was added _ comcentrated hydrochloric acid (3 mls) and ethanol ~100 mls). This solution was heated undeT reflux overnight. The volatiles were rem~ved in vacuo, to a~ford the sub title compound (2.3g). N~M.R.
_ ~6 , 08/B~25 -47 ~
and M~ss Spectroscopy confl~m~d the structure.
(c) Dimethyl N-(5-methoxy-2-e~t~oxycarbonyl-4-oxo-4H~ enzopyran-8-yl)-2-amino~but-2-en~ -dioate To ~he product of step Cb~ C2-3g) was added ethanol (20~ mls) and dimethyl ace~ylene di~arboxylate (1.3 mls). The whole was heated under reflux ~or bwenty hur hours. The v~latiles were ~hen remDved in vacuo to aford a sticky yellow-orange solid ~hich was triturated with a petroleum ether-diethyl ether mixture. The ~ resulting solid was ~iltered under reduced pressure affording ; 10 (1.8gn) of the sub-title compound. N.M.R. Spectroscopy and M~ss Spectroscopy confirmed ~he structure.
(d) Methyl 2-ethox~carbony_1-5-metho -4,7-dioxo-4H,7H-pyranoL~3 : q~inoline-9-c~Iboxyla~e To refluKIng diphenyl ether (5C) mls) was ad~ed the product of step k~ (1.8gm). R~fluxing was cc~ltinued for five minutes, and ~he moxture was then all~wed to coo].. Light petroleum e~her was added an~ the precipitated p~oduct was filtered under Teduced p~essu~e, and w~shed wi~h a ll~tle diethyl ether, affording l.Og of crud~ sub title compound. This solid was tIiturated wi~h a n~xture o~ hot ethyl ace~ate ana chloro~o~m, filtered under reduced pressure and dr~ed. The ma~erial was recrystallised fr~m toluene, and dried in vacuo at 89C over phosphorous pentoxide for ~our hours, - ~esulting in 0.2g of the sub title compound, mp ~60-261C.
. -47-'. ' l~
. ~, ~ "
:, .
-48- ~L~L~ 9 ~e~ 5iMethoxy-4~7-dioxo-4H~7H-py~a~oL~?2-~;7quinoline-2 dicarboxylic acid To a stir~ed suspension of methyl 2-ethoxycarbonyl-5-m~thoxy-4~7-dioxo-~H97H-pyræno C3~2~h~ quinoline-9-carboxylate ~2g) in ~
glacial acetic acid (16 mls~ was added concentrated hydrochloric acid (4 mls). The whole was hea~ed on a steam bath for two hours, cooled and the result~nt solid was ~iltered off under reduced pressure. me solid was washed with acetic acid and ether, End ~hen dried under reduced pressure o~er phospho~us pentoxide ~nd sodium hydroxide at 80C, yielding ~O.~g) of the sub-title-compound, mp 294-6C ~dec).
Analysis .~ Found: C, 49.1; H9 3.4; N, 3.6 N08.9~6% ~ 0 Requires: C, 49~1; H, 3.5; N~ 3,8~
NMR spectroscopy and mass SpeCtl~SC~py con~irm the structure.
~f) D~s~dium 5-methoxy-4?7-dioxo-4H~7H-pyrano r3~2-h 7quinoline-. 2~9-dica~boxylate : 5-M~hoxy-4,7-di~xo-4H~7H-pyranoL~3,2-h 7quinoline-2,9-dicarbo~ylic acid (0.~231g~ was suspended in distilled wa~er (50 nl5).
Sodium bica~bonate ~0~286 gm) was added, and the ~hole was vigorously shaken. me resul~ant solu~ion was ~iltered and the filtrate was ~reeze dried, afording (0.6g) of ~he title compound.
Analysis Found: C, 41.07; H, 2.7; N, 3.3%
25~5H7NNa208.14.4~ ~ 0 RequQr~s: C, 41.07; H, 3.1; N, 3.2 . ,~, , ~ , 10/~/25 %~
-49 ~
~ . .
4,6-Dioxo-10- &r~p-2-e~yl)-4H,6H-pyranoL~,2-g7 qui ine-2 dicaTb xylic acid (a) Eth~l 7-~mino-4-oxo-8-~pro~-2-enyl)-4H-benz~y~an-2-carboxylate :
1-(4-A~ety1amino-2-hyd~oxy-3-~prop-2-enyl)-phenyl~ethanone (20g) and diethyl oxalate (30.95g; 28.7 ml) w~re added to a previously fo~ed solution of sodium ethoxide (~rom add;tion of sodium ~9.7g) to dry ethanol (243.4 ml)) with stirring.
The Teac*ion mixture was stirred und0r neflux ~or 3 hours, cooled and then poured into wa*er. The precipi*ated product was - extracted into chlorof~rm, dried and evaporated to dryness unde~
reduced pressure. The yell~w residual solid was dissolved in fresh, dry ethanol (324.5 ml)~ concentrated hydrochloric acid (3.25 ml) added and the reaction mi~;ure refluxed for 17 houTs.
The ~lole w~s poured ~nto water (1.5 litre3, extracted into ethyl ace~ate, washed with water and dried ov~r magnesium sulphate. The solvent was evaporated to d~yness and the rssidue tritura~ed wi~h 40-60 p~troleum ether to give 19.6g of brown crystall me solid~ A
l.Og sample of the crude product was recrystallised from ethanol to give ~ crystalline solid, mp 142.5-143C.
~b~ Dime~y~l_N-~2-ethoxyca o~yl-4-oxo-8-~pr~p 2-enyl)-4H-l-benzopyTan-7-yl)-2-aminobut-2-ene-1~4-dioate Th0 ploauct vf step ta~ (18.6g) and dimethylacetylene-dicaTboxylate (11.95g; 10.86 ml) in e~hanol (148 ml) were refluxed together for 17 hours. The reaction mLxture was cooled to 10C and ll/B/25 50 ~
the precipitate was collec*ed by filtration, washed with a little ethanol and dried to give 15q8g of product. A O.9g sample was recrystallised from ethanol to ~e a crystalline solid, mp 148-148.5C.
` (c) Ethyl 8-me~hoxycarbonyl-4,6-dioxo-lO-(prop-2-enyl) 4H,6H-~
The product of step Cb) tl4.0g) was added to diphe~yl ether (200 ml) under r~lux wnth stirTing~ The ~eaction mixture was ~efluxed ~o~ a further 5 minutes, cooled and poured into 60-80 petroleum ether (2.0 1). The precipita~ed product was collected by filtration, dried and lecrystallised fr~m ethyl acetate to gi~e 3.5g of yellow solid.
(d3 476-Dioxo-10-~pr~p-2-enyl~-4H~H~-pyrano ~3 9 2- ~ quinoline-298-~icarb~ lic acid The product of step (c) was hydrolysed by ~he method of Example 3(c) ~o afford the title con~und. Structure was confirmed by N.M.R.
Example 9 4,10-Di~xo-4H~OH-pyrano~,3-hJ qu~loline-2,8-dicarboxylic acid (a) E*hyl 5-ami~o-4-oxo-4H-benzopyran-2-ca~bo~ylate E~hyl 5-nitro-4-oxo-4H~benzopyTan-2-caTboxylate tlOg, 38.022 mmolcs) in ethanol ~250 mls) was added ~o 5~ Pd/C ~lg) in ethanol t50 m~) în : a hydrogenation v~ssel. I~o drops of concentra$ed hydrochloric acid were then added to the above m~xture. The mixture ~as ~hen hydrogenated at 3 atmospheres pressure at rD~m tem~erature for 2 hours.
The ca~alyst was filtered of~ through a filter aid ~hich was : -50-.. . s . . ..
- , , , .,., ~.
,: . , , , . . .
, " ' ~2~
washed ~th ~hloro~orm. The filtrate wæ evapo~ated to give a yellaw solid ~8.1g9 91.5~. NMR and m~ss spectra confirm2d that ; the desired c~mpound had been made.
~h~ 8-E~hoxy~a~bonyl-2-methoxy ca~bo~n~l-4,10-dioxo-4H~lGff-pyrano-r ~ -~uinollne The product of step (a~ ~6.1g, 26.1~ Dle) and dimethyl ace*ylene-dica~boxylate (llg; 77.46 mm~le) were heated ~n e~hanol (180 ~il) fo~r 7 hours. The ~eaction nL~xture was cooled and was :: diluted wi~ water. Half of ~he original v~lw~ of ethanol was 10 nemoved an~ the concentrated mdxtNre was. extracted with ethyl acetate. ~e org mic layer was washed ~h a la~ge volume of water, dried and evaporated to give a yellow solid (8.5g, S6~).
lhe solid ~8.5g, 22.66 ~ole) WclS added sl~wly to p~eheated diphenyl e~er (90 n~, 240C) ~der N2 wi~:h stirring. A~ter 15 addition th~ n~xture was brought to ~reflux or 15 ~utes. Ihe n~x~e was ~led and poured into pet~leum et31er (4~6bc, 200 n~) to give ~e slibtitle p~oduct as a li~ht grey solid (4g, 51.3~ 166-7~)C.
(c) 4,1~Dioxo-4H,l~H-Er~,3-h~ inol~e-2,8-dicaTbo~ylic aci_ SoditDn hydroxide solution (O.lN, 58.,27 ml; 5.8267 ~nDle3 was added slowly to a boiling methanolic solutio~ of tihe product of s~p ~b). After additiorl, ~e reaction was heated to reflux for 25 nanu~es. me mixture was cooled and was acidified with dilute hydro~hloric acid (10~) ~o give a very fine precipi~ate, lhis was 25 filtered off and was collected as a light bro~ solid and d~ied _ 51 _ .~ .
in vacuD ove~ P205 at 70C o~e~ ht to give the sub-title p~ uct 6:17g) m~ 200C.
~lysis Found: C3 50~91 H" 2.78; N, 4.12 8.8~ H2û Rsquires: C, 50~9 H, 3.1; N, 4.2%
~d) sodi~n 4~lo-dioxo-4H?loH~o~?3-hJquin~li~e-2~8 dicarbo~rlate ;
~ e product of step (c) tO.4117g, 1.2462 ~nole) was dissolved wit~h sodium bicarbo~ate (0.20~4g~ 2.4922 Dmole3 in water (30 ml).
10 lhis was filtered to ~emwe ally insoluble particles. The solutio~
was ~hen freeze d~ied to give 1~he s~ title product as a bro~
solid (0.4137g~.
~alysis Found: C, 41.82; H, 2.96; N, 3.44~
14~14~ ~ O ~equires: C~ 41.82; ~, 2.82; ~, 3.49%
(a) 3-Ethox~ca~bonyl-10-h~dro ~ -8-methcxycarbanyl-1-oxo-lH-pyran _ D,~f71 1 w : Ethyl 6-amino-4-oxo-4H-l-benz~pyran-2~carboxy1ate ~3.9g; 1607 mo~le~
2U in ethanol (70 ml) and dimethylacetylene-dica~boxylate (2.84g; 20 mm~le~
were heated under reflux for 2 h~s. The solu~ion was cooled ~nd the solvent rem~ved on the rotary evaporator to give a green solid.
The solid w~s added all at ance to re~luxing diphenylether ~50 ~1) and heating was continued ~or 25 nins. The mixture was allowed to cool and then poured ~nto a mixture of diethylether (25 ml) and - ~2 -., :;
;:
' ' . ' ' , ,, . ~ ~ ~ , . i , 14/~2~
~2~
~ 53 -petroleum eth~r ~bp 40-60) (40 ml) and ~he br~wn solid was filtered off and recrystallised from chloroform to giYe the title compound as a dark green solid (2.9g ; 50.6~)5 mp 247-8.5.
~b) _sodium 10-hyd~ l-oxo-lH-p~ oL~3,2-f~7quinoline-3~8-dicarboxylate The product of step ~a) was hydrolysed by the method of Ex3~ple 5 ~d) to afford the disodium salt.
~ysiS
~4~ 5NNa~U706.11~ ~ 0 requires: C 45.74% H 2.1~ N 3.8%
10~ound: C 45.74% H 2.45~ N 3.6 ~1 Disodium 4,1C-dioxo-4H-loH-yyranoL~93-f 7quinol ~ -2,8-dicarboxylate :~ .
: (a) thyl 7-amono-4-oxo-4H-l-benzo~ an-2-carboxylate A solutio~ of sodium m~tal, (18.4g, 0.8 gatom), in dry ethanol (1200 ma), was tTeated with N-(4-acetyl-3-hydroxyphenyl~acetamide, (30.88g, 0.16 le~. This mixture was stirTed for 15 m ms then diethyl ocalate, (58.4g, 5403 ml, 0.4 mole), was add~d dropwise over 30 monsO ~he resulting mixture w~s heated and stirred at 60C for 2 hrs, allowed to c~l and poured into a mnxture of chlorofo~m (60~ m~), conc HK~ (85 ml), and water (2000 ml). The organic layer was isola~ed and combined with a chloro~DTm wash of ~he aqueous layer. The conbined chlor~onm extracts were washed well with water then evaporated to dryness. The residue was taken into ethanol (4(~ ml), ~nd conc. HCl (10 ml~, was added. The soluti~n was Z5 heated at reflux for 30 minutes ~hen eYaporated to dIyness4 The . .~;
~ 3 -''~ ' ~ , ;
. . . ..
. . . .. .. .
., ~ . .
, ,, , :; , ,~ : .
, . .
.
Ele~nental Analysis: C - 51.49~ H = 2.43~ N = 3.75 Found: ~ = 44.1~ H = 3.7~ N = 3~2nO
Containing 14.4~ H20 , Disodium-9-(3-methylbutyl)-4 ? 6-dioxo-4H/6H-pyTano L3,2-g 7 quinoline-2,8-dicarboxylate (a~ Methyl 6-acety~ 7-hydr xy-1-(3-methylbutyl)-4-oxo-4H-quinoline-2-. ~ .
Polyphosphoric acid ~50 ml) was added to E-dimethyl 2- ~N-(4-acetyl-3-hydroxyphenyl)-N-~3-methylbutyl)amino~7-but-2-ene-1,4-- 36 ~
~f~
dioate, (10089g) and the resultin~ viscous dar~ red oil ~as stirred on a steambath for ten mlnutes9 then poured into an iced l~rater/
ethyl acetate mixture and stirred vigorously ~or one hour. The ~esulting moxture ~as extracted into ethyl acetate? dried using magnesium sulphate, iltered and the volatiles were removed m vacuo af~ording a mixture (8.0g) of the required sub-title eo~pound and methyl 6-acetyl-S-hydroxy-1-(3-methylbutyl)-4-oxo-4~-quinoline-2-carboxyla~e.
~ eparation of the isomers was achie~ed using column chromatography wi~h sIlica gel as the stationary phase and eluting primarily with ether~ then chlorofonm. This process removed some of the unwanted isomerJ the required sub-title compound being adsorbed on the silica-gel. The silica gel was removed from the column, refluxed with ethyl acetate, filtered o~ and ~he filtTate evaporated yiélding a cTude sample of the required sub-title compound ~2.7g).
This was further purifled us m~ high pressure liquid chromatgraphy affording 0.5g o the sub-title compound. MP 108-110C.
Anal~is Found: CJ 65.4~0: H, 6.3~o: N~ 3.9~
C18H21N03 Requires: C, 55.3~: H~ 6.3~0: N, 4~2~o N~ spectroscopy and mass spectroscopy con~inmed the structure.
(b) Diethyl-9-(3-meth~lbu~yl)-4~6-dioxo-4H~6H-pylano L3,2-g 7quinolin~-2,8-dica boxylate A solution o the product o~ step (a~ (2~3g) and diethyl o~alate (~.5 ml) in dry dImethyl-Eormamide (60 ml3 was adde~ to a stirred ~;
, ~ , ., ' ;
suspension of ether waslled sodium hydride (0~65g) in dry dLmethylformamide ~75 ml) under nitrogen. I~e whole was then stirred at a~bient *emperature for t~en~y four hours9 then poured into iced water and extracted into ethyl acetate. This solution was dried using magnesium sulphate, filtered and volatiles removed in vacuo, affording an oil.
To this oil was added saturated ethanolic hydrogen chloride t300 ml) and the whole heated under reflux for two hours, then poured into iced water and ex*racted into ethyl acetate, which was washed with water, saturated aqueous sodium chloride solution and then dried using magnesium sulphate. The organic solution was filtered and Yolatiles were removed in acuo. The resulting oil was subjected to column ~hromatography with silica gel as the statio~ary phase and diethyl ether as eluan~ affording a solid, ~hich was triturated with light petroleum ether>w~shed with a little ether, and dried undeT
reduced pressure oYer phosphorus pentoxide at 100C for three hours yielding l.Zg of sub-title co~p~und. MP 149-150C.
Analysis Found: C, 64.2~: H, 6.0~: N, 3.0 C23H2~i!107 Requi~es: C, 64O6~i~ H, 5.9~: N~, 3.3~
NMR a~ectroscopy a~d mass spectroscopy confi~med ~e structure.
~c~ 9 (3-Methylbutyl) -4 ~6-dioxo-4H,6H-pyranoL~3,2-~7quinol~
di~ic acid The product of step ~b) (l.OOOg) was dissolved in methanol ~150 ml) and heated to re~lux. 0.1 M NaCH (46.8 ml) was then added and the whole ~ 1 6~
heated at re1ux for ~hree minutes. The soluti~n was cooled, acidified, and the precipitated product collected and dried under reduced pressure over phosphorus pentoxide at 80C for ~o hours, and then at 100C for one and one half hours, affording the sub-title compound (0.7g) MP 302-304C.
Analysis Found: C, 59.7~: H, 4.9~: N, 3.5 ClgH17N07 Requires: C, 59.7~: H, 4.6%: N, 3.6 2.9~ H20 Hemihydrate requireso C, 60,0~: H, 4.5%: N, 3.7~
(d) Disodium-9-~3-methylbutyl)-4~6-dioxo-4H~6H-pyTanoL 3~2-g~7quinoline-2,8-dicarboxylate - The product of step (c) 2.9% H20 (0.5g) was suspended in distill~d water (100 ml). Sodium bicarbonate ~0~243g) was added and the whole mixture was shaken vigoIously. The r~sulting solution was filteTed and freeze drled a~fording 0.7 g o~ the title compoundi .
Found: C, 45.4~: H, 5.2~: N, 2~g5 C19H15NNa207 Requires: C, 45.4~: ~, 4.9~: N, 2.8%
17.Z~ H20 NMR spectroscopy confirmed the structure.
.
- 3~ -" ~, "
.~
,6~
a~ple 6 Disod;um 7-(3-me~ylbutyl)-4~lo-dioxo-4H?loH-pyTan-o--c223-fJ quinoline-2 ~-dicarboxy~
(a) N-(3-Methoxyphenyl)-N (3-methylbutyl)ethanoamide Sodium hydride ~14.4gm) was washed with dry ether, then suspended in dry di~ethylformamide CloO ml) under dry nitrogen. N-t3-Methoxy-phenyl)ethanoan~de ~74.3g~ was dissolved in dry dimethylform3mide (400 ml) and added to ~he NaH suspension. The resulting suspension was cooled to 0C and stirred until hydrogen evolu~ion ceased.
3-~lethylbutylbromQde ~88.5g) was then added dropwise and the whole stirred at room temperature for two hours The mixture was then poured in~o water containing a little ethanol, extracted into ether, washed l~th water~ dried UsiIIg magr~esium sulphate, filtered and the volatiles were removed in vacuo. The resulting oil was subjected to a vacuum distillation~ accepting the raction at 126~146C and 0.5 mm Hg p~essure3 yleldin~ 9S.5 gm o~ the sub-title compound. N~
spectroscopy and ~ss sepctroscopy confilmed the stru~ture.
~b) N-t3-Hydroxyphenyl)-N-~3-methylbutyl)ethanoamide To a stirred solution of the product of step ~a) (10.8g) in d~y dichloroethane ~100 ml) at -70C was added borontribromide (1~.4g).
The tempera~ure was allowed to rise to room temperature and the mixture was stirred at this temperature ~or 12 hours, then poured into water, extracted into chloroform, dried using magnesium sulphate~
iltered and the ~olatiles were removed în ~acuo, afording (10.4g) o the sub-title compound. NMR spectroscopy and mass spectrDscopy . ~,. .
: .. . : ,. .
.. ,~ :
confirmed the structure.
(c) N-Acetyl-N-(3-methylbutyl) aminophenyl-ethano te To the product of step (b) ~92.2g) in dry *oluene ~2L~ was added acetyl chloride (49.1g) and pyridine (2 ml). The resulting solution was re~luxed for five hours, poured into water and the organic layer ~Tas separated, ~ashed with more water, dried using magnesium sulphate9 filtered and the volatiles were removed in vacuo, aEforalng (102g) of the sub-title compound.
N~R spectroscopy and mass spectroscopy confiTmed the structure.
(d) N-~4-Acetyl-3-hydroxyphen~ N-(3-methy-lbutyl)-ethanoamide The produc~ of step ~c~ (11.3g) was mixed with aluminium chloride (18g) and sodium chloride (2~5g) and then heated a* 160C
for two hours. Iced water was added cautiously and the resultm g nixture was extracted with 10~ sodium hydroxide solution,which was the~ washed wlth ether. ~e alkaline extracts were acid;fied, extracted in*o ether, dried using magnesium sulphate, filtered and the Yolatiles ~ere r ~ Yed in vacuo, af~ording 7.5g o the sub-title compound.
N~R spectroscopy ~nd ~ss spectroscopy confirmed the structure.
(e) l L ~ 4-~3-methylbutyl)amino-phenyl~7-et~mone To the product of step (d~ ~49.9g) in gIacial acetic acid ~550 ml~
~as added 48~ aqueous hydrogen bromide solution ~110 ml). The mixture was ~efluxed for two hours, poured into water and extracted into diethyl ether. The ether was washed well wqth water, then with saturated sodiumn bicarbonate solution7 dried using magnesium sulphate, -. , ~ ,... . . .
: : , :
~ : :
~ 42 -filtered and finally the volatiles were removed in vacuo, afording 38.0g of the sub-title compoundO
N~ spectroscopy and mass spectroscopy confinmed the structure.
(f~ Iy~ aL~3-hydroxyphenyl)-N-(3-methylbutyl~-amino-1,4-but-2-enedioate To the product of step (e~ (38.0g) in ary ethanol (300 ml) was added dimethyl acetylene dicarboxylate ~31.8g). The resulting solu~ion was heated under reflux for seven hours, after which time the volatiles were removed in vacuo, affording ~75 gm) of crude sub-title compound. The crude sample YaS sub~ected to column chromatography using silica-gel as the stationary phase and a 1:1 mixture of petroleum ether and diethyl ether as eluant. This process aforded (41.4 gm) of pure su~-title compound.
~ ~ spectroscopy and mass spectroscopy confirmed the st~ucture and that of the iso~ric fo~m of the product~
(~ thyl 6-Acetyl-5-hv~rox~ 3-methylbu~y_)-4-oxo-4H-c- . .
quinolIne-2-carbox~ate The product of step ~f) ~3.3g) was added to stirred viscous polyphosphoric acid ~15 ~1~ and the moxture was heated o~ a $team bath for fifte~n minutes. The whole was then poured onto ~n iced water~ ethyl acetate ~i~ture and vigorously stirred for one hour.
The organic layer was sepa~ated, washed well wqth water, dried using magnesium s~lphate~ filtered and Yolatiles ~ere removed m Ya~lo affo~ding a crude sample ~1.7g3 sub-title conpound, 0.7g of which was recrystallised from methanol to gi~e 0.3g of the pure .. ,, ~; i .
,, ~, , i; , .: ~ .. ~.... . .
.
.. ..
. . . ~
~.
sub-title compound. MP 140-141C.
A~alysis Found: C, 65~2%: H, 6.5~ N~ 4.1 ClgH21N05 Requires: C, 65~3~o H~ 6~3~o N, 4.2~
N~ spectroscopy and mass spectroscopy confirmed preparation of the sub-title compound.
Ch) Diethyl 7-(3-met~ylbutyl)-4,10-dioxo-4H,lOH-EyT~c~L~73- D -quinoline~2,8-dicarboxylate To sodium hydride ~0~26g)~ which had been washed lnth dry ether, was added dry dimethylformamide (20 ml) under nitr~gen, with stirr mg. The product of s~ep tg) (0.9g) and diethyl oxalate 3.18g~ in dry dimethylformamide ~20 ml) were added to the above N~H suspension and the whole ~s stirred at room temperature ~or twenty four hours, the~ heated on a steam bath for two hours. The reaction mixture was cooled, poured into water, acidified and extracted Lnto ethyl acetate. The organic layer was dried using m2gnesium sulphate~ il.ered and volatiles were Temoved in va wo.
The residue was dissolv~d in saturated ethanolic HCl ~200 ml) and re1uxed for 15 ~ tes. The whole ~as poured into water7 extracted into ethyl acetate and dried. Evaporation gave a sticky solid which was crystallised from aqueous ethanol to give 0.5g ~f a light bro~n crystalline solid. This was fur~her purified using c~lumn chromatography wnth silica gel as the stationary phase and et~yl acetate as eluant~ affording 0.26g of sub-title compound. MP 144-146C.
.
., : " .' :' ~
.:.
.. .
~.; ~. .
~ 44 - ~L~L
~lysis Found: C, 64.2~: H, 6.2~: N, 3.37~
C23H25N07 Requ;res: C~ 64.6~: H, 5.84~: N, 3.2g~
N~ spectroscopy and mass spectroscopy confi~med prcparation of the sub-title compound (i) 7-(3-Me hylbutyl)-4,10-dioxo-4H,l~H-pyra o L~,3-f~7quinoline-2,8-dicarboxylic acid The product of step th) ~0.9lgg~ was dissolved in methanol ~50 ml) and ~eated to ~eflux. O.lM NaOH ~43 ml) was added and the whole was refluxed for ive ~anutes. The resulting solution was then acidified with O.lNHCl and allowed to cool. A yellow solid crystallised out of solution, was filte~ed off, washed with ether and dried under a ~educed pressure of 0.2 mm Hg at 70C over phosphorus pentoxide, affording 0.67g of sub-title co~ound.
~nalysis Found: C~ 55~7~: H, 4.9~: N, 3.0%
ClgH17N07 9.4~ ~ O ~eo~ui,es: C, 55.7~: H, 5~2~: N, 3.4~
Dihydrate R~qui.es: C, 56.0~: Ho 5.16~: N, 3.4%
Dis~dium-7-(3-m thylbutyl)-4,10-dioxo_4H,lOH_pyrano L~,3- V -quinoline-2~8-dicarboxylate l~e product of step ~i) 9~4~ H20 (005568g) was suspended in distilled wrater ~40 ml). Solium bicarbonate tO.~3g) was then added ~nd the whole vigorously shaken until solution was achievedD The solution was then filtered, and the filtrate freeze-dried3 to give 0~59g of the title compound.
g~
, :, ,, , . ,:
, . . ,. . : .
, ; .: ,, ~, , :
. i : , " ., ,:; '., . ~,, 64~
Analysis Fo~d: C, 46.7%: H, 407% N, 2.8~
ClgH15NNa207 Requires: C, 46.7~o H, 4~7~ N, 2~8Co 14.9% H20 N~R spectroscopy confirmed preparation of the ti~le con~ d.
.:
.
- 45 - .
. ~, : , ,........ ~ .
., .,.~
....
.. , . : .~ :,:
, . . ..
Example 7 Disodium 5~m~hoxy-4,7-dioxo-4H ? 7H-pyranoL~,2-~7quinoline-2,9 dica~boxylate ~a) N~(3-Acetyl~2-hydro~y-4-m~thoxyQhenyl~acetamide 1-~3-~mino-2-hydroxy-6-n~ho~y-phenyl)ethanone (12.9g) was added to a mixture of acetic acid ~3 mls) and water (20 m~s) and heated to 60C. Acetic aRhydride (9.5 mls) was then added and the ~hole heated on a steam bath for ~hirty minutes. The reaction mixture was poured into water and extracted into ether, which was 1~ dried using magn~sium sulphat~, and after filt~ation the volatiles WeTe ~emoved in vacuo7 affording a golden b~own:solid which was triturated wqth chloroform and dried under reduced pressure, yielding 3.7g of the sub t;tle compound, mp 160-162C.
~b) Ethyl 8-~mmo-6-metho~y-4-ox~ 4H~l-benzoEy~ 2-carbox~l te : 15 Sodium (1.4g) was reacted wnth ethan~l (150 m~s3. me ~esultant solu~ion was cooled and sti~red vigorously, and to this solution was added a slurry of the product o~ step ~a) (305g) and Methyl oxalate ~5.4 mls) in ethanol (50 n~s)~ The maxture was heated under reflux for three hours, poured into water ~nd the aqueous solution w~s extracted into ethyl aceta~e, which was washed with a little water and dried using magnesium sulphate. After filtration the solvent was reved in vacuo. Ihis procedure yielded an oil to which was added _ comcentrated hydrochloric acid (3 mls) and ethanol ~100 mls). This solution was heated undeT reflux overnight. The volatiles were rem~ved in vacuo, to a~ford the sub title compound (2.3g). N~M.R.
_ ~6 , 08/B~25 -47 ~
and M~ss Spectroscopy confl~m~d the structure.
(c) Dimethyl N-(5-methoxy-2-e~t~oxycarbonyl-4-oxo-4H~ enzopyran-8-yl)-2-amino~but-2-en~ -dioate To ~he product of step Cb~ C2-3g) was added ethanol (20~ mls) and dimethyl ace~ylene di~arboxylate (1.3 mls). The whole was heated under reflux ~or bwenty hur hours. The v~latiles were ~hen remDved in vacuo to aford a sticky yellow-orange solid ~hich was triturated with a petroleum ether-diethyl ether mixture. The ~ resulting solid was ~iltered under reduced pressure affording ; 10 (1.8gn) of the sub-title compound. N.M.R. Spectroscopy and M~ss Spectroscopy confirmed ~he structure.
(d) Methyl 2-ethox~carbony_1-5-metho -4,7-dioxo-4H,7H-pyranoL~3 : q~inoline-9-c~Iboxyla~e To refluKIng diphenyl ether (5C) mls) was ad~ed the product of step k~ (1.8gm). R~fluxing was cc~ltinued for five minutes, and ~he moxture was then all~wed to coo].. Light petroleum e~her was added an~ the precipitated p~oduct was filtered under Teduced p~essu~e, and w~shed wi~h a ll~tle diethyl ether, affording l.Og of crud~ sub title compound. This solid was tIiturated wi~h a n~xture o~ hot ethyl ace~ate ana chloro~o~m, filtered under reduced pressure and dr~ed. The ma~erial was recrystallised fr~m toluene, and dried in vacuo at 89C over phosphorous pentoxide for ~our hours, - ~esulting in 0.2g of the sub title compound, mp ~60-261C.
. -47-'. ' l~
. ~, ~ "
:, .
-48- ~L~L~ 9 ~e~ 5iMethoxy-4~7-dioxo-4H~7H-py~a~oL~?2-~;7quinoline-2 dicarboxylic acid To a stir~ed suspension of methyl 2-ethoxycarbonyl-5-m~thoxy-4~7-dioxo-~H97H-pyræno C3~2~h~ quinoline-9-carboxylate ~2g) in ~
glacial acetic acid (16 mls~ was added concentrated hydrochloric acid (4 mls). The whole was hea~ed on a steam bath for two hours, cooled and the result~nt solid was ~iltered off under reduced pressure. me solid was washed with acetic acid and ether, End ~hen dried under reduced pressure o~er phospho~us pentoxide ~nd sodium hydroxide at 80C, yielding ~O.~g) of the sub-title-compound, mp 294-6C ~dec).
Analysis .~ Found: C, 49.1; H9 3.4; N, 3.6 N08.9~6% ~ 0 Requires: C, 49~1; H, 3.5; N~ 3,8~
NMR spectroscopy and mass SpeCtl~SC~py con~irm the structure.
~f) D~s~dium 5-methoxy-4?7-dioxo-4H~7H-pyrano r3~2-h 7quinoline-. 2~9-dica~boxylate : 5-M~hoxy-4,7-di~xo-4H~7H-pyranoL~3,2-h 7quinoline-2,9-dicarbo~ylic acid (0.~231g~ was suspended in distilled wa~er (50 nl5).
Sodium bica~bonate ~0~286 gm) was added, and the ~hole was vigorously shaken. me resul~ant solu~ion was ~iltered and the filtrate was ~reeze dried, afording (0.6g) of ~he title compound.
Analysis Found: C, 41.07; H, 2.7; N, 3.3%
25~5H7NNa208.14.4~ ~ 0 RequQr~s: C, 41.07; H, 3.1; N, 3.2 . ,~, , ~ , 10/~/25 %~
-49 ~
~ . .
4,6-Dioxo-10- &r~p-2-e~yl)-4H,6H-pyranoL~,2-g7 qui ine-2 dicaTb xylic acid (a) Eth~l 7-~mino-4-oxo-8-~pro~-2-enyl)-4H-benz~y~an-2-carboxylate :
1-(4-A~ety1amino-2-hyd~oxy-3-~prop-2-enyl)-phenyl~ethanone (20g) and diethyl oxalate (30.95g; 28.7 ml) w~re added to a previously fo~ed solution of sodium ethoxide (~rom add;tion of sodium ~9.7g) to dry ethanol (243.4 ml)) with stirring.
The Teac*ion mixture was stirred und0r neflux ~or 3 hours, cooled and then poured into wa*er. The precipi*ated product was - extracted into chlorof~rm, dried and evaporated to dryness unde~
reduced pressure. The yell~w residual solid was dissolved in fresh, dry ethanol (324.5 ml)~ concentrated hydrochloric acid (3.25 ml) added and the reaction mi~;ure refluxed for 17 houTs.
The ~lole w~s poured ~nto water (1.5 litre3, extracted into ethyl ace~ate, washed with water and dried ov~r magnesium sulphate. The solvent was evaporated to d~yness and the rssidue tritura~ed wi~h 40-60 p~troleum ether to give 19.6g of brown crystall me solid~ A
l.Og sample of the crude product was recrystallised from ethanol to give ~ crystalline solid, mp 142.5-143C.
~b~ Dime~y~l_N-~2-ethoxyca o~yl-4-oxo-8-~pr~p 2-enyl)-4H-l-benzopyTan-7-yl)-2-aminobut-2-ene-1~4-dioate Th0 ploauct vf step ta~ (18.6g) and dimethylacetylene-dicaTboxylate (11.95g; 10.86 ml) in e~hanol (148 ml) were refluxed together for 17 hours. The reaction mLxture was cooled to 10C and ll/B/25 50 ~
the precipitate was collec*ed by filtration, washed with a little ethanol and dried to give 15q8g of product. A O.9g sample was recrystallised from ethanol to ~e a crystalline solid, mp 148-148.5C.
` (c) Ethyl 8-me~hoxycarbonyl-4,6-dioxo-lO-(prop-2-enyl) 4H,6H-~
The product of step Cb) tl4.0g) was added to diphe~yl ether (200 ml) under r~lux wnth stirTing~ The ~eaction mixture was ~efluxed ~o~ a further 5 minutes, cooled and poured into 60-80 petroleum ether (2.0 1). The precipita~ed product was collected by filtration, dried and lecrystallised fr~m ethyl acetate to gi~e 3.5g of yellow solid.
(d3 476-Dioxo-10-~pr~p-2-enyl~-4H~H~-pyrano ~3 9 2- ~ quinoline-298-~icarb~ lic acid The product of step (c) was hydrolysed by ~he method of Example 3(c) ~o afford the title con~und. Structure was confirmed by N.M.R.
Example 9 4,10-Di~xo-4H~OH-pyrano~,3-hJ qu~loline-2,8-dicarboxylic acid (a) E*hyl 5-ami~o-4-oxo-4H-benzopyran-2-ca~bo~ylate E~hyl 5-nitro-4-oxo-4H~benzopyTan-2-caTboxylate tlOg, 38.022 mmolcs) in ethanol ~250 mls) was added ~o 5~ Pd/C ~lg) in ethanol t50 m~) în : a hydrogenation v~ssel. I~o drops of concentra$ed hydrochloric acid were then added to the above m~xture. The mixture ~as ~hen hydrogenated at 3 atmospheres pressure at rD~m tem~erature for 2 hours.
The ca~alyst was filtered of~ through a filter aid ~hich was : -50-.. . s . . ..
- , , , .,., ~.
,: . , , , . . .
, " ' ~2~
washed ~th ~hloro~orm. The filtrate wæ evapo~ated to give a yellaw solid ~8.1g9 91.5~. NMR and m~ss spectra confirm2d that ; the desired c~mpound had been made.
~h~ 8-E~hoxy~a~bonyl-2-methoxy ca~bo~n~l-4,10-dioxo-4H~lGff-pyrano-r ~ -~uinollne The product of step (a~ ~6.1g, 26.1~ Dle) and dimethyl ace*ylene-dica~boxylate (llg; 77.46 mm~le) were heated ~n e~hanol (180 ~il) fo~r 7 hours. The ~eaction nL~xture was cooled and was :: diluted wi~ water. Half of ~he original v~lw~ of ethanol was 10 nemoved an~ the concentrated mdxtNre was. extracted with ethyl acetate. ~e org mic layer was washed ~h a la~ge volume of water, dried and evaporated to give a yellow solid (8.5g, S6~).
lhe solid ~8.5g, 22.66 ~ole) WclS added sl~wly to p~eheated diphenyl e~er (90 n~, 240C) ~der N2 wi~:h stirring. A~ter 15 addition th~ n~xture was brought to ~reflux or 15 ~utes. Ihe n~x~e was ~led and poured into pet~leum et31er (4~6bc, 200 n~) to give ~e slibtitle p~oduct as a li~ht grey solid (4g, 51.3~ 166-7~)C.
(c) 4,1~Dioxo-4H,l~H-Er~,3-h~ inol~e-2,8-dicaTbo~ylic aci_ SoditDn hydroxide solution (O.lN, 58.,27 ml; 5.8267 ~nDle3 was added slowly to a boiling methanolic solutio~ of tihe product of s~p ~b). After additiorl, ~e reaction was heated to reflux for 25 nanu~es. me mixture was cooled and was acidified with dilute hydro~hloric acid (10~) ~o give a very fine precipi~ate, lhis was 25 filtered off and was collected as a light bro~ solid and d~ied _ 51 _ .~ .
in vacuD ove~ P205 at 70C o~e~ ht to give the sub-title p~ uct 6:17g) m~ 200C.
~lysis Found: C3 50~91 H" 2.78; N, 4.12 8.8~ H2û Rsquires: C, 50~9 H, 3.1; N, 4.2%
~d) sodi~n 4~lo-dioxo-4H?loH~o~?3-hJquin~li~e-2~8 dicarbo~rlate ;
~ e product of step (c) tO.4117g, 1.2462 ~nole) was dissolved wit~h sodium bicarbo~ate (0.20~4g~ 2.4922 Dmole3 in water (30 ml).
10 lhis was filtered to ~emwe ally insoluble particles. The solutio~
was ~hen freeze d~ied to give 1~he s~ title product as a bro~
solid (0.4137g~.
~alysis Found: C, 41.82; H, 2.96; N, 3.44~
14~14~ ~ O ~equires: C~ 41.82; ~, 2.82; ~, 3.49%
(a) 3-Ethox~ca~bonyl-10-h~dro ~ -8-methcxycarbanyl-1-oxo-lH-pyran _ D,~f71 1 w : Ethyl 6-amino-4-oxo-4H-l-benz~pyran-2~carboxy1ate ~3.9g; 1607 mo~le~
2U in ethanol (70 ml) and dimethylacetylene-dica~boxylate (2.84g; 20 mm~le~
were heated under reflux for 2 h~s. The solu~ion was cooled ~nd the solvent rem~ved on the rotary evaporator to give a green solid.
The solid w~s added all at ance to re~luxing diphenylether ~50 ~1) and heating was continued ~or 25 nins. The mixture was allowed to cool and then poured ~nto a mixture of diethylether (25 ml) and - ~2 -., :;
;:
' ' . ' ' , ,, . ~ ~ ~ , . i , 14/~2~
~2~
~ 53 -petroleum eth~r ~bp 40-60) (40 ml) and ~he br~wn solid was filtered off and recrystallised from chloroform to giYe the title compound as a dark green solid (2.9g ; 50.6~)5 mp 247-8.5.
~b) _sodium 10-hyd~ l-oxo-lH-p~ oL~3,2-f~7quinoline-3~8-dicarboxylate The product of step ~a) was hydrolysed by the method of Ex3~ple 5 ~d) to afford the disodium salt.
~ysiS
~4~ 5NNa~U706.11~ ~ 0 requires: C 45.74% H 2.1~ N 3.8%
10~ound: C 45.74% H 2.45~ N 3.6 ~1 Disodium 4,1C-dioxo-4H-loH-yyranoL~93-f 7quinol ~ -2,8-dicarboxylate :~ .
: (a) thyl 7-amono-4-oxo-4H-l-benzo~ an-2-carboxylate A solutio~ of sodium m~tal, (18.4g, 0.8 gatom), in dry ethanol (1200 ma), was tTeated with N-(4-acetyl-3-hydroxyphenyl~acetamide, (30.88g, 0.16 le~. This mixture was stirTed for 15 m ms then diethyl ocalate, (58.4g, 5403 ml, 0.4 mole), was add~d dropwise over 30 monsO ~he resulting mixture w~s heated and stirred at 60C for 2 hrs, allowed to c~l and poured into a mnxture of chlorofo~m (60~ m~), conc HK~ (85 ml), and water (2000 ml). The organic layer was isola~ed and combined with a chloro~DTm wash of ~he aqueous layer. The conbined chlor~onm extracts were washed well with water then evaporated to dryness. The residue was taken into ethanol (4(~ ml), ~nd conc. HCl (10 ml~, was added. The soluti~n was Z5 heated at reflux for 30 minutes ~hen eYaporated to dIyness4 The . .~;
~ 3 -''~ ' ~ , ;
. . . ..
. . . .. .. .
., ~ . .
, ,, , :; , ,~ : .
, . .
.
- 5~ -residue was treated ~ ~h ether and ethanol was added d~o ~ se until the residue began to solidify. Insoluble material was filtered o~f, washed again with e~her and the Tequired sub-title produc~ was recovered æ a brown solid (20.5g)9 ~55~), mp 192-194~ NMR and m~ss spectra confirmed ~he structure.
~b) Dimethyl N ~2-ethoxyca~bony~-4-oxo-4H-l-benzopyran-7-~l~-2 amLno-bu~-Z-ene-dioate A solution of the product of step (a) ~4~2g, 0.018 mole), and dime~hylac0tylenedica~boxylate5 ~7.68g, 6.6 ml, 0.054 mole), in e~hanol (200-ml), was heated ~t re~lux for 3~ hrsO Solvent was evap~rated off and the residue was tritu~ated nth ether. Insoluble ma~erial was filtered off and washed with e~her to give the required product as a buff coloured solid (4.3g), (64~), mp 147-51. NMR and mass spectra confirmed the structure.
(c) 2-E~h~ ca~bonyl-8-me~h~xycarbcnyl-4~10-dioxo 4H,lOH-pyrano-L ~,3-f~7quinoline Diphenyl ether ~140 ml), was heated to 240C and the pnoduct - of step ~b) ~3.85g~ 0.01027 mole), was added quickly but in small porti~ns. The resulting soluti~n was heated at re~lux for S minutes then all~wed to cool, when a gel-like precipitate ~.ormed. This was ~ddea to a nixture of ~ther and 40-60 petroleum ether and allowed to stand. Insoluble material was filtered off, washed well with e~her and dried in vacuo to lea~e the required prod~lct as a pale br~w~
p~wder (3.25g), 92~9 mp 239-411 The structure was confirmed by NMR
and m~ss spectra.
~ 54 -, ~ , ;
, . ..
: ' - g5 -~d) Lisod ~
A solution o the product of step (c) ~0.517g, 1.506 mmDle) in methanol (lOO ml), was stirred and heated at reflux during the dropwise addition of 0.1015M sodium hydroxide solution (29.7 ml, 3.012 ~mole)~
The addition was complete after 15 minutes. After contmum g at reflux for 5 minutes the mnxture was evaporated to d~yness, the residue was ~edissolved in water. This soluton was filtered and ~he filtrate was swamped with acetone. Ater standing overnight the precipitated solid was filtered o ff, washed wnth acetone and dried in vacuw .~o leave the required disodium salt as ~ da~k yellow p~wder (0.45g), 86.5~. The structuTe was coni~med by NMR spectrum and elemental analysis:
Found~ C, 44.36~ : H, 2.18~ : N, 3.54 requiTed for C14H5NNa27-2~ C, 44.1~ : H, ~.38% : N, 3.67 '~
. ' .l - 55 -, , , .,,; ~ , : .
~" . ; , ,~ . .
.
2~
(~) 2-(2-Carboxy-8-methyl-4-oxo-~4~q--nolin-7-ylo~y-but-2-en 1,4-dioic acid -Dimethyl acetylenedicarboxylate (12~3 ml) was added dropwise to 3-amino-2-methylphenol (12.4g) in ethanol (100 ml), at room temperature.
AfteT 0.5h, N-benzyltrinethylammonium hydroxide (0.5 ml), and dimethyl acetylenedicarboxylate (12.3 ml~ were added, and the reaction mixture was refluxed for 4h. The solution was cooled, poured into chloroform (500 ml) and washed wi~h water (5 x 200 ml). The chloroform layer was dried over magnesium sulphate, and concentrated in vacuo to give a dark oil, to which was added polyphosphoric acid (70g~. The whole was stirred on a steam bath for 0.5h, then poured onto ice and extracted wnth ethyl acetate (2 x 200 ml)~ The organic extracts were combined, dried over magnesium sulphate and concentrated in vacuo to give a dark oil (27.4g~. This oil was dissolved in ethanol (200 ml) which contained sodium hydroxide (12g) in water (100 ml), and refluxed for 5h. The clear solution was cooled, the ethanol removed by distillation in vacuo, and the residue ~as ~cidified with S-_-hydrochloric acid, to give on standing overnight the sub-title compound (12.7g). N.m.r. and i.r.
spectra were consistent with the proposed structure.
~b) 10-Methyl-4,6~dioxo-4H,6H-pyranof~3,2-g 7quinoline-2,8-dicarboxylic acid The product of step ~a) above (5.8g; 17.4 mole) was added portionwise to chlorosulphonic acid (20 ml) with stirring while cooling in an ice bath. The mixture was allowed to warm to ro~n temperature and stirred for 1 hour, ~hen it was added dropwise to a mixture of ice and water with rapid stirr mg. The brown solid was filtered off and recrystallised fr~n dimethylfornEunide to y;eld a light brown crystalline solid (2.82g; 51~) containing 1 molar equivalent of d~nethylformamide .
of crystallisation, m.p. = 302.
.. . .
, ~ :. . :
;,.. . . .
4,6-Dioxo-10-propyl-4H,6H pyr~ano[3,2-g]quinoline-2,8-dicarboxylic acid .
The title compound may be made by the process of the invention, the diethyl ester thereof having an m.p. of 211 -212C.
~ .
", ~: ~ - 57 ' :~`
' ' ' ' '' ':
~245/74 _ 58 -ExamDle 14
~b) Dimethyl N ~2-ethoxyca~bony~-4-oxo-4H-l-benzopyran-7-~l~-2 amLno-bu~-Z-ene-dioate A solution of the product of step (a) ~4~2g, 0.018 mole), and dime~hylac0tylenedica~boxylate5 ~7.68g, 6.6 ml, 0.054 mole), in e~hanol (200-ml), was heated ~t re~lux for 3~ hrsO Solvent was evap~rated off and the residue was tritu~ated nth ether. Insoluble ma~erial was filtered off and washed with e~her to give the required product as a buff coloured solid (4.3g), (64~), mp 147-51. NMR and mass spectra confirmed the structure.
(c) 2-E~h~ ca~bonyl-8-me~h~xycarbcnyl-4~10-dioxo 4H,lOH-pyrano-L ~,3-f~7quinoline Diphenyl ether ~140 ml), was heated to 240C and the pnoduct - of step ~b) ~3.85g~ 0.01027 mole), was added quickly but in small porti~ns. The resulting soluti~n was heated at re~lux for S minutes then all~wed to cool, when a gel-like precipitate ~.ormed. This was ~ddea to a nixture of ~ther and 40-60 petroleum ether and allowed to stand. Insoluble material was filtered off, washed well with e~her and dried in vacuo to lea~e the required prod~lct as a pale br~w~
p~wder (3.25g), 92~9 mp 239-411 The structure was confirmed by NMR
and m~ss spectra.
~ 54 -, ~ , ;
, . ..
: ' - g5 -~d) Lisod ~
A solution o the product of step (c) ~0.517g, 1.506 mmDle) in methanol (lOO ml), was stirred and heated at reflux during the dropwise addition of 0.1015M sodium hydroxide solution (29.7 ml, 3.012 ~mole)~
The addition was complete after 15 minutes. After contmum g at reflux for 5 minutes the mnxture was evaporated to d~yness, the residue was ~edissolved in water. This soluton was filtered and ~he filtrate was swamped with acetone. Ater standing overnight the precipitated solid was filtered o ff, washed wnth acetone and dried in vacuw .~o leave the required disodium salt as ~ da~k yellow p~wder (0.45g), 86.5~. The structuTe was coni~med by NMR spectrum and elemental analysis:
Found~ C, 44.36~ : H, 2.18~ : N, 3.54 requiTed for C14H5NNa27-2~ C, 44.1~ : H, ~.38% : N, 3.67 '~
. ' .l - 55 -, , , .,,; ~ , : .
~" . ; , ,~ . .
.
2~
(~) 2-(2-Carboxy-8-methyl-4-oxo-~4~q--nolin-7-ylo~y-but-2-en 1,4-dioic acid -Dimethyl acetylenedicarboxylate (12~3 ml) was added dropwise to 3-amino-2-methylphenol (12.4g) in ethanol (100 ml), at room temperature.
AfteT 0.5h, N-benzyltrinethylammonium hydroxide (0.5 ml), and dimethyl acetylenedicarboxylate (12.3 ml~ were added, and the reaction mixture was refluxed for 4h. The solution was cooled, poured into chloroform (500 ml) and washed wi~h water (5 x 200 ml). The chloroform layer was dried over magnesium sulphate, and concentrated in vacuo to give a dark oil, to which was added polyphosphoric acid (70g~. The whole was stirred on a steam bath for 0.5h, then poured onto ice and extracted wnth ethyl acetate (2 x 200 ml)~ The organic extracts were combined, dried over magnesium sulphate and concentrated in vacuo to give a dark oil (27.4g~. This oil was dissolved in ethanol (200 ml) which contained sodium hydroxide (12g) in water (100 ml), and refluxed for 5h. The clear solution was cooled, the ethanol removed by distillation in vacuo, and the residue ~as ~cidified with S-_-hydrochloric acid, to give on standing overnight the sub-title compound (12.7g). N.m.r. and i.r.
spectra were consistent with the proposed structure.
~b) 10-Methyl-4,6~dioxo-4H,6H-pyranof~3,2-g 7quinoline-2,8-dicarboxylic acid The product of step ~a) above (5.8g; 17.4 mole) was added portionwise to chlorosulphonic acid (20 ml) with stirring while cooling in an ice bath. The mixture was allowed to warm to ro~n temperature and stirred for 1 hour, ~hen it was added dropwise to a mixture of ice and water with rapid stirr mg. The brown solid was filtered off and recrystallised fr~n dimethylfornEunide to y;eld a light brown crystalline solid (2.82g; 51~) containing 1 molar equivalent of d~nethylformamide .
of crystallisation, m.p. = 302.
.. . .
, ~ :. . :
;,.. . . .
4,6-Dioxo-10-propyl-4H,6H pyr~ano[3,2-g]quinoline-2,8-dicarboxylic acid .
The title compound may be made by the process of the invention, the diethyl ester thereof having an m.p. of 211 -212C.
~ .
", ~: ~ - 57 ' :~`
' ' ' ' '' ':
~245/74 _ 58 -ExamDle 14
6-Amino-7,10-dihydro-5-methoxy-4,7-dioxo-4H-pyrano[3,2-hJ-quinoline-2,9-dicarboxylic acid (a) Diethyl 7,10-dihydro-5-methoxy-6-nitro-4,7-dioxo-4H-pyrano~3,2-h]quinoline-2,9-dicar~oxylate Diethyl 7,10-dihydro-5-methoxy-4,7-dioxo-4H-pyrano-~3,2-h]quinoline-2,9-dicarboxylate (0.82g) was dissolved in a mixture of concentrated sulphuric acid ~5ml) and concentrated nitric acid (lml) and heated at 75C for 36 hours. The mixture was poured into water (lOOml), and the precipitate was collected, and dried to afford the title compound (O.llOg) as a brown powderO The structure was confirmed by n.m.r. and mass spectroscopy.
(b) Diethyl 6-amino-7,10-dihydro-r~-methoxy-4,7-dioxo-4H-p~rano-[3,2-h]quinoline-2,9-dicarboxylate The product of step (a) (0.105g) was dissolved in glacial acetic acid (5ml) and`hydrogenated over 5% Pd/C
catalyst at 1 atmosphere and room temperature until hydrogen uptake ceased. Filtration removed the catalyst and dilution with water afforded a yellow precipitate ` which was collected and dried. Separation by high pressure liquid chromatography afforded the sub-title compound (0.033g) as an off-white solid. The structure was confirmed by n.m.r. and mass spectroscopy.
- 58 _ , ~, ,:
,, ,'' , ~ :
4245/74 ~ 59 ~ ~ ~ ~26~
(c) 6-Amino-7,10-dihydro~5-methoxy-4,7-dioxo-4H-pyrano-[3,2-h]quinoline-2,9-dicarboxylic acid The product of step (b) (0.03g) in glacial acetic acid ~lml) was treated with 48~ aqueous EIBr (2 drops) and refluxed 18 hours. The reaction mixture was poured into water (lOml) and an o~f-white solid was filtered off.
Drying aforded the title compound (0.018g).
NMR~ DMSO 3~95t3H,s); 6.95(lH,s); 7.4(lH,s); 9.6(brs-4H).
Example 15 10-Bromo-6,9-dihydro-4,6-dioxo-4H-pyrano[3,2-g]quinoline-2,8-dicarboxylic acid ~, (a) Diethyl 10-bromo-6,9-dihydro-4,6-dioxo-4H-pyrano-[3,2-~quinoline-2,8-dicarboxylate Ethyl 7-amino-8-bromo-4-oxo-4H-l-benzopyran-2-carboxy-late (5.3g) and dimethyl acetylenedicarboxylate (3.35g) in methanol (50ml) were heated under reflux for 18 hours. ;~
The solvent was evaporated ln vacuo, and the oil residue was poured into refluxing diphenyl ether (150ml) in one portion. After 10 minutes continued refluxing, the mixture was cooled and poured into petroleum ether -;
(40-60C, 1 litre). The precipitated solid was collected, washed with petroleum ether and dried. The - solid was separated into its components by high pressure ~ liquid chromatography, and the sub-title compound was - 25 obtained as a fluffy yellow solid (0.28g). The structure .
,.
42~5/7~ ~ 60 ~ ~ 6 was confirmed by n.m.r. and mass spectroscopy.
(b) lO-~romo-6,9-dihydro-4,6-dioxo-4H-pyrano[3,2-g)-~__noline ~,8-dicarboxylic acid The product of step (a) (0.279) was heated under reflux in glacial acetic acid (5ml) containing 48% HBr (lO
drops) for l8 hours; the reaction mixture was then poured into water (lOOml) and the precipitate was collected.
Drying afforded the title compound (O.llg) as an amorphous powder.
NMR ~DMSO: 6.gS(lH,s); 7.0¦l~,s); 8.6(l~,s).
Example_15 N,N'-Di-(tetrazol-5-yl)-9-(but 3-enyl)-6!9-dihydro-4-oxo-10-propyl-4H-7~yrano[3!2-g]quinoline-2,8-dlcarboxamide (a) 6-Acetyl-3-~but~3-enyl)amino-2~ Ey~ y~
lS 6-Acetyl-3-acetylamino-2-propylphenol (23.5g) was added to a stirred solution of lithium diisopro~pylamide (2l.49) in dry tetrahydrofuran (SOOml) under a nitrogen ~` atmosphere at 0C. After stirring for 2 hours, but-3-enylbromide (13.5g) was added. The reaction was allowed Y~ 20 to warm to ambient temperature, and was then left for 72 hours.
The solvent was evaporated in vacuo, and concentrated -~ hydrochloric acid (lOOml), water (lOOml) and glacial ~- acetic acid (50ml) were added. This mixture was heated under reflux for 18 hours, then cooled, basified with , ~ 60 , , : ~ ~
: . , , :" ~' '. , ~ :::
' : .,, ~, , :
26~
4245/74 ~ 61 ammonia, and ether extracted. Drying and evaporation yielded the sub-title compound (19.7g). The structure was confirmed by n.m.r. and mass spectroscopy.
(b) Methyl 6-acetyl-1-(but-3-enyl)-1,4-dihydro-7-hydroxy-4-oxo-8-propylquinoline-2-carboxylate The product of step (a) (19.5g), dimethyl acetylenedi-carboxylate (13.5g~ and methanol (lOOml) were heated under reflux for ~4 hours and then the solvent was evaporated in vacuo. The residue was added to stirred polyphosphoric acid ~l50ml) heated to 95C. After 2 hours the reaction was poured into ice (1 litre) and ether exracted. The ethereal extract was washed well with dilute hydrochloric acid, brine and sodium bicarbonate solution, and then dried. Evaporation afforded a gum which solidified r partially. The solid was collected and shown to be the sub-title compound (3.39~ by n.m.r. and mass spectroscopy.
(c) 9-~But-3-~nyl)-6,9-dihydro-4-oxo-10-propyl-4H-pyrano-~3,2-g]quinoline-2,8-dicarboxYlic acid :
.
The product of step (b) (3.2g) was added to a solution 20of sodium (l.lSg) in dry ethanol (50ml) and diethyl oxalate (3~5g) was added. After stirring at room temper-ature for 18 hours, gaseous hydrogen chloride was passed ; into the ice-cooled mixture until saturated. The mixture was heated to reflux for 1 hour, then evaporated, and the 25residue was taken up into glacial acetic acid (50ml) and , , ,, , : ~ ................................ ,, :
, 4245/7~ - 62 ~ Z~ ~ ~
48% aqueous HBr (lml). The mixture was heated to reflux overnight, then cooled and poured into water (1 litre).
Filtration and drying afforded a fawn solid (1~8g) which was shown to be the sub-title compound by n.m.r. and mass spectroscopy.
(d) N,N'-Di(tetrazol-5-yl~-9-(but 3-enyl)-6,9-dihydro-4-oxo-10-propyl~4~-p~rano~3,2-~quinoline-2,8-dicarboxamide The product of step (c) (1.759), thionyl chloride (1006g) dichloroethane (20ml) and dry dimethyl formamide (1 drop) were heated under reflux for 4 hours. On cooling a precipitate appeared which was collected and dried in vacuo.
,. _ .
~` The solid was added to a solution of 5-aminotetrazole ~1.5g) in dry dimethylacetamide t20ml). After 48 hours at room temperature the mixture was poured into water (150ml) ~ . .
and the precipitated solid was collected. Drying in vacuo afforded the title compound tO.8g) as an off-white powder.
NMR DMSO: 1.0(3H,t); 1.8(2H,m); 2.2(2H,m); 3.8(4H,m);
4.65(2H,m); 5.3(1H,mi; 7.0(1H,s); 8.5(1H,s); 8.7(1H,s);
10.3(br).
'. .
, ~, .. . :,. ; . . ;
. .
...
,, ,: ~:
.. :.
4245/74 ~ 63 ~ ~ 6 9-Ethyl-6,9-dihydro-4,6-dioxo-lO-propyl-4H-pyranoc3~2 -quinoline-2,8~dicarboxylic acid -(a) 6-Acetyl-l-ethyl-1,4-dihydro-7-nydroxy-4-oxo-9-propyl~
quinoline-2-carboxylic acid Methyl 6-acetyl-1-ethyl-1,4-dihydro-7-hydroxy-4-oxo-8-propylquinoline-2-carboxylate (209) was heated under reflux in glacial acetic acid (150ml) containing 48~
,, .
aqueous HBr (23ml). After 18 hours the mixture was cooled and poured into water. Ammonia was added until pH3. The ':
precipitate was collected and dried in vacuo, and was identified as the sub-title compound (14.3g) by n.m.r. and mass spectroscopy.
(b) 2-Ethoxycarbonyl-9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano[3~2-~l3gl~9ll~g~=5l5~9~ c acid The product of step (a) (14.2g) was added to a solution of sodium (5.2g) in ethanol (200ml), and then ~; diethyl oxalate ~16g1 was added. The mixture was heated under re~lux for 5 hours then cooled and poured into chloroform (l litre). The mixture was shaken with dilute hydrochloric acid (150ml), then the organic phase was dried and evaporated in vacuo. The residue was dissolved in ethanol (200ml) containing concentrated hydrochloric acid (2ml) and refluxed for 18 hours. The solvent was evaporated, and ~he residue was recrystallised from 4245/74 ~4 ~ 26~4 ethanol to afford the sub-title compound (3.2g). The structure was confirmed by n.m.r. and mass spectroscopy.
(c) 9-Ethyl-6,9-dihYdro-4,6-dioxo-10-propyl-4H-pyrano-[3,2-g]~inoline-2,8-dicarboxylic acid The product of step (b) was hydrolysed by the process of step (a) to afford a product (l.lg) identical with that of Example 2 by thin layer chromatographic compar i50n .
Example 18 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano~3,2-g]-quinoline-2,8-dicarboxylic acid (a) Methyl~9-ethyl-5,9-dihydro-2-methyl-4,6-dioxo-10-: propyl-4H-pyrano[3,2-~]quinoline-8-carboxylate 6-Acetyl-l-ethyl-7-hydroxy-4(:LH)-oxo-8-propylquinoline-~ 2-carboxylic acid (3.15g) was dissolved in dry dimethyl--~ 15 formamide (SOml) containing washed sodium hydride ~1.05g) and then ethyl acetate (4.4g) was introduced. After stirring overnight gaseous hyarogen chloride was passed into the mixture with ice cooling until saturated. The mixture was warmed to 75C for 8 hours, then cooled, ``- 20 poured into water and the mixture was extracted with ethyl acetate. The organic phase was dried and evaporated and the residue was chromatographed (SiO2/ethyl acetate) to provide the sub-title compound (0.8g). The structure was con~irmed by n.m.r. and mass spectroscopy.
.
, . . .
,.,. , ,,' .
4245/74 - ~5 Ib) g-~thyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano-8-dicarboxylic ac_d The product of step (a) (0.75g) was heated under reflux with selenium dioxide (1.5g) in glacial acetic acid (50ml) for 48 hour~. Filtration through "Celite" afforded a clear filtrate which was treated with concentrated `~ hydrochloric adid (25ml) and heated under reflux for 12 hours. On cooling and pouring into water a precipitate was obtained (0.19) which was identical to the product of Example 2 by thin layer chromatographic comparison.
Example 19 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-py ano[3,2-g]-quinoline-2,8~dicarboxylic acid (a) N-[3-(1,2-dicarboxyethenYloxy~-2~propYlphenyl~-N-ethYl-2-amino-but-2-ene-1,4-dioic acid 3-Ethylamino-2-propylphenol (17.99), dimethyl acetyl-enedicarboxylate (359~, potassium hydroxide (0.569), water (50ml) and ethanol (lOOml) were heated under reflux for 24 hours. Potassium hydroxide (1.659) was added and reflux-ing was continued for another 24 hours.
Concentrated hydrochloric acid (4ml) was added and the solvent was evaporated. The residue was dried in vacuo and extracted into ether. The ether was evaporated to afford the sub-title compound (3069). The structure was confirmed by n.m.r. and mass spectroscopy~
~ 65 ;..~, ~2~g ~24S/7~ ~ 66 (b) 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-~yrano-_ 2-g]quinoline 2,8-dicarboxylic acid The product of step ~a) (3.55g) was added in small portions to chlorosulphonic acid (lOOml) cooled to -78C
with stirring. The solution was allowed to warm slowly to room temperature and was then warmed to 50C for 1 hour~ The reaction mixture was cautiously poured onto ice (1 litre) and extracted into ethyl acetate. After drying f the ethyl acetate was evaporated and the residue was separated by high pressure liquid chromatography to afford the title compound ~0.2g) chromatographically idential to the product of Example 2.
~; Example 20 9-Ethyl-6,9-dihydro-4,6-dioxo-lO-~propyl=4H~pyrano[3-2--~]
~uinoline-2,8-dicarboxylic acid (a) l-Ethyl-6-(3-carboxy-3-diethy]amino-1-oxo-prop-2-enyl)-1,4-dihydro-7-hYdroxy-4-oxo-8-propylquinoline-2 carboxylic .
acid 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano-[3,2-g~quinoline-2,8-dicarboxylic acid (lg) and diethyl-amine (5ml) were heated together in an autoclave for 12 hours at 100C, then the volatile materials were evapor-ated at 60C. The residue was triturated with ether to afford the sub-title compound (0.78g). Structure was 25 confirmed by n.m.r. and mass spectroscopy.
.. .. .
~3 :
,`. `.... : :
., .... ,`
,,.. ` . . .,` . ~ .
~245/74 - 67 (b) 9-Ethyl-6,9 dihydro-4,6-dioxo-lO-propyl-4H-pyrano-[3,2-g]quinoline-2,8-dicarboxylic acid The product of step (a) (0.77g) was suspended in ethanolic hydrogen chloride (20ml) and heated under reflux for 24 hours. Evaporation of the solvent aEEorded a residue which was separated by high pressure liquid chromatography to give the title compound (0.2g) which was chromatographically identical to the product of Example 2.
~;~ Example 21 9-Ethyl-6,9-dihydro-4,6-di_xo-'0-pro~yl-4H-pyrano-L3,2-~3quinoline-2,8-d carboxylic acid (a) Dieth~1_9-eth~1-6,9-dihydro-10-propyl-4,6-dithioxo-4H-py~ano~3,2-g]quinoline-2,8-dicarboxylate Diethyl 9-ethyl-6,9-dihydro-4,6-dioxo-lO~propyl-4M-pyrano[3,2-g]quinoline-2,8-dicarboxylate (lOg) and penta-phosphorus decasulphide (20g) were fused together at 160C for 6 hours, then cooled and the product mixture was extracted into ethyl acetate. Chromatography (silica gel/ethyl acetate) afforded the sub-title compound (5.6g). The structure was verified by n.m.r. and mass spectroscopy.
(b) 9-EthYl-6,9-dihydro~4,6-dioxo-lO-propyl-4H-pyrano-[3,2-g]quinoline-2,8-dicarboxylic acid The diester from step (a) was heated at 100C in glacial acetic acid (50ml) containing concentrated hydro-.. . .
,~
, ; :: , : - .
.. ..
4245/74 ~ 68 ~ ~ ~ Z ~ ~ ~
chloric acid (5ml~ for 24 hours. The acetic acid solvent was evaporated and the residue was triturated with ether.
The solid residue was dissolved in acetonitrile 150ml) containing water (lml), and was stirred vigorously with mercuric cnloride (2g). After 48 hours the solution was filtered, and the filtrate was diluted with water (250ml) and then acidified. The precipitated solid was purified by high pressure liquid chromatography to afford the title compound (2.1g~ which was chromatographically identical with the product of Example 2.
Example 22 . , 9-Ethyl-6,9 dihydro-4,6-dioxo-10-propyl-4H-pyrano[3,2-g)- ~;
., .
quinoline~2,8-dicarboxylic acid - (a) 9-Ethyl-2,3,6,9-tetrahydro-4,6-dioxo-10-propyl- H-pyrano~3,2-g]quinoline-2L8-dicarboxylic acid Diethyl 6,9-dihydro-4,6-dioxo~10-propyl-4H-pyrano-[3,2-glquilloline-2~8-dicarboxylate (5g) in glacial acetis acid (lOOml) was hydrogenated over Adams catalyst (0~5g) at 4 atmospheres until hydrogen uptake ceased. The catalyst was removed and concentrated hydrochloric acid (5ml) was added~ The solution was refluxed for 24 hours then evaporated. High pressure liquid chromatography of the residue gave the sub-title compound (0.9g). The structure was supported by n.m.r. and mass spectroscopy.
., :: -:.,: : . ,~
4245/74 ~ 69 r (b) 9-Ethyl-5,9~dihydro-4,G-dioxo-10-pro~yl-4H-pvrano-[3,2-g~quinoline-2,8-dicarboxylic acid .. .
- The product of step (a) (0.85y~ was suspended in cymene (lOml) and treated with 10~ Pd/C catalyst at reflux for ~ hours. Filtration and evaporation afforded a gum which was purified by high pressure liquid chromatography ; to give the title compound (0.15g) chromatographically identical wlth the product of Example 2.
Example 23 9-Ethyl-6,9-dihydro 4,6-dioxo-10-propyl-4H-pyrano[3,2-g]-quinoline-2,8-dicarboxylic acid .
(a3 1-Ethyl-1,4-dihydro-7-hy_r_xy-6-methoxycarbonyl-4-oxo-8-eropylquinoline-2-carboxylic acid Diethyl 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano[3,2-gJquinoline-2,8-dicarboxylate (4.279) and sodium hydroxide (1.69) in water (lOml) were heated to reflux for 24 hours, then the`water was evaporated and the residue was suspended in ethanol (SOml) saturated with hydrogen chloride gas and refluxed for 1 hour. Evaporation of the solvent afforded a residue which was chromato-graphed (silica gel/ether) to afford a diester (1.3g) which was boiled with a solution of sodium hydroxide (0.139g) in water (20ml). On acidification a precipitate wa~ formed which was shown to be the desired product (0.93g) by n.m.r. and mass spectroscopy~
~ 69 ~ ' .. ~
,: ''-'" ''' -' ~ , 6~
~245/74 - 7~ -, (b) 9-Ethyl-6,9-dihydro-4,6-dioxo-10-pro~yl~4H-pyrano-[3,2 glquinoline-2,8-dicarboxYlic acid .-- , The product of step ~aj (0.9g) dissolved in dry di-~ methyl sulphoxide (lOml) was added to a solution of dimsyl `~ 5 sodium (lg) in dry dimethul sulphoxide (50ml) at 40C
under N2. After 48 hours the reaction mixture was poured into water (500ml) and ether extracted. Drying and evaporation afforded a red oil which was suspended in toluene (20ml) and treated with piperidine (l.lg) and gly-;~ 10 oxylic acid hydrate (1.5g). After refluxing for 5 hours, the mixture was cooled, poured into ethyl acetate (lOOml) and washed with saturated sodium bicarbonate solution.
The sodium bicarbonate solution was acidified and extrac- -ted with ethyl acetate. Drying and evaporation gave a gum which was separated by high pressure liquid chromatography to yive the title compound (0.139) ~hich was identical chromatographically to the product of Example 2.
Example 24 9-Ethyl-10-propyl-2,3-di-tetrazol 5-yl-4H-pyrano[3,2-~]~
quinoline-4_6(9~)-dione (a~ 9-Ethy_ 6,9-dihyd o-4/6-dioxo-10-propyl-4H-pyrano-[3,2-g]quinoline-2/8-dlcarbonitrile 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano-13,2-g]quinoline-2,8-dicarbonyl chloride (lOg) was added dropwise to cooled aqueous ammonia solution (lOOml) with ~ 7~
.. . ~ . ~
.~
stirring. The insoluble material ~as collected and washed well with water, then dried ln vacuo at 80C.
The solid was added to a solution of phosphoryl chloride (209) in dry dimethyl formamide (lOOml) and warmed to 60C for 48 hours. The reaction mixture was cooled and poured into water (1 litre), and extracted into ether. Drying and evaporation afforded an oil which was chromatographed (silica gel/ether) to afford the sub-title compound ~3.79). The structure was supported by n.m.r.
and mass spectroscopyO
(b) 9-Ethyl-10-propyl-2,8-di-tetrazol-5-yl-4H-Pyrano-; [3,2-g]quinoline-4,6(9H)-dione The product of step (a) t3.6g~ and ammonium azide (1.3g) in dry dimethyl formamide (lOOml) were heated to 140C for 16 hours then cooled ancl poured into water.
On acidification a precipitate was obtained which was chromatographed (silica gel~ethyl acetate) to produce the title compound ~1.69).
NMR ~DMSO: 1.0(3H,t); 1.1(3XIt); 1.8(2X,m); 3.8(2EI,m);
4.5(2H,m); 7.1(1H,s~; 8.65(1H,s); 8.8(1H,s); 10.1(2Hbrs).
'~ ' `
(b) Diethyl 6-amino-7,10-dihydro-r~-methoxy-4,7-dioxo-4H-p~rano-[3,2-h]quinoline-2,9-dicarboxylate The product of step (a) (0.105g) was dissolved in glacial acetic acid (5ml) and`hydrogenated over 5% Pd/C
catalyst at 1 atmosphere and room temperature until hydrogen uptake ceased. Filtration removed the catalyst and dilution with water afforded a yellow precipitate ` which was collected and dried. Separation by high pressure liquid chromatography afforded the sub-title compound (0.033g) as an off-white solid. The structure was confirmed by n.m.r. and mass spectroscopy.
- 58 _ , ~, ,:
,, ,'' , ~ :
4245/74 ~ 59 ~ ~ ~ ~26~
(c) 6-Amino-7,10-dihydro~5-methoxy-4,7-dioxo-4H-pyrano-[3,2-h]quinoline-2,9-dicarboxylic acid The product of step (b) (0.03g) in glacial acetic acid ~lml) was treated with 48~ aqueous EIBr (2 drops) and refluxed 18 hours. The reaction mixture was poured into water (lOml) and an o~f-white solid was filtered off.
Drying aforded the title compound (0.018g).
NMR~ DMSO 3~95t3H,s); 6.95(lH,s); 7.4(lH,s); 9.6(brs-4H).
Example 15 10-Bromo-6,9-dihydro-4,6-dioxo-4H-pyrano[3,2-g]quinoline-2,8-dicarboxylic acid ~, (a) Diethyl 10-bromo-6,9-dihydro-4,6-dioxo-4H-pyrano-[3,2-~quinoline-2,8-dicarboxylate Ethyl 7-amino-8-bromo-4-oxo-4H-l-benzopyran-2-carboxy-late (5.3g) and dimethyl acetylenedicarboxylate (3.35g) in methanol (50ml) were heated under reflux for 18 hours. ;~
The solvent was evaporated ln vacuo, and the oil residue was poured into refluxing diphenyl ether (150ml) in one portion. After 10 minutes continued refluxing, the mixture was cooled and poured into petroleum ether -;
(40-60C, 1 litre). The precipitated solid was collected, washed with petroleum ether and dried. The - solid was separated into its components by high pressure ~ liquid chromatography, and the sub-title compound was - 25 obtained as a fluffy yellow solid (0.28g). The structure .
,.
42~5/7~ ~ 60 ~ ~ 6 was confirmed by n.m.r. and mass spectroscopy.
(b) lO-~romo-6,9-dihydro-4,6-dioxo-4H-pyrano[3,2-g)-~__noline ~,8-dicarboxylic acid The product of step (a) (0.279) was heated under reflux in glacial acetic acid (5ml) containing 48% HBr (lO
drops) for l8 hours; the reaction mixture was then poured into water (lOOml) and the precipitate was collected.
Drying afforded the title compound (O.llg) as an amorphous powder.
NMR ~DMSO: 6.gS(lH,s); 7.0¦l~,s); 8.6(l~,s).
Example_15 N,N'-Di-(tetrazol-5-yl)-9-(but 3-enyl)-6!9-dihydro-4-oxo-10-propyl-4H-7~yrano[3!2-g]quinoline-2,8-dlcarboxamide (a) 6-Acetyl-3-~but~3-enyl)amino-2~ Ey~ y~
lS 6-Acetyl-3-acetylamino-2-propylphenol (23.5g) was added to a stirred solution of lithium diisopro~pylamide (2l.49) in dry tetrahydrofuran (SOOml) under a nitrogen ~` atmosphere at 0C. After stirring for 2 hours, but-3-enylbromide (13.5g) was added. The reaction was allowed Y~ 20 to warm to ambient temperature, and was then left for 72 hours.
The solvent was evaporated in vacuo, and concentrated -~ hydrochloric acid (lOOml), water (lOOml) and glacial ~- acetic acid (50ml) were added. This mixture was heated under reflux for 18 hours, then cooled, basified with , ~ 60 , , : ~ ~
: . , , :" ~' '. , ~ :::
' : .,, ~, , :
26~
4245/74 ~ 61 ammonia, and ether extracted. Drying and evaporation yielded the sub-title compound (19.7g). The structure was confirmed by n.m.r. and mass spectroscopy.
(b) Methyl 6-acetyl-1-(but-3-enyl)-1,4-dihydro-7-hydroxy-4-oxo-8-propylquinoline-2-carboxylate The product of step (a) (19.5g), dimethyl acetylenedi-carboxylate (13.5g~ and methanol (lOOml) were heated under reflux for ~4 hours and then the solvent was evaporated in vacuo. The residue was added to stirred polyphosphoric acid ~l50ml) heated to 95C. After 2 hours the reaction was poured into ice (1 litre) and ether exracted. The ethereal extract was washed well with dilute hydrochloric acid, brine and sodium bicarbonate solution, and then dried. Evaporation afforded a gum which solidified r partially. The solid was collected and shown to be the sub-title compound (3.39~ by n.m.r. and mass spectroscopy.
(c) 9-~But-3-~nyl)-6,9-dihydro-4-oxo-10-propyl-4H-pyrano-~3,2-g]quinoline-2,8-dicarboxYlic acid :
.
The product of step (b) (3.2g) was added to a solution 20of sodium (l.lSg) in dry ethanol (50ml) and diethyl oxalate (3~5g) was added. After stirring at room temper-ature for 18 hours, gaseous hydrogen chloride was passed ; into the ice-cooled mixture until saturated. The mixture was heated to reflux for 1 hour, then evaporated, and the 25residue was taken up into glacial acetic acid (50ml) and , , ,, , : ~ ................................ ,, :
, 4245/7~ - 62 ~ Z~ ~ ~
48% aqueous HBr (lml). The mixture was heated to reflux overnight, then cooled and poured into water (1 litre).
Filtration and drying afforded a fawn solid (1~8g) which was shown to be the sub-title compound by n.m.r. and mass spectroscopy.
(d) N,N'-Di(tetrazol-5-yl~-9-(but 3-enyl)-6,9-dihydro-4-oxo-10-propyl~4~-p~rano~3,2-~quinoline-2,8-dicarboxamide The product of step (c) (1.759), thionyl chloride (1006g) dichloroethane (20ml) and dry dimethyl formamide (1 drop) were heated under reflux for 4 hours. On cooling a precipitate appeared which was collected and dried in vacuo.
,. _ .
~` The solid was added to a solution of 5-aminotetrazole ~1.5g) in dry dimethylacetamide t20ml). After 48 hours at room temperature the mixture was poured into water (150ml) ~ . .
and the precipitated solid was collected. Drying in vacuo afforded the title compound tO.8g) as an off-white powder.
NMR DMSO: 1.0(3H,t); 1.8(2H,m); 2.2(2H,m); 3.8(4H,m);
4.65(2H,m); 5.3(1H,mi; 7.0(1H,s); 8.5(1H,s); 8.7(1H,s);
10.3(br).
'. .
, ~, .. . :,. ; . . ;
. .
...
,, ,: ~:
.. :.
4245/74 ~ 63 ~ ~ 6 9-Ethyl-6,9-dihydro-4,6-dioxo-lO-propyl-4H-pyranoc3~2 -quinoline-2,8~dicarboxylic acid -(a) 6-Acetyl-l-ethyl-1,4-dihydro-7-nydroxy-4-oxo-9-propyl~
quinoline-2-carboxylic acid Methyl 6-acetyl-1-ethyl-1,4-dihydro-7-hydroxy-4-oxo-8-propylquinoline-2-carboxylate (209) was heated under reflux in glacial acetic acid (150ml) containing 48~
,, .
aqueous HBr (23ml). After 18 hours the mixture was cooled and poured into water. Ammonia was added until pH3. The ':
precipitate was collected and dried in vacuo, and was identified as the sub-title compound (14.3g) by n.m.r. and mass spectroscopy.
(b) 2-Ethoxycarbonyl-9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano[3~2-~l3gl~9ll~g~=5l5~9~ c acid The product of step (a) (14.2g) was added to a solution of sodium (5.2g) in ethanol (200ml), and then ~; diethyl oxalate ~16g1 was added. The mixture was heated under re~lux for 5 hours then cooled and poured into chloroform (l litre). The mixture was shaken with dilute hydrochloric acid (150ml), then the organic phase was dried and evaporated in vacuo. The residue was dissolved in ethanol (200ml) containing concentrated hydrochloric acid (2ml) and refluxed for 18 hours. The solvent was evaporated, and ~he residue was recrystallised from 4245/74 ~4 ~ 26~4 ethanol to afford the sub-title compound (3.2g). The structure was confirmed by n.m.r. and mass spectroscopy.
(c) 9-Ethyl-6,9-dihYdro-4,6-dioxo-10-propyl-4H-pyrano-[3,2-g]~inoline-2,8-dicarboxylic acid The product of step (b) was hydrolysed by the process of step (a) to afford a product (l.lg) identical with that of Example 2 by thin layer chromatographic compar i50n .
Example 18 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano~3,2-g]-quinoline-2,8-dicarboxylic acid (a) Methyl~9-ethyl-5,9-dihydro-2-methyl-4,6-dioxo-10-: propyl-4H-pyrano[3,2-~]quinoline-8-carboxylate 6-Acetyl-l-ethyl-7-hydroxy-4(:LH)-oxo-8-propylquinoline-~ 2-carboxylic acid (3.15g) was dissolved in dry dimethyl--~ 15 formamide (SOml) containing washed sodium hydride ~1.05g) and then ethyl acetate (4.4g) was introduced. After stirring overnight gaseous hyarogen chloride was passed into the mixture with ice cooling until saturated. The mixture was warmed to 75C for 8 hours, then cooled, ``- 20 poured into water and the mixture was extracted with ethyl acetate. The organic phase was dried and evaporated and the residue was chromatographed (SiO2/ethyl acetate) to provide the sub-title compound (0.8g). The structure was con~irmed by n.m.r. and mass spectroscopy.
.
, . . .
,.,. , ,,' .
4245/74 - ~5 Ib) g-~thyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano-8-dicarboxylic ac_d The product of step (a) (0.75g) was heated under reflux with selenium dioxide (1.5g) in glacial acetic acid (50ml) for 48 hour~. Filtration through "Celite" afforded a clear filtrate which was treated with concentrated `~ hydrochloric adid (25ml) and heated under reflux for 12 hours. On cooling and pouring into water a precipitate was obtained (0.19) which was identical to the product of Example 2 by thin layer chromatographic comparison.
Example 19 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-py ano[3,2-g]-quinoline-2,8~dicarboxylic acid (a) N-[3-(1,2-dicarboxyethenYloxy~-2~propYlphenyl~-N-ethYl-2-amino-but-2-ene-1,4-dioic acid 3-Ethylamino-2-propylphenol (17.99), dimethyl acetyl-enedicarboxylate (359~, potassium hydroxide (0.569), water (50ml) and ethanol (lOOml) were heated under reflux for 24 hours. Potassium hydroxide (1.659) was added and reflux-ing was continued for another 24 hours.
Concentrated hydrochloric acid (4ml) was added and the solvent was evaporated. The residue was dried in vacuo and extracted into ether. The ether was evaporated to afford the sub-title compound (3069). The structure was confirmed by n.m.r. and mass spectroscopy~
~ 65 ;..~, ~2~g ~24S/7~ ~ 66 (b) 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-~yrano-_ 2-g]quinoline 2,8-dicarboxylic acid The product of step ~a) (3.55g) was added in small portions to chlorosulphonic acid (lOOml) cooled to -78C
with stirring. The solution was allowed to warm slowly to room temperature and was then warmed to 50C for 1 hour~ The reaction mixture was cautiously poured onto ice (1 litre) and extracted into ethyl acetate. After drying f the ethyl acetate was evaporated and the residue was separated by high pressure liquid chromatography to afford the title compound ~0.2g) chromatographically idential to the product of Example 2.
~; Example 20 9-Ethyl-6,9-dihydro-4,6-dioxo-lO-~propyl=4H~pyrano[3-2--~]
~uinoline-2,8-dicarboxylic acid (a) l-Ethyl-6-(3-carboxy-3-diethy]amino-1-oxo-prop-2-enyl)-1,4-dihydro-7-hYdroxy-4-oxo-8-propylquinoline-2 carboxylic .
acid 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano-[3,2-g~quinoline-2,8-dicarboxylic acid (lg) and diethyl-amine (5ml) were heated together in an autoclave for 12 hours at 100C, then the volatile materials were evapor-ated at 60C. The residue was triturated with ether to afford the sub-title compound (0.78g). Structure was 25 confirmed by n.m.r. and mass spectroscopy.
.. .. .
~3 :
,`. `.... : :
., .... ,`
,,.. ` . . .,` . ~ .
~245/74 - 67 (b) 9-Ethyl-6,9 dihydro-4,6-dioxo-lO-propyl-4H-pyrano-[3,2-g]quinoline-2,8-dicarboxylic acid The product of step (a) (0.77g) was suspended in ethanolic hydrogen chloride (20ml) and heated under reflux for 24 hours. Evaporation of the solvent aEEorded a residue which was separated by high pressure liquid chromatography to give the title compound (0.2g) which was chromatographically identical to the product of Example 2.
~;~ Example 21 9-Ethyl-6,9-dihydro-4,6-di_xo-'0-pro~yl-4H-pyrano-L3,2-~3quinoline-2,8-d carboxylic acid (a) Dieth~1_9-eth~1-6,9-dihydro-10-propyl-4,6-dithioxo-4H-py~ano~3,2-g]quinoline-2,8-dicarboxylate Diethyl 9-ethyl-6,9-dihydro-4,6-dioxo-lO~propyl-4M-pyrano[3,2-g]quinoline-2,8-dicarboxylate (lOg) and penta-phosphorus decasulphide (20g) were fused together at 160C for 6 hours, then cooled and the product mixture was extracted into ethyl acetate. Chromatography (silica gel/ethyl acetate) afforded the sub-title compound (5.6g). The structure was verified by n.m.r. and mass spectroscopy.
(b) 9-EthYl-6,9-dihydro~4,6-dioxo-lO-propyl-4H-pyrano-[3,2-g]quinoline-2,8-dicarboxylic acid The diester from step (a) was heated at 100C in glacial acetic acid (50ml) containing concentrated hydro-.. . .
,~
, ; :: , : - .
.. ..
4245/74 ~ 68 ~ ~ ~ Z ~ ~ ~
chloric acid (5ml~ for 24 hours. The acetic acid solvent was evaporated and the residue was triturated with ether.
The solid residue was dissolved in acetonitrile 150ml) containing water (lml), and was stirred vigorously with mercuric cnloride (2g). After 48 hours the solution was filtered, and the filtrate was diluted with water (250ml) and then acidified. The precipitated solid was purified by high pressure liquid chromatography to afford the title compound (2.1g~ which was chromatographically identical with the product of Example 2.
Example 22 . , 9-Ethyl-6,9 dihydro-4,6-dioxo-10-propyl-4H-pyrano[3,2-g)- ~;
., .
quinoline~2,8-dicarboxylic acid - (a) 9-Ethyl-2,3,6,9-tetrahydro-4,6-dioxo-10-propyl- H-pyrano~3,2-g]quinoline-2L8-dicarboxylic acid Diethyl 6,9-dihydro-4,6-dioxo~10-propyl-4H-pyrano-[3,2-glquilloline-2~8-dicarboxylate (5g) in glacial acetis acid (lOOml) was hydrogenated over Adams catalyst (0~5g) at 4 atmospheres until hydrogen uptake ceased. The catalyst was removed and concentrated hydrochloric acid (5ml) was added~ The solution was refluxed for 24 hours then evaporated. High pressure liquid chromatography of the residue gave the sub-title compound (0.9g). The structure was supported by n.m.r. and mass spectroscopy.
., :: -:.,: : . ,~
4245/74 ~ 69 r (b) 9-Ethyl-5,9~dihydro-4,G-dioxo-10-pro~yl-4H-pvrano-[3,2-g~quinoline-2,8-dicarboxylic acid .. .
- The product of step (a) (0.85y~ was suspended in cymene (lOml) and treated with 10~ Pd/C catalyst at reflux for ~ hours. Filtration and evaporation afforded a gum which was purified by high pressure liquid chromatography ; to give the title compound (0.15g) chromatographically identical wlth the product of Example 2.
Example 23 9-Ethyl-6,9-dihydro 4,6-dioxo-10-propyl-4H-pyrano[3,2-g]-quinoline-2,8-dicarboxylic acid .
(a3 1-Ethyl-1,4-dihydro-7-hy_r_xy-6-methoxycarbonyl-4-oxo-8-eropylquinoline-2-carboxylic acid Diethyl 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano[3,2-gJquinoline-2,8-dicarboxylate (4.279) and sodium hydroxide (1.69) in water (lOml) were heated to reflux for 24 hours, then the`water was evaporated and the residue was suspended in ethanol (SOml) saturated with hydrogen chloride gas and refluxed for 1 hour. Evaporation of the solvent afforded a residue which was chromato-graphed (silica gel/ether) to afford a diester (1.3g) which was boiled with a solution of sodium hydroxide (0.139g) in water (20ml). On acidification a precipitate wa~ formed which was shown to be the desired product (0.93g) by n.m.r. and mass spectroscopy~
~ 69 ~ ' .. ~
,: ''-'" ''' -' ~ , 6~
~245/74 - 7~ -, (b) 9-Ethyl-6,9-dihydro-4,6-dioxo-10-pro~yl~4H-pyrano-[3,2 glquinoline-2,8-dicarboxYlic acid .-- , The product of step ~aj (0.9g) dissolved in dry di-~ methyl sulphoxide (lOml) was added to a solution of dimsyl `~ 5 sodium (lg) in dry dimethul sulphoxide (50ml) at 40C
under N2. After 48 hours the reaction mixture was poured into water (500ml) and ether extracted. Drying and evaporation afforded a red oil which was suspended in toluene (20ml) and treated with piperidine (l.lg) and gly-;~ 10 oxylic acid hydrate (1.5g). After refluxing for 5 hours, the mixture was cooled, poured into ethyl acetate (lOOml) and washed with saturated sodium bicarbonate solution.
The sodium bicarbonate solution was acidified and extrac- -ted with ethyl acetate. Drying and evaporation gave a gum which was separated by high pressure liquid chromatography to yive the title compound (0.139) ~hich was identical chromatographically to the product of Example 2.
Example 24 9-Ethyl-10-propyl-2,3-di-tetrazol 5-yl-4H-pyrano[3,2-~]~
quinoline-4_6(9~)-dione (a~ 9-Ethy_ 6,9-dihyd o-4/6-dioxo-10-propyl-4H-pyrano-[3,2-g]quinoline-2/8-dlcarbonitrile 9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano-13,2-g]quinoline-2,8-dicarbonyl chloride (lOg) was added dropwise to cooled aqueous ammonia solution (lOOml) with ~ 7~
.. . ~ . ~
.~
stirring. The insoluble material ~as collected and washed well with water, then dried ln vacuo at 80C.
The solid was added to a solution of phosphoryl chloride (209) in dry dimethyl formamide (lOOml) and warmed to 60C for 48 hours. The reaction mixture was cooled and poured into water (1 litre), and extracted into ether. Drying and evaporation afforded an oil which was chromatographed (silica gel/ether) to afford the sub-title compound ~3.79). The structure was supported by n.m.r.
and mass spectroscopyO
(b) 9-Ethyl-10-propyl-2,8-di-tetrazol-5-yl-4H-Pyrano-; [3,2-g]quinoline-4,6(9H)-dione The product of step (a) t3.6g~ and ammonium azide (1.3g) in dry dimethyl formamide (lOOml) were heated to 140C for 16 hours then cooled ancl poured into water.
On acidification a precipitate was obtained which was chromatographed (silica gel~ethyl acetate) to produce the title compound ~1.69).
NMR ~DMSO: 1.0(3H,t); 1.1(3XIt); 1.8(2X,m); 3.8(2EI,m);
4.5(2H,m); 7.1(1H,s~; 8.65(1H,s); 8.8(1H,s); 10.1(2Hbrs).
'~ ' `
Claims (11)
PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:-
1. A process for the production of a compound of formula I, I
in which an adjacent pair of R5, R6, R7 and R8, form a chain -OOCH=CE-O-, and the remainder of R5, R6, R7 and R8, which may be the same or different, each represent hydrogen, hydroxy, alkyl, halogen, alkenyl, alkoxy, or -NR1R2 in which R1 and R2, which are the same or different, are each hydrogen or alkyl, Rg is hydrogen, alkyl, alkenyl or phenyl-alkyl, and E is -COOH, a 5-tetrazolyl group or an (N-tetrazol-5-yl) carboxamido group, or a pharmaceutically acceptable derivative thereof, which comprises, (a) producing a compound of formula I in which E is -COOH by selectively hydrolysing or oxidising a compound of formula II, II
in which Rg is as defined above, R5a, R6a, R7a and R8a have the same significances as R5, R6, R7 and R8 above, save than an adjacent pair of R5a, R6a, R7a and R8a may represent a chain of formula -COCH=C(D1)O-, and one or both of D and D1 represents a group hydrolysable or oxidisable to a -COOH group, and the other may represent a -COOH
group, (b) producing a compound of formula I in which E is -COOH by cyclising a compound of formula III or IV, III
IV
or an ester of either thereof, in which Rg is as defined above, R5b, R6b, R7b and R8b have the same significances as R5, R6, R7 and R8 above, save that an adjacent pair of R5b, R6b, R7b and R8b may represent the pair of groups -H and -O-C(COOH)=CH-COOH, (c) producing a compound of formula I in which E is -COOH by cyclising a compound of formula V, V
or an ester thereof, in which Rg is as defined above, R5c,R6c,R7c, and R8c have the same significances as R5,R6, R7 and R8 above save that an adjacent pair of R5c,R6c,R7c and R8c, instead of forming a chain -COCH=C(COOH)-O-, represent the pairs of groups:
(i) -COCH2CO-COR" or -COCH=C(COOH)-NL1L2, or a suitable derivative therof; and -OM or a halogen atom, or (ii) -H and -O-C(COR")=CH-COR"
R" represents -OM, or a group which is hydrolysable thereto, L1 and L2 which may be the same or different are each hydrogen, aryl or alkyl, or together form a saturated or unsaturated alkylene chain, and M represents hydrogen or an alkali metal, and if necessary or desired hydrolysing the group -COR", to a group -COOM, (d) conversion of a compound of formula VI, VI
or an ester thereof, m which Rg and E are as defined above, R5d, R6d, R7d and R8d have the same significances as R5, R6, R7 and R8 above save that an adjacent pair of R5d, R6d, R7d and R8d may represent the chain -C(R9R10)CH=CE-O-, at least one of the pairs of groups Rg and R10 together form =S or together form an -S(CH2)nS- chain in which n is 2 or 3, and the other pair Rg, R10 may represent=O, to a corresponding compound of formula I, (e) selectively removing the groups A and B from a compound of formula VII, .
VII
or an ester thereof, in which Rg and E are as defined above, R5e, R6e, R7e and R8e have the same significances as R5, R6, R7 and R8 above save that an adjacent pair of R5e, R6e, R7e and R8e may represent a chain -COCHA-CBE-O-, in at least one of the pairs of groups A and B both A and B
are hydrogen, or one of A and B is hydrogen and the other is halogen or hydroxy, and the other pair A, B may together form a double bond, (f) producing a compound of formula I in which E is -COOH by cyclising a compound of formula VIII, VIII
or an ester thereof, in which Rg is as defined above, R5f, R6f, R7f and R8f have the same significances as R5, R6, R7 and R8 above save that an adjacent pair of R5f, R6f, R7f and R8f, instead of forming a chain -COCH=C(COOH)-O-, represent the pair of groups -COCH(SOR10)-CH(OH)-COOR" and -OM, R" and M are as defined above, and R10 represents an alkyl C 1 to 10 group, (g) producing a compound of formula I in which E is a 5-tetrazolyl group by reacting a corresponding compound of formula I in which E
is -CN, with an azide in a solvent which is inert under the reaction conditions, (h) producing a compound of formula I in which E is an (N-tetrazol-5-yl)carboxamido group by reacting a corresponding compound of formula I in which E is -COOH, or an acid halide, ester or mixed anhydride thereof, with 5-aminotetrazole, or (i) producing a pharmaceutically acceptable salt of a compound of formula I, by treating a compound of formula Ic, Ic in which Rg is as defined above, R5j, R6j, R7j and R8j have the same significances as R5, R6, R7 and R8 above, save that an adjacent pair of R5j, R6j, R7j and R8j may form a chain -O-C(X)-CHCO-, and X is a 5-tetrazolyl group, an (N-tetrazol-5-yl) carboxamido group, a carboxylic acid group (or an ester thereof, or another salt thereof), a nitrile group, an acid halide group or an amide group, with a compound containing an available pharmaceutically acceptable cation and capable of converting the group X to a pharmaceutically acceptable salt of group E, and if necessary or desired hydrolysing the ester of the compound of formula I and/or converting the compound of formula I
to a pharmaceutically acceptable derivative thereof.
in which an adjacent pair of R5, R6, R7 and R8, form a chain -OOCH=CE-O-, and the remainder of R5, R6, R7 and R8, which may be the same or different, each represent hydrogen, hydroxy, alkyl, halogen, alkenyl, alkoxy, or -NR1R2 in which R1 and R2, which are the same or different, are each hydrogen or alkyl, Rg is hydrogen, alkyl, alkenyl or phenyl-alkyl, and E is -COOH, a 5-tetrazolyl group or an (N-tetrazol-5-yl) carboxamido group, or a pharmaceutically acceptable derivative thereof, which comprises, (a) producing a compound of formula I in which E is -COOH by selectively hydrolysing or oxidising a compound of formula II, II
in which Rg is as defined above, R5a, R6a, R7a and R8a have the same significances as R5, R6, R7 and R8 above, save than an adjacent pair of R5a, R6a, R7a and R8a may represent a chain of formula -COCH=C(D1)O-, and one or both of D and D1 represents a group hydrolysable or oxidisable to a -COOH group, and the other may represent a -COOH
group, (b) producing a compound of formula I in which E is -COOH by cyclising a compound of formula III or IV, III
IV
or an ester of either thereof, in which Rg is as defined above, R5b, R6b, R7b and R8b have the same significances as R5, R6, R7 and R8 above, save that an adjacent pair of R5b, R6b, R7b and R8b may represent the pair of groups -H and -O-C(COOH)=CH-COOH, (c) producing a compound of formula I in which E is -COOH by cyclising a compound of formula V, V
or an ester thereof, in which Rg is as defined above, R5c,R6c,R7c, and R8c have the same significances as R5,R6, R7 and R8 above save that an adjacent pair of R5c,R6c,R7c and R8c, instead of forming a chain -COCH=C(COOH)-O-, represent the pairs of groups:
(i) -COCH2CO-COR" or -COCH=C(COOH)-NL1L2, or a suitable derivative therof; and -OM or a halogen atom, or (ii) -H and -O-C(COR")=CH-COR"
R" represents -OM, or a group which is hydrolysable thereto, L1 and L2 which may be the same or different are each hydrogen, aryl or alkyl, or together form a saturated or unsaturated alkylene chain, and M represents hydrogen or an alkali metal, and if necessary or desired hydrolysing the group -COR", to a group -COOM, (d) conversion of a compound of formula VI, VI
or an ester thereof, m which Rg and E are as defined above, R5d, R6d, R7d and R8d have the same significances as R5, R6, R7 and R8 above save that an adjacent pair of R5d, R6d, R7d and R8d may represent the chain -C(R9R10)CH=CE-O-, at least one of the pairs of groups Rg and R10 together form =S or together form an -S(CH2)nS- chain in which n is 2 or 3, and the other pair Rg, R10 may represent=O, to a corresponding compound of formula I, (e) selectively removing the groups A and B from a compound of formula VII, .
VII
or an ester thereof, in which Rg and E are as defined above, R5e, R6e, R7e and R8e have the same significances as R5, R6, R7 and R8 above save that an adjacent pair of R5e, R6e, R7e and R8e may represent a chain -COCHA-CBE-O-, in at least one of the pairs of groups A and B both A and B
are hydrogen, or one of A and B is hydrogen and the other is halogen or hydroxy, and the other pair A, B may together form a double bond, (f) producing a compound of formula I in which E is -COOH by cyclising a compound of formula VIII, VIII
or an ester thereof, in which Rg is as defined above, R5f, R6f, R7f and R8f have the same significances as R5, R6, R7 and R8 above save that an adjacent pair of R5f, R6f, R7f and R8f, instead of forming a chain -COCH=C(COOH)-O-, represent the pair of groups -COCH(SOR10)-CH(OH)-COOR" and -OM, R" and M are as defined above, and R10 represents an alkyl C 1 to 10 group, (g) producing a compound of formula I in which E is a 5-tetrazolyl group by reacting a corresponding compound of formula I in which E
is -CN, with an azide in a solvent which is inert under the reaction conditions, (h) producing a compound of formula I in which E is an (N-tetrazol-5-yl)carboxamido group by reacting a corresponding compound of formula I in which E is -COOH, or an acid halide, ester or mixed anhydride thereof, with 5-aminotetrazole, or (i) producing a pharmaceutically acceptable salt of a compound of formula I, by treating a compound of formula Ic, Ic in which Rg is as defined above, R5j, R6j, R7j and R8j have the same significances as R5, R6, R7 and R8 above, save that an adjacent pair of R5j, R6j, R7j and R8j may form a chain -O-C(X)-CHCO-, and X is a 5-tetrazolyl group, an (N-tetrazol-5-yl) carboxamido group, a carboxylic acid group (or an ester thereof, or another salt thereof), a nitrile group, an acid halide group or an amide group, with a compound containing an available pharmaceutically acceptable cation and capable of converting the group X to a pharmaceutically acceptable salt of group E, and if necessary or desired hydrolysing the ester of the compound of formula I and/or converting the compound of formula I
to a pharmaceutically acceptable derivative thereof.
2. A process according to part (a) of Claim 1, wherein the group D is an ester, amide or nitrile group and the hydrolysis is carried out under mildly basic or under acidic conditions.
3. A process according to part (b) or (c)(ii) of Claim 1, wherein the reaction is carried out under anhydrous conditions and in the presence of a dehydrating agent.
4. A process according to part (c)(i) of Claim 1, wherein a group -OM is present and the cyclisation is carried out under acidic conditions at a temperature of from 20° to 150°C.
5. A process according to any one of Claims 1, 2 or 4 wherein each of R5, R6, R7 and R8, when they contain carbon, contain up to 8 carbon atoms.
6. A process according to any one of Claims 1, 2 or 4, wherein each of R5, R6, R7 and R8, when they contain carbon, contain up to 4 carbon atoms.
7. A process according to any one of Claims 1, 2 or 4, wherein R5, R6, R7 and R8 are selected from hydrogen, methoxy, propyl, allyl, methyl, ethyl, chlorine, bromine and hydroxy.
8. A process according to any one of Claims 1, 2 or 4 wherein E
is -COOH.
is -COOH.
9. A process according to any one of Claims 1, 2 or 4, wherein the -COCH=CE-O- chain is bonded in positions R6 and R7, the -O-part of the chain being in position R7.
10. A process according to any one of Claims 1, 2 or 4, wherein the compound of formula I is 4,6-Dioxo-10-propyl-4H,6H-pyrano[3,2-g] quinoline-2,8-di-carboxylic acid, or 4,6-Dioxo-1-ethyl-10-propyl-4H,6H-pyrano[3,2-g]quiinoline-2,8-dicarboxylic acid.
Claims Supported by the Supplementary Disclosure
Claims Supported by the Supplementary Disclosure
11. A process according to any one of Claims l, 2 or 4, wherein the compound of formula I is 7-Ethyl-4,10-dioxo-4H,10H-pyrano[2,3-f]quinoline-2,8-dicarboxylic acid, 9-(3-Methylbutyl)-4,6-dioxo-4H,6H-pyrano[3,2-g]-quinoline-2,8-dicarboxylic acid, 7-(3-Methylbutyl)-4,10-dioxo-4H,10H-pyrano[2,3-f]-quinoline-2,8-dicarboxylic acid, 5-Methoxy-4,7-dioxo-4H,7H-pyrano[3,2-h]quinoline-2,9-dicarboxylic acid, 4,6-Dioxo-10-(prop-2-enyl)-4H,6H-pyrano[3,2-g]quinoline-2,8-dicarboxylic acid, 4,10-Dioxo-4H,10H-pyrano[2,3-h]quinoline-2,8-dicarboxylic acid, 10-Hydroxy-1-oxo-1H-pyrano[3,2-f]quinoline-3,8-dicarboxylic acid, 10-Methyl-4,6-dioxo-4H,6H-pyrano[3,2-g]quinoline-2,8-dicarboxylic acid, 6-Amino-7,10-dihydro-5-methoxy-4,7-dioxo-4H-pyranoo-[3,2-h]-quinoline-2,9-dicarboxylic acid, 10-Bromo-6,9-dihydro-4,6-dioxo-4H-pyrano[3,2-g]-quinoline-2,8-dicarboxylic acid, N,N'-Di-(tetrazol-5-yl)-9-(but-3-enyl)-6,9-dihydro-4-oxo-10-propyl-4H-pyrano[3,2-g]quinoline-2,8-dicarboxamide, or 9-Ethyl-10-propyl-2,8-di-tetrazol-5-yl-4H-pyrano[3,2-g]-quinoline-4,6(9H)-dione.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB18597/77 | 1977-05-04 | ||
| GB1859777 | 1977-05-04 | ||
| GB45865/77 | 1977-11-04 | ||
| GB4586577 | 1977-11-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1112644A true CA1112644A (en) | 1981-11-17 |
Family
ID=26253475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA302,479A Expired CA1112644A (en) | 1977-05-04 | 1978-05-02 | Dioxopyranoquinoline dicarboxylic acid derivatives |
Country Status (16)
| Country | Link |
|---|---|
| JP (2) | JPS53137969A (en) |
| AU (1) | AU520816B2 (en) |
| CA (1) | CA1112644A (en) |
| CH (1) | CH634071A5 (en) |
| DE (1) | DE2819215A1 (en) |
| DK (1) | DK158266C (en) |
| ES (1) | ES469391A1 (en) |
| FR (1) | FR2389627B1 (en) |
| IE (1) | IE47051B1 (en) |
| IL (2) | IL54614A (en) |
| IT (1) | IT1158699B (en) |
| LU (2) | LU79579A1 (en) |
| NL (2) | NL184896C (en) |
| NO (1) | NO154497C (en) |
| NZ (1) | NZ187156A (en) |
| SE (2) | SE443561B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4760072A (en) * | 1984-04-13 | 1988-07-26 | Fisons, Plc | Solid nedocromil sodium, useful for the removal of obstructed air pathways |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2440371A1 (en) * | 1978-10-31 | 1980-05-30 | Fisons Ltd | NOVEL HETEROCYCLIC NITROGEN COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND METHODS FOR PREPARING THE SAME |
| ATE11774T1 (en) * | 1979-12-07 | 1985-02-15 | Fisons Plc | PROCESSES FOR THE PREPARATION OF 1,4-DIHYDRO-4-OXO-QUINOLINE-2-CARBONIC ACIDS OR SALTS, ESTERS OR AMIDES THEREOF AND INTERMEDIATE COMPOUNDS THEREOF. |
| DE3787274T2 (en) * | 1986-12-23 | 1994-01-27 | Fisons Plc | Pharmaceutical preparations containing an aqueous solution of a pyranoquinoline. |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2054503A1 (en) * | 1969-07-18 | 1971-04-23 | Bellon Labor Sa Roger | 1, 4-dihydro-4-oxo quinolyl-3-carboxylic aci |
-
1978
- 1978-05-01 IL IL54614A patent/IL54614A/en unknown
- 1978-05-02 CA CA302,479A patent/CA1112644A/en not_active Expired
- 1978-05-02 IT IT7822918A patent/IT1158699B/en active Protection Beyond IP Right Term
- 1978-05-02 DE DE19782819215 patent/DE2819215A1/en active Granted
- 1978-05-02 DK DK190178A patent/DK158266C/en not_active IP Right Cessation
- 1978-05-02 NO NO781549A patent/NO154497C/en unknown
- 1978-05-02 JP JP5240778A patent/JPS53137969A/en active Granted
- 1978-05-03 AU AU35731/78A patent/AU520816B2/en not_active Expired
- 1978-05-03 FR FR7813169A patent/FR2389627B1/fr not_active Expired
- 1978-05-03 NZ NZ187156A patent/NZ187156A/en unknown
- 1978-05-03 NL NLAANVRAGE7804749,A patent/NL184896C/en not_active IP Right Cessation
- 1978-05-03 ES ES469391A patent/ES469391A1/en not_active Expired
- 1978-05-03 IE IE890/78A patent/IE47051B1/en not_active IP Right Cessation
- 1978-05-03 SE SE7805105A patent/SE443561B/en not_active IP Right Cessation
- 1978-05-03 CH CH482978A patent/CH634071A5/en not_active IP Right Cessation
- 1978-05-03 LU LU79579A patent/LU79579A1/en unknown
-
1980
- 1980-12-30 IL IL61826A patent/IL61826A0/en unknown
-
1986
- 1986-06-02 SE SE8602492A patent/SE463920B/en not_active IP Right Cessation
-
1988
- 1988-12-22 JP JP63322239A patent/JPH01199909A/en active Pending
-
1993
- 1993-06-03 LU LU88281C patent/LU88281I2/en unknown
- 1993-06-09 NL NL930050C patent/NL930050I2/en unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4760072A (en) * | 1984-04-13 | 1988-07-26 | Fisons, Plc | Solid nedocromil sodium, useful for the removal of obstructed air pathways |
| EP0162556B1 (en) * | 1984-04-13 | 1991-11-06 | FISONS plc | Novels forms and formulations of nedocromil sodium |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0264586B1 (en) | Hydantoin derivatives for treating complications of diabetes | |
| US4474787A (en) | 7,6 Dioxo-4H,6H-pyrano[3,2-g]quinoline dicarboxylic acids and anti-allergic use thereof | |
| HK20585A (en) | Pyranoquinolinones | |
| Hauser et al. | A new procedure for regiospecific syntheses of benzopyran-1-ones | |
| CA1300626C (en) | Dihydropyridine compounds, processes for their preparation and their use | |
| CA1112644A (en) | Dioxopyranoquinoline dicarboxylic acid derivatives | |
| Brimble et al. | Synthesis of the cis-3a, 8b-dihydrofuro [3, 2-b] benzofuran-2 (3 H)-one ring system via a furofuran annulation to activated benzoquinones | |
| CA1327202C (en) | Substituted 1,3,4,9-tetrahydropyrano ¬3,4-b|indole-1-acetic acids | |
| Burke et al. | The structure of cleomeolide, an unusual bicyclic diterpene from Cleome viscosa L.(Capparaceae) | |
| US4698345A (en) | Quinoline derivatives and their use as anti-asthmatic agents | |
| HU228986B1 (en) | Process to produce 4-hydroxy-2-oxo-pyrane derivatives useful as protease inhibitors | |
| Bongui et al. | Synthesis and cytotoxic activity of acronycine analogues in the benzo [c] pyrano [3, 2-h] acridin-7-one and naphtho [1, 2-b][1, 7] and [1, 10]-phenanthrolin-7 (14H)-one series | |
| Morel et al. | New coumarins from Mesua racemosa: Isolation and synthesis | |
| CN1015710B (en) | Preparation method of clausenamide | |
| US4427686A (en) | Pharmacologically active benzopyranotriazole compounds | |
| EP0150966B1 (en) | Benzopyran derivatives, compositions containing them and processes for their preparation | |
| EP0094769A1 (en) | Preparing 7-alkoxybenzofurans and intermediates used therein | |
| Anderson et al. | Vinylogous carbinolamine tumor inhibitors. 14. 1, 3-dipolar cycloaddition reactions with tetrafluoroborate and trifluoromethanesulfonate salts of 1, 2-dihydro-and 1, 2, 3, 4-tetrahydroquinoline reissert compounds | |
| Narkhede et al. | Synthesis of (±)-neorautane | |
| Mbala et al. | Investigation towards an efficient synthesis of benzo [g] isoquinoline-1, 5, 10 (2H)-triones | |
| Martı́nez et al. | From Phenylacetylphenylacetic Acids and 1-Benzylisoquinolines to 6, 11-Dihydrobenzo [b] naphtho [2, 3-d] furan-6, 11-diones, 6H-Dibenzo [c, h] chroman-6-ones and 7, 12-Dihydro-5H-dibenzo [c, g] chroman-5, 7, 12-triones via 2-Phenyl-3-hydroxy-1, 4-dihydro-1, 4-naphthalenediones or 2-Phenyl-1-naphthols | |
| EP0008610B1 (en) | Furonaphthyridine compounds, process for their preparation and pharmaceutical compositions containing them | |
| EP0003084B1 (en) | Spirobenzofuranone compounds, processes for their preparation and their use as medicines | |
| US4228173A (en) | Thiopyrano-benzopyrans, compositions and method of use thereof | |
| CA1250584A (en) | Benzopyrans |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |